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ABSTRACT 
The initiation of protein biosynthesis is heavily-regulated and is considered the rate- 
limiting step. There are multiple mechanistically distinct modes for the translation of mRNA 
codons into protein. All modes of translation initiation, however, require coordinated 
manipulation of the ribosome through stimulation of eukaryotic translation initiation factors 
(eIFs), interaction with the ribosome, or a combination of the two. Most eukaryotic translation 
is directed by a modified nucleotide “cap” at the 5’ terminus of an mRNA. This structure is 
recognized by eIFs that direct the mRNA to the small ribosome subunit (40S), select the 
proper start codon, promote methionine delivery by the initiation-specific tRNA (Met- 
tRNAiMet), and finally recruit the large ribosome subunit (60S) for the formation of mature 
ribosome (80S). This process typically requires at least 12 eIFs. 
Translation initiation can be directed without some, or all, of the eIFs. This can be 
accomplished by internal ribosome entry sites (IRESs) which are highly structured RNAs 
that bind to eIFs or the ribosome and direct translation without a 5’ cap or the cap-binding 
protein, eIF4E. One such IRES controls translation of hepatitis C virus (HCV), which binds 
directly to the ribosome and requires only three eIFs to recruit the IRES (eIF3), promote 
stable binding of Met-tRNAiMet (eIF2), and deliver of the 60S (eIF5B). The HCV IRES is the 
archetype of a group of similar RNAs that belong to a diverse set of RNA viruses. These 
RNAs have been well-studied and their mechanism of action is well cataloged in vitro. 
There are discrepancies in the model of HCV-like IRES function in a cellular 
environment, rather than in vitro. This problem has been investigated over the last decade, 
though no clear answer has been reached. I have used cell- and lysate-based translation 
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assays, specialized ribosome purification strategies, and protein and RNA biochemistry to 
determine that the discrepancies in cellular and in vitro IRES function can be reconciled by 
the substitution of eIF2 with eIF1A during manipulation of tRNAiMet on preinitiation 
complexes (PICs). HCV-like IRES-mediated translation directed by only eIF3, 1A, and 5B is 
bacterial-like and strengthens the observation of trans-domain translation mechanisms in 
eukaryotes. 
The form and content of this abstract are approved. I recommend its publication. 
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MANIPULATION OF TRANSLATION INITIATION COMPLEXES 
The initiation step in translation is a highly coordinated, multi-step pathway that is 
centered on the placement of mRNA on the small ribosome subunit (40S), the identification 
of a start codon and open reading frame (ORF), and the successful joining of the large 
ribosome subunit (60S) to the bound 40S subunit-containing complex (Figure 1). After 
ribosome subunits have joined, the fully assembled ribosome (80S) can then proceed to the 
elongation step of translation, which is the processive decoding of the nucleotide triplets 
(codons) that code the ORF by the recognition of specific adapter molecules, aminoacylated 
tRNAs (aa-tRNAs), on the ribosome. After traversing the ORF, recognition of a stop codon 
leads to ribosome disassembly and the subunits are subsequently recycled to be used in 
another round of translation. 
The focus of this dissertation will be the understanding of a particularly important 
type of translation initiation used by a viruses in two pervasive viral families. The public and 
agricultural health consequences of many viruses that manipulate translation are of obvious 
general interest; my specific focus revolves around the lessons about fundamental aspects 
of translation initiation that we can learn from studying them. In this introductory chapter, I 
will first discuss translation initiation as it is currently understood, then I will discuss some 
focal points in the initiation pathway where specific regulatory pathways can enact control 
that leads to the repression of most translation within a cell during such conditions as viral 
infection or cellular stress. I will then frame the formation of translation initiation complexes 
within the translation cycle with specific emphasis on the function of an essential initiation 
factor. I will provide examples of specific ways viruses circumvent translation regulation or 
the canonical pathways by the use of structured RNAs that manipulate components of the 
translation machinery. Finally, I will introduce the specific viral internal ribosome entry site 
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(IRES) RNA structures that are the focus of my research, and I will close by presenting the 
key questions that formed the overarching goals of my dissertation work. 
 
Cap- and Scanning-Dependent Translation Initiation 
The initiation step of translation in eukaryotes is considered the rate limiting step. 
The majority of eukaryotic mRNAs are translated through a cap- and scanning-dependent 
mechanism that is significantly more complex than bacterial translation initiation (reviewed in 
(Jackson et al., 2010, Hinnebusch and Lorsch, 2012, Aitken and Lorsch, 2012)). In bacteria, 
the lack of a nuclear compartment allows for the spatial coupling of RNA transcription and 
translation (Antoun et al., 2006, Laursen et al., 2005). In contrast, eukaryotic transcription 
and translation are decoupled through nuclear processing and export (Wickramasinghe and 
Laskey, 2015). Instead of mRNAs being polycistronic (as in bacteria), eukaryotic mRNAs are 
primarily monocistronic. In bacteria, the start of an ORF is defined by a specific base-pairing 
event between the message and the 16S rRNA on the small bacterial subunit (30S) (Shine 
and Dalgarno, 1975), while in eukaryotes the ORF is identified by a 5’ to 3’ “search” for 
appropriate start sites within the mRNA (Kozak, 1978). These fundamental differences lay 
the groundwork for many additional layers of regulation in eukaryotes that are not present or 
not necessary in bacteria. Although there are examples of specific regulation of initiation in 
bacteria, the majority of translation is limited only by the rate of gene transcription and the 
local concentration of the translation components. Eukaryotic translation is interesting in that 
most steps in the complicated initiation process have been shown to be regulated in some 
fashion through a variety of mechanisms (Sonenberg and Hinnebusch, 2009). The high 
order of regulation certainly complicates the study of certain aspects of translation initiation, 
but also offers a remarkable spectrum of possibilities that have evolved in the billions of 
years since the divergence of bacteria and eukaryotes. 
Three general, and essential, steps must occur for any message to be poised to 
have its ORF decoded by the translation machinery. These three steps are required in 
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bacteria as well as eukaryotes, but are accomplished through very distinct pathways. First, a 
mature mRNA must be acquired by a small ribosome subunit either by base-pairing in 
bacteria (Shine and Dalgarno, 1975), or by a multi-protein complex in eukaryotes (Gross et 
al., 2003). Second, a methionine-linked initiation-specific tRNA structurally adapted for 
binding to the P-site of the ribosome (Met-tRNAiMet, formyl-(f)Met-tRNAifMet in bacteria), must 
be placed in the decoding groove of the small ribosomal subunit either by direct tRNA 
binding enhanced by initiation factors in bacteria (Wu and RajBhandary, 1997, Seong and 
RajBhandary, 1987), or by a specialized initiation factor in eukaryotes (Farrell et al., 1977). 
Third, the large ribosome subunit must be recruited to the initiation complex and 
successfully adjoined to the small subunit (Gualerzi et al., 1991, Pestova et al., 2000). 
As alluded to above, in eukaryotes these steps proceed through a fairly complex 
pathway. Mature eukaryotic mRNAs that have been successfully transcribed from DNA 
(Shandilya and Roberts, 2012), capped (Ramanathan et al., 2016), spliced (Pandya-Jones, 
2011), polyadenylated (Proudfoot, 2011), and processed for nucleocytoplasmic transport are 
delivered to the 40S by the concerted action of a multisubunit “cap-binding” complex. This 
complex, called eukaryotic initiation factor (eIF) 4F, is composed minimally of three subunits 
with a fourth and fifth often present. The body of the complex is composed of an 
approximately 200 kDa (it exists in multiple isoforms in most organisms) factor eIF4G that 
serves as a scaffold that interacts with the specific cap-binding protein eIF4E and the ATP- 
dependent RNA helicase eIF4A (Dominguez et al., 1999, Morino et al., 2000). The eIF4E 
protein specifically recognizes the mRNA by binding its 5’ modified nucleotide cap (m7G- 
cap). This binding event is considered rate limiting, as eIF4E is one of the least abundant 
eIFs in RRL (Hiremath et al., 1985), although it is more abundant than other eIFs in yeast 
(von der Haar and McCarthy, 2002). The same binding event is also highly specific, 
mediated by both base-pair-like hydrogen bonding and by pi-stacking of two tryptophan 
residues sandwiching the m7G-cap in the binding cleft of the protein (Volpon et al., 2006). 
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This binding event also stimulates conformational rearrangements that increase the affinity 
of eIF4E for mRNA (Haghighat and Sonenberg, 1997). Also, poly(A) binding protein (PABP) 
is often bound to mRNPs through both its ability to bind to the poly(A)-tail as well as a 
PABP-specific binding site in the N-terminus of eIF4G (Kahvejian et al., 2005). These 
interactions have been proposed to lead to circularization of the mRNA with PABP bridging 
between eIF4G and the poly(A) tail, leading to an enhancement of translation (Tomek and 
Wollenhaupt, 2012). 
Once associated through m7G-cap recognition, eIF4F and the mRNA function as an 
mRNP that is delivered to the 43S preinitiation complex (PIC), consisting basally of the 40S, 
eIF1, eIF1A, eIF2-TC, eIF3, and eIF5 (Sokabe and Fraser, 2014). In vertebrate translation 
the eIF4F mRNP is delivered to the 43S PIC through specific interactions between eIF4G 
and the large 12 protein complex eIF3 (Villa et al., 2013, LeFebvre et al., 2006, Korneeva et 
al., 2000). The specific binding of human eIF4G to eIF3 is mediated by eIF4G residues 975- 
1078 and this fragment of 4G is sufficient to compete with full length eIF4G for eIF3 binding 
in vitro (Korneeva et al., 2000). This fragment and a secondary interaction site of eIF4G 
interact specifically with portions of eIF3 subunit e (eIF3e) (LeFebvre et al., 2006) as well as 
subunits eIF3c and eIF3d as measured by crosslinking and fluorescence anisotropy (Villa et 
al., 2013). Once the mRNA is associated with the 43S complex, m7G-cap-proximal 
nucleotides must be properly placed within the decoding groove of the ribosome amid a 
number of eIFs present to facilitate later steps. As important as the specific event of mRNA 
docking into the decoding groove is, a precise mechanism is notably absent in the literature. 
Once an mRNA has been delivered to the 43S, the first tRNA must be acquired and 
placed on the ORF start site. To accomplish this, the newly formed 48S PIC (eIF4F mRNP 
and 43S PIC) must inspect each nucleotide triplet from the 5’ end to find an AUG triplet 
within a favorable Kozak consensus sequence (nucleotides 5’ of and +1 to the AUG 5’- 
(gcc)gcc(A/G)ccAUGG-3’ in vertebrates with lowercase nucleotides being less impactful, 
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(Kozak, 1987). As RNAs tend to form higher order structures, RNAs must often be unwound 
and linearized so that they can be threaded through the decoding groove of the 40S and 
properly inspected. The ribosome itself has an innate capacity for RNA unwinding, as 
explored by the Noller group and others (Yusupova et al., 2001, Vassilenko et al., 2011, 
Spirin, 2009), but the ribosome’s helicase activity is often not sufficient for highly stable RNA 
structures or for extended scanning through long UTRs (Qu et al., 2011, Lee et al., 2016). 
The aforementioned factor eIF4A, the archetypal member of the DEAD-box helicases, can 
now act on many mRNAs as a general helicase and likely serves to complement the 
helicase activity of the ribosome (Andreou and Klostermeier, 2014a, Andreou and 
Klostermeier, 2014b, Harms et al., 2014). eIF4A can operate with cofactor(s), eIF4B (and/or 
eIF4H). These cofactors enhance helicase activity; possibly by stabilizing the single- 
stranded regions generated by eIF4A. (Andreou and Klostermeier, 2014a, Rogers et al., 
2001).  A precise mechanical model coupling ATP hydrolysis and nucleotide cycles in 
unwinding has not been developed, but a number of inferential studies have given us a 
picture of the conformational switches in eIF4A that drive ATP hydrolysis, exchange, and 
generation of single-stranded nucleic acid (reviewed in (Andreou and Klostermeier, 2013). In 
short, ATP hydrolysis promotes rapid dissociation of ssRNA from eIF4A and a subsequent 
increase in affinity for ADP on the factor (Lorsch and Herschlag, 1998b, Lorsch and 
Herschlag, 1998a). The slow exchange of ADP likely is facilitated by interactions of eIF4G 
with the ATP-binding pocket of eIF4A (Hilbert et al., 2011), and re-association with RNA 
seems to be a function of the cofactors eIF4B/H, stabilizing ssRNA to prevent reannealing. 
Earlier studies suggest that eIF4A is bidirectional in function, but ribosome scanning itself is 
directional (Rogers et al., 2001, Rogers et al., 1999). It stands to reason that directionality 
might be imposed by its associated eIFs being placed upstream. For short, relatively 
unstructured UTRs, eIF4A is sufficient, but additional helicases have been implicated in 
5  
resolving long highly structured UTRs (DHX29), or on a mRNA-specific basis (reviewed in 
(Parsyan et al., 2011)). 
At this point it is worth noting that the scanning model of translation initiation is widely 
accepted for cap-driven translation and the rate of scanning has been measured at 
approximately 8 nucleotides per second (Berthelot et al., 2004). However, the precise 
mechanism of the processivity and directionality of scanning has yet to be elucidated. The 
model has been proposed to act as a Brownian ratchet, in that ribosome conformations are 
randomly generated that promote the translocation of nucleotide across the mRNA binding 
cleft (Spirin, 2009). An exciting development in the field of translation biology has provided a 
clearer view of this. A clever modification of ribosome profiling recently envisioned by 
Thomas Preiss’ group (Archer et al., 2016) has provided snapshots of ribosomes moving 
across a 5’ UTR traveling with a much larger footprint than an elongating ribosome. These 
large footprints seem to be sequentially disassembled at the translation start sites, implying 
that factors on the PIC are at the leading edge of ribosomes and, perhaps, are promoting 
helicase activity by forcing directionality in scanning. 
Once the issue of moving through the 5’ UTR has been resolved during scanning, a 
major hurdle remains between a PIC and placement of the first aa-tRNA. The start site must 
be properly selected, not just seen by a scanning PIC, and this start codon must be base- 
paired to the anticodon of a Met-tRNAiMet. This process is surprisingly complex. To discuss 
start site selection, I must first bring attention to two essential, and fundamentally distinct, 
conformations that the 40S adopts within a PIC. The first is a “closed” conformation in which 
the 40S head has moved toward the body in such a way that rRNA helix 34 (h34) in the 
head of the 40S and rRNA h18 in the body of the ribosome are in contact (Llácer et al., 
2015, Passmore et al., 2007). This is similar to a conformation that the 40S adopts in 
solution without factors bound (Passmore et al., 2007). The “closed” conformation prevents 
the mRNA from being loaded into the decoding groove, as the “latch” formed by their 
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interaction forms a hole in which the mRNA would need to be threaded (an unlikely event 
with a multi-kilobase RNA with a large complex of factors at the proximal end). The initiation 
factors eIF1 and eIF1A are delivered to the ribosome in a manner that is stimulated by eIF3 
(Majumdar et al., 2002). Their concordant binding is what is thought to stabilize the 
formation of the “open” complex ready for scanning (Pestova and Kolupaeva, 2002, Maag et 
al., 2006, Passmore et al., 2007). Though there are numerous structural differences 
between the two, the simplest distinction is in the accessibility of the decoding groove. The 
“open” complex has more space in the decoding groove, and the “closed” complex has less 
(Figure 2). The “open” complex is one in which the head of the ribosome has moved away 
from the body in such a way that the latch is no longer formed and mRNA can be placed 
across the decoding groove without blockade. On this subject, it is worth noting that 
traditionally eIF2 in complex with both a molecule of GTP and an aminoacylated initiator 
tRNA (Met-tRNAiMet), the so-called eIF2-TC, is present on an “open” complex with Met- 
tRNAiMet associated and poised to enter the P-site (in the Pout state). Review of recent 
structural information would suggest that the presence of eIF2-TC would preclude the easy 
access of mRNA to the decoding groove for scanning if it were already bound, suggesting 
that eIF2-TC should be recruited after mRNA (Llácer et al., 2015). Further, association 
experiments would suggest that eIF2-TC association with the 40S occurs later and is 
facilitated by eIF3 and an “open” complex (Chaudhuri et al., 1999, Maag and Lorsch, 2003). 
However, recruitment of mRNA with eIF4F to the ribosome is enhanced by a PIC containing 
eIF2-TC (Gingras et al., 1999). Ultimately, the precise timing of eIF2-TC association has not 
been teased out and may be mRNA-specific. The “open” conformation of the 48S PIC is 
also one that is scanning-competent, in that the mRNA can be inspected as it moves across 
the decoding grove (Pestova and Kolupaeva, 2002). The inspection of the nucleotides 
during scanning is seemingly accomplished by contributions from conserved nucleotides in 
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the 18S rRNA and base-pairing of the AUG to the tRNA anticodon on eIF2, at least in yeast 
(Dong et al., 2008, Hussain et al., 2014). 
Through genetic screens, it was determined that mutations to residues within h28 
and h44 of the yeast 18S rRNA stimulated increased leaky scanning (translation from 
upstream ORF start sites in poor Kozak context) while distinct residues in a bulge region of 
h28 perturbed the stability of eIF2-TC binding (Dong et al., 2008). These observations were 
further corroborated by crystal structures of the bacterial 70S ribosome that showed the 
wobble position of the start codon to be inspected by a single nucleotide, likely contributing 
to stringency (Korostelev et al., 2014). Also in the bacterial example, a recent structure 
shows a high resolution image of the decoding groove and nucleotides in the 16S rRNA 
flipped toward the decoding groove and effectively bracketing the nucleotide triplet in the P- 
site (Hussain et al., 2016). On an “open” complex the Met-tRNAiMet in eIF2-TC seems to be 
in a position to sample codon triplets with its anticodon, while not being fully engaged in 
base pairing (Pout state) (Zhang et al., 2015). Working simultaneously with rRNA, the 
anticodon of the tRNA is searching, and perhaps slowing, the movement of mRNA across 
the decoding groove during scanning and, upon recognition of an AUG, the Met-tRNAiMet 
can be fully accommodated into the ribosomal P-site in an initiation-competent state (Pin 
state) (Zhang et al., 2015, Llácer et al., 2015, Hussain et al., 2014). 
Final accommodation of Met-tRNAiMet and conformational rearrangements that 
commit a PIC to subunit joining are facilitated by eIFs 1, 1A, and 5. The primary function of 
eIF1 seems to be to promote the maintenance of the “open” complex and prevent premature 
selection of start codons (Asano and Sachs, 2007, Mitchell and Lorsch, 2008, Cheung et al., 
2007). In fact, the high affinity binding of eIF1 to the 40S is restricted to the “open” and not 
the “closed” complex conformation (Martin-Marcos et al., 2014, Martin-Marcos et al., 2013). 
eIF1, along with the C-terminal tail of eIF1A, bind in positions that extend toward the P-site 
and prevent non-specific association of tRNAs. In fact, superimposing structures of tRNA on 
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to structures of the ribosome containing eIF1 show a substantial steric conflict that would 
need to be resolved by conformational rearrangements or the ejection of eIF1 upon 
codon:anticodon base-pairing (Rabl et al., 2011, Weisser et al., 2013, Llácer et al., 2015). 
The latter seems to be the case, since one of the first consequences of base-pairing is the 
dissociation of eIF1 (Cheung et al., 2007). eIF5 is an essential eIF that facilitates translation 
by promoting the hydrolysis of GTP on the eIF2-TC. eIF5 could cause GTP hydrolysis at any 
step after eIF2-TC binding but before start codon recognition and codon:anticodon base- 
pairing. The exact point at which this occurs is a topic of debate, but what is clear is that 
hydrolysis is not sufficient for conformation changes in the PIC or for the release of 
hydrolyzed phosphate (Algire et al., 2005). The recognition of an AUG by Met-tRNAiMet is 
communicated through the PIC, and the resulting conformational changes trigger eIF2-TC 
GTP hydrolysis. A biophysical consequence of this GTP-GDP transition is the approximately 
15-fold lower affinity of eIF2-GDP for Met-tRNAiMet than its triphosphate-bound counterpart 
(Kapp and Lorsch, 2004). The lowered affinity is likely a mechanism to allow efficient 
deposition of Met-tRNAiMet while also not hindering the dissociation of eIF2. Once a start 
codon has been recognized, however, conformational rearrangements from the “open” to 
the “closed” complex lead to the dissociation of phosphate, several eIFs (including eIF1, 
eIF3, and eIF5) and partial loss of eIF2-GDP (Asano and Sachs, 2007). The remaining eIFs 
are displaced as a result of subunit joining or the transition from initiation to elongation 
(Unbehaun et al., 2004). 
The last steps of initiation are mediated by eIF5B, the eukaryotic homolog of 
bacterial IF2. These homologs share a similar structure and both promote final subunit 
joining and the transition of the 80S ribosome into a translationally competent form. eIF5B is 
recruited partially through an interaction with the C-terminal residues in eIF1A that have 
been displaced from the P-site upon start codon recognition (Acker et al., 2006, Marintchev 
et al., 2003, Olsen et al., 2003). eIF5B also interacts with 18S rRNA at h5 and with a portion 
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of the acceptor stem of Met-tRNAiMet (though to a lesser extent than the interaction between 
IF2 and fMet-tRNAifMet) (Kuhle and Ficner, 2014, Yamamoto et al., 2014). In a GTP- 
dependent step eIF5B promotes the formation of elongation-competent 80S complexes. 
Elongation-competent is an important distinction because eIF5B itself can stimulate the 
association of 40S and 60S subunits (Pestova et al., 2000). The transition to its GDP-bound 
form, like on eIF2, changes the affinity of eIF5B for the ribosome and thus allows its 
dissociation. In addition, the hydrolysis of GTP on eIF5B seems to alter the conformation of 
the ribosome in such a way that promotes eIF1A release (Fringer et al., 2007). We can 
surmise that this disassociation of eIF1A and eIF5B allows access to the A-site by 
elongation factors. 
It is assumed that eIFs must be dissociated from the ribosome. However, there are 
examples of eIFs staying bound to 80S ribosomes after initiation is complete and even into 
elongation (Szamecz et al., 2008, Nielsen et al., 2004). One particular case is the translation 
of small upstream ORFs as a matter of regulation (discussed in more detail later in this 
chapter). eIFs presumably can stay bound, and can facilitate translation of downstream 
ORFs when sufficiently supplied with eIF2-TC (Mueller and Hinnebusch, 1986). An 
interesting example is found with eIF3, the large complex that in most cases is no longer 
associated with 80S ribosomes after the initiation to elongation transition. What actually 
triggers or promotes eIF3 release is still a mystery, though, and because the majority of the 
factor is bound to the solvent-accessible face of the 40S it is easy to imagine how it could 
stay associated with an 80S ribosome during elongation (in some cases). The only clear 
example of dissociation of a component of eIF3, eIF3j. eIF3j is a peripherally associated, E- 
site adjacent subunit that must be displaced to allow mRNA acquisition in the steps leading 
to formation of a 48S complex (Fraser et al., 2007). Once all factors have been displaced, 
an 80S is then set to acquire eukaryotic elongation factor (eEF)1A bound to aminoacylated 
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elongator tRNA (aa-tRNA) and receive the second encoded amino acid, beginning peptide 
synthesis and elongation (Dever and Green, 2012). 
 
Regulation of Canonical Translation Initiation 
The majority of the research described here revolves around the interplay between 
the initiation of translation driven by viral IRESs, the regulation of eIF2, and consequences 
of viral infection. Although my research focused primarily on the cellular control of Met- 
tRNAiMet delivery by eIF2, it should be noted that eukaryotic cells have evolved a number of 
other regulatory mechanisms that govern the rate of translation. The majority of these 
mechanisms occur during the initiation step and are covered briefly below. In general terms, 
two things are required for translation to work properly: mRNAs need to be accessible to the 
translation machinery for decoding, and the initiation complexes (ribosome and associated 
factors) need to function correctly. I will cover the latter first in detail, and then I will briefly 
cover the former. 
Controlling Initiation Factor Activity 
The initiation step is, for the most part, considered the rate-limiting step of 
translation. To that point, initiation itself requires a number of specialized factors and 
because of their specificity, there is obvious potential for regulation. The most well studied 
cases of cellular regulation of translation revolve around the protein that binds the m7G-cap, 
(eIF4E) (Figure 1, left) and the delivery of the first tRNA for most messages through the 
eIF2-TC (Figure 1, right). There is a large body of literature describing each individual factor 
and principles of their regulation, but I will briefly mention that other eIFs can be regulated 
as well. 
Many components of the initiation machinery can be reversibly phosphorylated 
during various cellular conditions, including eIF5 (Majumdar, 2002), eIF5B (Jiang et al., 
2016), eIF4A (Morley et al., 1993), eIF4B (Shahbazian et al., 2006), eIF4H, eIF4G (Dobrikov 
et al., 2011), eIF3 (Farley et al., 2011), eIF2β, eIF2B (Wang, 2001), eIF1 (Zach et al., 2014), 
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and some ribosomal proteins (Martin et al., 2014, Biever et al., 2015, Roux et al., 2007, 
Mikulk et al., 2011, Volovelsky et al., 2015). These modifications seem to be ubiquitous in 
the translation machinery but, surprisingly, it is rare to find direct evidence that 
phosphorylation affects overall translation, except for eIF2 and 4E-BP phosphorylation 
(discussed below). Ribosomal protein rpS6 phosphorylation is perhaps the best studied of 
this list and is a downstream target of the mammalian target of rapamycin complex 1 
(mTORC1). A number of studies have implicated rpS6 phosphorylation in developmental or 
proliferative defects in specific systems (Biever et al., 2015), but a clear understanding of 
how it regulates translation does not exist. 
eIF4E 
eIF4E is a core constituent of the eIF4F complex and is essential for the recognition 
of the special nucleotide cap attached to the 5’ end of most mRNAs. eIF4E-dependent cap 
recognition was determined to be the rate-step in most translation initiation events (Duncan 
et al., 1987). It seems to be rate-limiting in translation initiation because it is a low 
abundance protein in RRL and multiple pathways tightly regulate its availability (Gingras et 
al., 2000). Dysregulation in eIF4E availability and/or function is a hallmark of many cancers 
and simple overexpression of the factor is enough to drive transformation in some cell lines 
(Siddiqui and Sonenberg, 2015, Truitt et al., 2015). There are two main pathways governing 
eIF4E availability for cap structures and cap-binding complexes (1) the mTORC1-4E-BP 
pathway, and (2) the MNK pathway. 
The mammalian target of rapamycin complex 1 (mTORC1) is a protein complex 
found in cells with the catalytic unit being a serine/threonine kinase (mTOR) and is the 
downstream target of the PI3K-ERK kinase pathways (Shahbazian et al., 2006). This 
complex functions in many cellular processes and, most notable to this text, governs 
translation in response to nutrient availability (amino acids, hormones, growth factors, etc.) 
(Kim et al., 2002). Under normal circumstances, the kinase activity of mTOR1 leads to a 
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hyperphosphorylated state of a binding partner of eIF4E, 4E-BP (Gingras et al., 2001). 
There are multiple isoforms of 4E-BPs that exist, though the specific functions of each are 
enigmatic. However, different 4E-BP isoforms are differentially expressed in some cancers 
(Siddiqui and Sonenberg, 2015). Hyperphosphorylated 4E-BPs are unable to interact with 
eIF4E, leading to free eIF4E that can associate with mRNAs or eIF4G. When appropriate 
stresses are in place, the mTOR1 complex is no longer able to phosphorylate 4E-BPs and in 
their hypophosphorylated state they are free to bind and sequester eIF4E, thus removing it 
from translation (Khaleghpour et al., 1999). The binding of eIF4E to 4E-BPs occurs at 
effectively the same position as where eIF4E and eIF4G interact, thus blocking this 
interaction and competitively inhibiting a necessary step in translation initiation (Mader et al., 
1995). 
In addition to regulation of eIF4E by the phosphorylation state of 4E-BPs, eIF4E itself 
can be phosphorylated at a single site in its C-terminus, Ser209 (Flynn and Proud, 1995). 
Modification at this position is carried out by a group of protein kinases called Mitogen- 
Activated Protein Kinase (MAPK)-Interacting Protein Kinases (MNK) (Ueda et al., 2004). 
There are two MNK genes, with a total of four isoforms due to variant splicing of each gene. 
They have variable activity in response to ERK/MAPK signaling along with either 
cytoplasmic (MNK1) or nuclear (MNK2) localization (Ueda et al., 2004). Despite different 
subcellular position, MNK proteins serve the same purpose in eIF4E regulation. They 
associate directly with eIF4G through their N-termini and thus are poised to act on their only 
known in vivo substrate, eIF4E (Pyronnet et al., 1999). The overall function of the site- 
specific phosphorylation of eIF4E by MNK is not well understood, but recent data has 
provided a link between MNK function and the expression of an alternate isoform of eIF4E 
(eIF4E3) (Landon et al., 2014), which may be responsible for the translation of a specific 
subset of cancer-related genes. Additionally, the MNK activation led to the dissociation of a 
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protein complex implicated in Fragile X syndrome from eIF4E (Richter et al., 2015), though 
the precise method of control over these events is not expressly known. 
 
eIF2 
eIF2 is a heterotrimeric G-protein that is responsible for an essential step in most 
translation, the delivery of the specialized initiator tRNA to the P-site of the ribosome for 
translation from methionine-led ORFs . It would be inefficient for eIF2 to be a “single- 
serving” factor, so after GTP-hydrolysis and Met-tRNAiMet deposition, the eIF2 factor must be 
recycled (Pavitt et al., 1998). GDP-exchange and the subsequent acquisition of a new Met- 
tRNAiMet is facilitated by the guanine nucleotide exchange factor (GEF) complex called 
eIF2B (Kimball et al., 1998a). I will focus mainly on what happens to eIF2 during this 
process, but it bears mention that eIF2B itself can be regulated, and that while it is a five- 
subunit complex, only two subunits are catalytic while the remaining three regulate the 
process (Baird and Wek, 2012). 
The structural basis for regulation of eIF2 is actually quite simple given its profound 
importance in cell biology. The alpha-subunit of eIF2 (eIF2α) is phosphorylated at a serine 
residue at position 51 (Ser51). This modification effectively turns eIF2 from an initiation 
factor to a competitive inhibitor of its own GEF (eIF2B) (Kimball et al., 1998b). Once bound, 
eIF2 in the phosphorylated state cannot dissociate from eIF2B, likely because 
conformational changes in eIF2B required for nucleotide exchange cannot occur (Kuhle et 
al., 2015). eIF2 is a highly abundant translation factor, whereas eIF2B is present at much 
lower levels (Krishnamoorthy et al., 2001). Thus, effectively eIF2B is rate-limiting in eIF2-TC 
turnover, and so even small changes in the amount of phosphorylated eIF2α can “soak up” 
all eIF2B and have dramatic changes in overall translation (Krishnamoorthy et al., 2001, 
Jennings et al., 2013). 
What adds multiple layers of complication to the regulation of eIF2 activity are the 
proteins responsible for the deposition of a phosphate at Ser51. There are at least four 
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separate eIF2-specific kinases that are specifically adapted to sense environmental changes 
and facilitate translation shutoff (Jiang et al., 2006). UV damage and amino acid starvation 
can be sensed by GCN2. The hemin-regulated inhibitor (HRI) phosphorylates eIF2 in 
response to problems with iron metabolism. Of particular consequence to viral infection, also 
to this text, are both the interferon-inducible double-stranded RNA-dependent kinase (PKR) 
and the PKR-endoplasmic reticulum-related kinase (PERK). PKR is predominantly 
responsible for sensing viral dsRNA replication intermediates. PERK senses the 
accumulation of misfolded proteins in the ER; often activated during viral infection. All of 
these protein intersect at eIF2 to provide a cellular outlet for rapid gene expression shutoff in 
response to harmful stimuli. 
Consider also, that while translation shutoff is a general phenomenon during harmful 
environmental conditions, many mRNAs are still efficiently translated even in the absence of 
eIF2. In fact, many stress-responsive genes are translated even more efficiently during eIF2 
limitation, presumably because they are needed to respond to whatever problem caused the 
decrease in translation. A prime example of this is the eIF2 depletion-regulated translation of 
ATF4 by upstream ORFs (uORFs) (Lu et al., 2004) that I will discuss briefly later in this 
chapter. 
mRNA-specific Control of Translation Initiation 
 
Control from the 5’ end 
The recent outpouring of transcriptome-wide data sets stemming from polysome 
analyses, ribosome profiling and similar methods, have revealed a greater diversity in the 
recruitment pathways of mRNAs to ribosomes than was previously appreciated. The 5’ end 
of the mRNA is associated with recruitment to ribosomes, but recruitment is not necessarily 
achieved through the cap-dependent pathway. During conditions that regulate translation at 
the cap-binding and Met-tRNAiMet delivery steps, different mRNA recruitment strategies can 
be used. 
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The first I will mention involves the multiple isoforms of eIF4G. Some mRNAs are 
able to recruit eIF4G directly through RNA sequence or structure in their 5’ UTR, and many 
of these mRNAs are highly eIF4G-dependent while simultaneously operating in an eIF4E- 
and IRES-independent fashion (Kaiser et al., 2008). Why is this important? It shows that 
cellular mRNAs have the capacity to bypass at least one translation checkpoint in the cap- 
binding step and can operate differentially in an mRNA-specific manner. This is the most 
critical characteristic of an IRES, though cellular IRESs are often more complicated than the 
highly structured viral RNAs I will discuss in this text (Jackson, 2005, Jackson, 2013). 
Further, eukaryotes from yeast to mammals encode multiple isoforms of eIF4G with the first 
(eIF4G1) being the one generally associated with the eIF4F complex. In plants, however, 
the two predominant isoforms of eIF4G seem to have distinct functional roles (Gallie, 2015). 
Two isoforms of eIF4G are known to exist; eIF4G1 (TIF4631) and eIF4G2 (TIF4632) in 
yeast (Goyer et al., 1993) and eIF4G1 (eIF4GI) and eIF4G3 (eIF4GII) (Sun et al., 2010) in 
vertebrates with multiple eIF4G-like proteins also being encoded (e.g. CBP80, PAIP1, CTIF, 
and SLIP1). eIF4G is even further functionalized by the existence of promoter and splice 
variants of each isoform, and an N-terminally truncated isoform that lacks both the eIF4E- 
and PABP-binding domains (eIF4G2) (Byrd et al., 2002, Bradley et al., 2002, Kim et al., 
1999). The other isoforms are now thought to facilitate translation of specific subsets of 
messages during conditions that limit overall translation and contribute to transformation of 
cells when overexpressed (Coldwell and Morley, 2006, Bauer et al., 2001, Bauer et al., 
2002). An often underappreciated feature of eIF4GI are two RNA-binding domains that likely 
facilitate eIF4F assembly and/or recruitment on mRNAs (Berset et al., 2003). These 
isoforms are largely capable of functionally replacing one another to some extent, but 
microarray and polysome analyses show that differential subsets of mRNAs can be 
translated by many of the different isoforms (Clarkson et al., 2010). This eIF4G-dependent 
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tuning of gene expression highlights an mRNA-specific regulation that is not accounted for 
in the canonical model of translation initiation 
Recently, the Cate lab has provided another example of 5’ end-dependent 
regulation. In the absence of eIF4E, the capped ends of some mRNAs are recognized 
directly by a subunit of eIF3, eIF3d (Lee et al., 2016). An endonuclease-like fold within eIF3d 
can recognize the 5’ cap structure of an mRNA and can recruit it to an initiation complex 
without the contribution of eIF4F. In the example they test, the c-JUN mRNA, specific 
recognition of the cap-structure by eIF3d is accompanied by an RNA fold that inhibits eIF4E 
binding. Ultimately, this study shows us that not only is direct cap recognition by eIF3 
possible, RNA-dependent inhibition of eIF4E binding is also possible. Together, they can 
facilitate regulated expression of an important cell proliferation factor (Schreiber et al., 
1999). Furthermore, one could expect one or both of these regulatory mechanisms to be 
present in other mRNAs and now that the first mRNA has been identified we are sure to find 
others. 
In addition, protein factors can bind stem loops in the 5’ or 3’ UTRs of specific 
mRNAs to negatively or positively regulate translation. For example, the expression of the 
ferritin gene is negatively regulated by the binding of the IRP-1 or IRP-2 proteins to a cap- 
proximal position in the 5’ UTR of the ferritin-encoding mRNA (Muckenthaler et al., 1998, 
Kim et al., 2007). In the absence of iron, the regulatory proteins assume conformations that 
allow them to bind to an iron response element (IRE) RNA structure located near the 5’ end 
of the ferritin mRNA. The binding of this factor prevents the 43S PIC from loading on the 
mRNA even though the cap-binding complex can find the cap structure. Negative regulation 
presumably works only because IRP-1 binds close enough to eIF4F that a ribosome does 
not have a clear “landing pad”. 
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Control from the 3’ end 
Interestingly, although the IRE-IRP interaction described above inhibits translation 
from the 5’ end of one iron responsive gene, the same interaction can increase the half-life, 
and overall expression, of the mRNA of another iron responsive gene when placed at the 3’ 
end of the mRNA. Once IRP-bound this mRNA’s half-life is lengthened thus promoting the 
expression of a receptor that is specifically purposed to induce iron uptake, the transferritin 
receptor (Theil, 1990). Other iron homeostasis genes have similar IRE’s in the 3’ UTR 
(reviewed by (Wang and Pantopoulos, 2011). This is one example; certainly other proteins 
can bind the 3’ UTR of messages and regulate either the lifetime of the mRNA, the 
translation, or both. 
The second example is surely the most prevalent. The poly(A) binding protein 
(PABP) can theoretically bind to and stabilize any polyadenylated mRNA. An associated 
PABP can then concurrently interact with an N-terminal domain of eIF4G and facilitate 
efficient translation. PABP is effectively a peripheral component of the eIF4F complex and a 
crucial component of the “closed-loop” model of translation (Tomek and Wollenhaupt, 2012). 
This protein itself is generally considered essential for cellular mRNA translation, but more 
rigorous analysis would suggest it is stimulatory by nature (Proweller and Butler, 1997, 
Borman et al., 2000). I should also mention that models of translation initiation denote the 
importance of PABP (also PABPC1), but there are up to six isoforms of polyadenylate- 
binding proteins in the vertebrate cells. A nuclear form (PABPN1) participates in 
cotranscriptional mRNA processing (Lemieux and Bachand, 2009) while the five remaining 
isoforms are cytoplasmic and seem to have either the predominant role in somatic cells 
(PABPC1) or serve functions in gene expression during development or in a tissue specific 
fashion (Vasudevan, 2006, Kini et al., 2014). Furthermore, PABP is capable of being post- 
translationally modified in a fashion that likely modulates one of its many functions (Brook et 
al., 2012). A similar mode of translation regulation revolves around histone mRNAs that lack 
18  
poly(A) tails. Instead of PABP, a stem-loop binding protein (SLBP) binds to a 3’ terminal 
stem-loop in histone mRNAs and subsequently causes the recruitment of eIF4G (eIF4F) 
albeit through an intermediate, SLBP-interacting protein, SLIP-1 (Cakmakci et al., 2008). 
The final general regulator of gene expression that I would like to cover is microRNA- 
mediated gene silencing. The “linear” canonical pathway of miRNA processing is the most 
common. miRNAs can be generated by either RNA polymerase II or III into primary miRNAs 
(pri-miRNAs) that must be heavily processed before becoming active substrates for 
silencing (Jonas and Izaurralde, 2015). The pri-miRNA can be formally edited by adenosine 
deaminases (ADARs) to effectively manipulate the targeting potential of primary transcripts 
(Tomaselli et al., 2013). Edited primary transcripts can then be cleaved into precursor- 
miRNAs (pre-miRNAs) by the microprocessor endonuclease complex (Drosha-DGCR8), 
then exported to the cytoplasm. Stem-loop pre-miRNAs are then further processed into a 
miRNA duplex by endonucleolytic cleavage of the loop by Dicer and its associated factors. 
Once cleaved, the miRNA duplex is loaded into an RNA-induced silencing complex (RISC). 
This process involves binding of the duplex by Argonaut (Ago) proteins, unwinding of the 
duplex by a number of possible helicases, the selection of the guide (targeting) strand, and 
the subsequent degradation of the unused strand. Once a RISC has found its target, the 
guide RNA places the complex onto a particular region of the mRNA (usually the 3’ UTR) 
and can silence gene expression by either translational repression or targeting the message 
for decay pathways. Translational repression is a process by which RISC association 
inhibits cap-dependent translation, but precise mechanisms that cause this phenomenon are 
largely unknown. RISC-mediated decay is a little better understood in that the assembly of a 
miRNA-bound complex on the mRNA can cause the endonucleolytic cleavage of perfectly 
complementary mRNAs in an Ago-2-dependent fashion or can trigger deadenylation in a 
GW182- and PABP-dependent fashion (Pfaff et al., 2013). Deadenylated messages are 
subject to recruitment of decapping complexes that remove the cap-structure and allow 
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access to 5’-3’ exonucleases while a deadenylated message is also accessible to the 
exosome complex which can degrade mRNAs in a 3’-5’ manner (Schoenberg and Maquat, 
2012). Ultimately miRNA targeting exerts control over gene expression by either inhibiting 
translation specifically or by removing a particular molecule from translation by degradation. 
The Translation Cycle 
A ribosome that has initiated translation must, in an ideal sense, elongate a 
polypeptide, terminate the chain appropriately, and prepare for re-use. Understanding the 
process by which this happens is critical for the understanding of what ribosomes “look like” 
and what an mRNA encounters. The above section details the highly regulated process that 
results in the production of translation-competent ribosomes. The majority of this text 
revolves around describing the specific details of eukaryotic translation initiation which is a 
significant departure from bacterial initiation. The mechanism of translation elongation is well 
conserved between bacteria and eukaryotes as is the termination step, with some 
exceptions. Ribosome recycling in eukaryotes presents another departure from bacterial 
translation, but accomplishes the same goal in tying the last and first steps in the translation 
cycle together. 
Elongation 
After initiation, an 80S ribosome is sitting at the start site of an ORF with an 
aminoacylated tRNA in the P-site. The second codon is poised in the A-site of the ribosome, 
and is awaiting the delivery of its cognate aa-tRNA. eEF1A (EF-Tu in bacteria) arrives with a 
charged tRNA and GTP in a ternary complex (eEF1A-TC) that can decode an A-site codon 
(Carvalho et al., 1984). eEF1A can bind any aa-tRNA in a GTP-dependent manner and the 
specific delivery of a cognate tRNA is largely stochastic (Almlof et al., 2007). Codon 
recognition triggers (Pape et al., 1999) GTP-hydrolysis by eEF1A and dissociation of the 
factor from the tRNA and the 80S (Slobin and Moller, 1978). At this point the aa-tRNA can 
be fully accommodated into the ribosome (in both the 40S and 60S A-sites) (Whitford et al., 
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2010b, Whitford et al., 2010a). After accommodation, peptide bond formation occurs quickly 
and is catalyzed by the peptidyl transferase center (PTC) in the 60S (Polacek and Mankin, 
2005). The PTC is comprised primarily of rRNA and is conserved through all life. The PTC 
positions the amino-terminus of the incoming A-site aa-tRNA in proximity to the α-carbon of 
the P-site amino acid (often methionine in the first elongation step) and facilitates 
nucleophilic attack of the amine on the carbonyl carbon the amino acid of the peptidyl-tRNA 
(Wolfenden, 1963). 
After peptide bond formation, the next step is the repositioning of the deacylated 
tRNA to the E-site, and the movement of the acylated tRNA from the A-site to the P-site. So- 
called “ratcheting” between ribosomal subunits causes hybrid-state formation in which the P- 
site (now deacylated) tRNA contacts the P- (40S) and E-sites (60S) while the peptidyl-tRNA 
now occupies the A- (40S) and P-sites (60S) (Julian et al., 2008). A full translocation event, 
that is the movement of the tRNAs from hybrid-states into the classical E- and P-sites, 
requires a second GTP-dependent step facilitated by the translocase eEF2 (EF-G in 
bacteria) (Ryazanov and Davydova, 1989). The movement of the tRNAs across the 
ribosome is accompanied by the maintenance of the reading frame and concomitant 
repositioning of the mRNA three nucleotides downstream of its original position. GTP- 
hydrolysis on EF2 promotes the return of the 80S back into a state with an empty A-site and 
available codon while simultaneously preventing the backward movement of mRNAs and 
tRNAs in the decoding groove (reviewed in (Kaul et al., 2011). In the post-translocated state, 
a deacylated tRNA sits in the E-site. Release of E-site tRNA is not strictly coupled to the 
acquisition of a new eEF1A-TC, but they both are necessary for subsequent rounds of 
peptide bond formation (Uemura et al., 2010). This process is repeated with high efficiency 
throughout the length of the gene except when a codon and tRNA match cannot be made, 
traditionally this occurs because a UAA, UGA or UAG stop codon enters the A-site and 
translation termination is the next step. 
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Termination and Recycling 
Once a stop codon has arrived in the A-site, no tRNAs are present to decode it and 
so the polypeptide is signaled for chain termination. Termination is carried out by eukaryotic 
termination factors eRF1 (related to bacterial RF1 and RF2) and a GTPase, eRF3 (related to 
RF3). eRF1 is effectively a tRNA-shaped protein that enters the A-site, recognizes the stop 
codon primarily through its N-terminal domain, a tRNA acceptor stem mimic in its middle 
domain, and a C-terminal domain that interacts with eRF3 (Cheng et al., 2009). eRF3 and 
GTP travel as a complex with eRF1 and the association of eRF1 with eRF3-GTP prevents 
premature GTP-hydrolysis until a stop codon has been recognized (Pisareva et al., 2006). 
GTP-hydrolysis once bound to the ribosome deposits the middle domain of eRF1 into the 
PTC and allows the release of eRF3-GDP (Frolova et al., 1996). An 80S positioned at a stop 
codon with eRF1 bound can then encounter the recycling factor ATP-binding cassette sub- 
family E member 1 (ABCE1, originally described as RNase L inhibitor Rli1) (Bisbal et al., 
1995, Pisarev et al., 2010, Pisarev et al., 2007). ABCE1 binding enhances the hydrolysis of 
the peptide bond by directing the catalytic GGQ loop of the middle domain eRF1 toward the 
PTC (Preis et al., 2014). Structurally in the eRF1:eRF3-bound ribosomes state, the catalytic 
loop of eRF1 is packed against eRF3, preventing access to the PTC. eRF3 dissociation and 
ABCE1 association seems to allow the GGQ loop to access the PTC and stimulate 
hydrolysis of the aminoacyl. 
After peptide release, a deacylated tRNA and mRNA are still bound to an 80S 
ribosome that must be appropriately split. Subunit dissociation is enhanced, in an ATP- 
dependent manner, by ABCE1 (Pisarev et al., 2010). It is at this point that, most often, 
mRNA and tRNA species are removed from the ribosomal subunits and subsequent rounds 
of translation require recycling and acquisition of new mRNA. Sometimes however, the 40S 
can stay associated with the mRNA and a process called reinitiation can occur at 
downstream ORFs (mentioned below). The precise timing of the remaining steps are still 
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being parsed out, but it is clear that the acquisition of factors like ABCE1 somehow couples 
the loading of a new batch of eIFs to the complete dissociation of deacyl-tRNA and mRNAs. 
It is thought that once subunits have been split, it is simply a competition between the 
loading of 40S-bound eIFs and displacement of leftover RNA species (Nrenberg and Tamp, 
2013, Becker et al., 2012). This process can be facilitated, at least partly, by eIF2D (Ligatin) 
and the complex MCT-1/DENR (containing SUI1 domains homologous to eIF1) perhaps by 
stabilization of an “open” ribosome preinitiation complex prepared for the next initiation 
event (Skabkin et al., 2010). 
Translation Preinitiation Complexes 
All translation events that do not end with the degradation of the ribosome are 
geared toward the regeneration of an initiation-competent set of ribosome subunits. For 
example, a terminated ribosome must be stripped of eRFs and reloaded for subsequent 
rounds of translation (Pisarev et al., 2010). For another example, a stalled ribosome must be 
stripped of Pelota:Hbs1 to be rescued from stalled translation (Pisareva et al., 2011). 
Recycling and rescue of ribosomes ultimately leads to the production of a 43S preinitiation 
complex (PIC). A 43S PIC is a factor-bound 40S that serves as the landing platform for the 
cap-binding complex and the mRNA to be loaded. Minimally, the 43S PIC is defined as a 
40S subunit bound to eIFs 1, 1A 3, 5, and eIF2-TC. These factors are recruited primarily 
through eIF3 and are bridged to the 40S subunit. eIF3 makes specific contacts with the 40S 
through the shoulder/platform region, and the solvent-exposed face (des Georges et al., 
2015). The core of eIF3 is comprised of eIF3a, c, e, l, k, and m while the remaining subunits 
are peripherally associated. This ~600 kDa core complex contacts the 40S at rpS1 (eIF3a), 
rpS26 (eIF3a), 18S rRNA helix (h)26 expansion segment (ES)7 (eIF3a, and c), rpS27 and 
h22 (eIF3c), and rpS15 (eIF3C) (Hashem et al., 2013a). eIF3 is responsible for bridging the 
interactions between other eIFs and the 40S and recruiting smaller eIFs. eIF1 binds to eIF3a 
and c and is deposited on the 40S at the top of the decoding groove near the E-site in a 
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manner that is enhanced by the presence of eIF3 (Majumdar et al., 2002, Aylett et al., 
2015). It also interacts with the β-subunit of eIF2 and eIF5 though the N- and C-termini, 
respectively (Valsek et al., 2004, Singh et al., 2004). eIF5 is recruited through its 
simultaneous interactions with eIF3c and eIF1, and again, is a critical enhancer of eIF2- 
mediated GTP hydrolysis (Majumdar and Maitra, 2005, Asano et al., 2003). The most 
peculiar factor may be eIF1A. It is associated with 43S PICs and has been reported to 
interact with eIF2 and eIF3 through its N-terminal tail (Maag et al., 2006, Olsen et al., 2003, 
Anand et al., 2003). It can bind to the 40S independently of other factors in vitro but it is 
much more stable on a “closed” complex (Passmore et al., 2007, Maag and Lorsch, 2003). It 
is stable on ribosomes in the “open” conformation (as seen in 43S PICs) only in the 
presence of eIF1. eIF2-TC recruitment is essential for the deposition of tRNAiMet on 43S 
PICs in most types of initiation. It interacts with eIF1, 5, and eIF3a with additive binding 
strength (Martin-Marcos et al., 2013, Gai et al., 2012, Sokabe and Fraser, 2014). Some 
confusion exists over the timing of the association of eIF2-TC considering that its binding 
effectively occludes the decoding groove (Llácer et al., 2015). It would stand to reason that 
eIF2 would be recruited after the mRNA had been bound and placed on the 40S, but 
analysis of a subcomplex of translation initiation suggests that it is associated with other 
eIFs  before 40S binding (Asano et al., 2000). 
The MFC is a multi-eIF complex comprised of eIFs 1, 3, 5, and eIF2-TC. Publications 
regarding the MFC are primarily from yeast systems, though it has also been observed in 
humans (Sokabe et al., 2012, Asano et al., 2000). The MFC exists stably in the absence of 
a 40S subunit and its binding is important for finishing the recycling step of translation by 
priming the 40S with initiation factors (Pisarev et al., 2010). Recall, the removal of ABCE1 
and perhaps eIF2D (or MCT-1/DENR) is linked to the association of eIF3. eIF3 is bound to 
other eIFs when not bound to ribosomes. This complex is stable enough to be purified and 
the stability of the complex, inferred by disruption of non-core eIF3 component eIF3b, is 
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important for efficient translation in yeast (Valasek et al., 2002). The assembly of the MFC 
on ribosomes is necessary to adopt an initiation-competent conformation that is distinct from 
that of an apo-40S or one bound only to eIF3 (Llácer et al., 2015, Passmore et al., 2007, 
des Georges et al., 2015). It is similar, however, to a conformation induced by the co-binding 
of eIF1 and eIF1A (Weisser et al., 2013). It has been suggested that MFC formation 
kinetically enhances PIC formation by the pre-assembly of many factors, but data from in 
vitro systems would suggest that its formation is not necessary for efficient 43S PIC 
assembly (Sokabe et al., 2012). 
A number of non-translation factors can associate with the ribosome. My data, and 
that of many others demonstrates that ribosomes do not exist solely in either unbound, or 
translation factor-bound states. This is important to consider in that many studies of 
translation, and surely my own simplistic descriptions of PICs above, do not consider the 
complex nature of factors associating with translation machines. Ribosomes exist 
throughout the cell and interact with important cellular machines like the cytoskeleton, the 
ER, and AARS complexes. Having cellular machinery associated with ribosomes potentially 
accelerates dynamic protein-based biological processes. In turn, having a hodgepodge of 
tRNA synthetases (AARS complex) directly bound to translation complexes could drastically 
increase local concentrations of charged tRNAs and, thus improve the speed of translation 
itself. 
Bacterial Translation Initiation and Homologous Initiation Factors 
The initiation step of translation in bacteria is the most significant departure from 
eukaryotic (and archaeal) translation. The first difference is evident in the co-transcriptional 
nature of translation. Without a nucleus, there is no compartmental separation of the two 
processes. The rate of assembly of ribosomes on mRNAs in bacteria is on the order of 
seconds, compared to minutes in eukaryotes, though elongation rates seem to be quite 
similar, ~12 amino acids per second versus ~10 in eukaryotes (Wagner et al., 1982, Kennell 
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and Riezman, 1977, Morisaki et al., 2016). The initiation phase specifically requires the 
ribosome, mRNA, formylated methionine-tRNAiMet (fMet-tRNAifMet), and only three IFs 
(reviewed by (Laursen et al., 2005). The preinitiation complexes formed on 30S subunits are 
formed to accomplish the same goal as 43S PICs, start codon dependent binding of the 
initiator tRNA. 30S PICs however, are somewhat less stable than 43S PICs but must 
accomplish mRNA binding, tRNA placement, conformation changes, and subunit joining 
without an extended complement of factors. The process of mRNA recruitment is relatively 
simple in that it requires only the base-pairing between the 3’ end of the 16S rRNA and a 
purine-rich consensus sequence (AGGAGG in E. coli) approximately eight bases upstream 
of the AUG (Shine and Dalgarno, 1975). This binding, the Shine-Dalgarno (SD): anti-SD 
interaction effectively stabilizes mRNA on the 30S while also directing the AUG near the P- 
site (Hussain et al., 2016). This form of mRNA recruitment is, in effect, replicated by type 3 
IRESs. The subsequent steps in initiation are effected by the three bacterial IFs discussed 
below. 
IF1 is a small globular protein (~8 kDa) that binds near the A-site of the 30S subunit. 
Its eukaryotic homolog is eIF1A (Kyrpides and Woese, 1998). Structurally, it belongs to the 
oligonucleotide binding (OB) fold protein family and consists of a five-stranded beta-barrel. It 
binds to the 16S rRNA at h44 and interacts with bacterial rpS12 in close proximity to the A- 
site (Simonetti et al., 2008). Its binding position near the A-site at least partially overlaps with 
the binding site of A-site tRNA in a 70S ribosome (Selmer et al., 2006). Its binding can 
enhance the dissociation rate of ribosomal subunits in manner that is also dependent on IF2 
and IF3 (Pon and Gualerzi, 1984). Association of IF1 also stimulates the association of IF2 
and promotes the specific recruitment of tRNAifMet to the P-site cooperatively with IF2 and by 
blocking access of tRNAs to the A-site (Celano et al., 1988, Moreno et al., 1999). 
IF2 is the single translational GTPase in bacterial translation initiation. Its eukaryotic 
homolog is eIF5B and it is the largest translation factor in bacteria. The protein is arranged 
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in six domains (I-VI) with domains III-VI being the most universally conserved, and can be 
more generally arranged into N-domain, GTPase domains (G and II), and the C-domains 
(C1 and C2) (Eiler et al., 2013, Roll-Mecak et al., 2000). The N-domain is the most variable 
region of the protein and, depending on the organism, may serve to interact near the A-site 
with IF1 but that interaction is not necessary (Boileau et al., 1983). Domain II bridges the N- 
domain to the G domain while an extended helix (helix 8) connects the GTPase domain to 
the C-terminal domains. C2 is responsible for specific interaction with the formylated 
methionine on the tRNA (Spurio et al., 2000, Gualerzi et al., 1991), denoting its function in 
initiation versus elongation. Like eIF5B, IF2 is responsible for subunit assembly, but GTP 
hydrolysis is only necessary for the efficient dissociation of the factor (Marshall et al., 2009, 
Simonetti et al., 2013). Unlike other IFs it has affinity for both subunits, underscoring its role 
in subunit association. Many hypotheses exist for the mechanism of action of IF2 in this 
capacity. The dynamic nature of the protein, as seen from many crystal forms, would imply 
that it changes conformation as it carries out its function, raising or lowering affinity for the 
ribosome and GTP as it does so (Marzi et al., 2003). 
IF3 is a two-domain initiation factor important for start codon selection and fidelity 
(Petrelli et al., 2001). IF3 is most homologous to eIF1, though only through its C-terminal 
domain (Kyrpides and Woese, 1998). The N-terminal domain of IF3 creates a larger and 
more dynamic IF than its eukaryotic counterpart, eIF1. IF3 binds across a large region of the 
30S (Hussain et al., 2016, van Duin et al., 1975). The C-terminal domain is E-site adjacent, 
and the protein extends across the platform to the shoulder region of the mRNA-binding 
cleft. It is critical for regulating premature subunit association (Grunberg-Manago et al., 
1975). It is also highly important for start codon fidelity, and dissociates improper tRNAs or 
can dissociate entire 30S initiation complexes with non-AUG codons in the P-site. Moreover, 
like eIF1, it auto-regulates its own expression by modulating AUG fidelity (Sacerdot et al., 
1996, Ivanov et al., 2010). In a function opposing subunit dissociation, it promotes the full 
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accommodation of coding RNA into the decoding groove when an AUG is present (La 
Teana et al., 1995). Interestingly, the C-terminal domain can accomplish all of these 
functions suggesting that the N-terminal domain is important for 30S association rather than 
directing initiation components. 
An important consideration is that the initiation pathway described for bacterial 
translation is not necessarily a linear assembly pathway. Reports have suggested that 
mRNA-binding is the first step, others suggest IF association is preliminary. The question of 
tRNA delivery is also important considering bacteria do not have an initiator tRNA-specific 
GTPase like eukaryotes. IF1 and IF2 stimulate tRNAifMet association, and IF2’s C2 domain is 
responsible for formyl-specific recognition. Does IF2 associate with tRNA first? Do IFs bind 
before mRNAs? Are the steps of factor recruitment mRNA-specific? These questions and 
more are outstanding in the field, and highlight how little is really known about the molecular 
movements of translation components. It also implies the versatility of bacterial IFs and their 
eukaryotic counterparts, one of which I will discuss specifically in the next section. 
eIF1A Function in Eukaryotic Translation 
Recall, the general contribution of eIF1A to eukaryotic translation is that it works 
cooperatively with eIF1 to promote scanning and start codon selection (reviewed in (Mitchell 
and Lorsch, 2008). This is the function of eIF1A as it is often laid out in reviews or as 
summary assessments of translation initiation. However, it was first identified as part of the 
mammalian translation initiation machinery by extensive biochemistry characterizing 
components of RRL in 1977 (Trachsel et al., 1977, Schreier et al., 1977). Its original 
designation was eIF-4C due to its apparent low molecular weight and purification alongside 
cap-binding factors. From 1977 up until 2003, eIF1A’s function in translation initiation was 
reported to revolve around a plethora of related, but distinct, functions; tRNAiMet delivery to 
40S subunits in an mRNA-independent manner (Trachsel et al., 1977); subunit joining 
(Benne et al., 1978); preventing subunit association (Goumans et al., 1980); stimulating 40S 
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initiation complexes (Timmer et al., 1993); stimulating 80S initiation complexes (Davis et al., 
1996); delivering eIF2-TC to 40Ss without mRNA (Chaudhuri et al., 1997); catalyzing eIF2- 
TC deposition in an eIF3-dependent manner (Chaudhuri et al., 1999); moving ribosomes to 
scan mRNA with the help of eIF1 (Pestova et al., 1998a); binding mRNAs by its OB-domain 
to promote scanning; functioning with eIF1 and eIF3 to stabilize PICs and recruit eIF2-TC 
(Choi et al., 2000, Battiste et al., 2000); communicate with basically every factor on a PIC 
(Olsen et al., 2003, Majumdar et al., 2002). From that point, eIF1A’s many functions were 
effectively framed by scanning because scanning is so critical to most eukaryotic mRNAs. 
Its participation in scanning also provides an interesting evolutionary concept that 
distinguishes it from its bacterial, non-scanning counterpart, IF1. As we learned more about 
this factor, from primary contributions from the Pestova, Hinnebusch, and Lorsch groups, it 
became clear that eIF1A does indeed participate in a number of critical steps in translation 
initiation, much like IF1. Further, when one considers the many confusing reports on its 
function they are easily reconciled by understanding that eIF1A and eIF5B communicate on 
PICs (e.g. tRNA delivery, subunit association, etc.) (Fringer et al., 2007, Acker et al., 2006, 
Marintchev et al., 2003). Principal biochemical analysis of eIF1A has been done using 
mammalian eIF1A (often from RRL), though genetic analysis is often left to yeast systems. 
Important for my work is that it is a critical component of 43S PICs that is already ribosome 
bound, likely occupying most 40S subunits in a cell (Thompson et al., 1977, Smith and 
Henshaw, 1975). It obviously can function in a scanning-dependent fashion, but likely does 
not have to. As one of only three conserved IFs, eIF1A is likely to carry out very similar 
roles as IF1. Divergence between eIF1A and IF1 is largely at the point of the unstructured 
N-terminal and C-terminal tails (NTT and CTT). It is likely that the eukaryotic specific roles of 
eIFs (e.g. facilitating scanning) may rely on those extensions. 
The NTT is a long unstructured tail of eIF1A that is highly basic and spans 
approximately 30 residues (Battiste et al., 2000). It specifically interacts in vivo with eIF2, 
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eIF5, and eIF3 on ribosomes (Yu et al., 2009, Maag et al., 2006, Olsen et al., 2003, 
Majumdar et al., 2002). Its removal decreases translation presumably by preventing the 
formation of a “closed” complex (Llácer et al., 2015, Passmore et al., 2007). Extensive 
alanine substitutions to the NTT of eIF1A are lethal, in data consistent with the idea that 
specific residues are not as important as the overall electrostatic contribution of the basic tail 
to stabilizing the PIC (Fekete et al., 2007). Less severe mutagenesis of the NTT leads to the 
suppression of Sui- (suppressor of initiation) phenotypes (Ssu- phenotype) (Fekete et al., 
2007). More clearly, mutations in eIFs that allow increased translation from non-AUG (UUG) 
codons are called Sui- mutants. Mutation of the NTT of eIF1A rescues start codon stringency 
when coupled to Sui- mutations in eIF5 and eIF2β, perhaps because it can no longer recruit 
defective (mutant eIF5 eIF2β) eIFs. Further, it has been suggested that mutation of the NTT 
promotes an “open” complex and does not facilitate the necessary transition to a scanning- 
arrested “closed” PIC (Saini et al., 2010). In fact, the only structure available with strong 
density observed for the NTT of eIF1A is the “closed” complex in Llácer et al. (2015). The 
NTT is directly contacting the codon:anticodon helix. This tail will become important for my 
studies, as it has an apparent capability to stabilize tRNAiMet on HCV IRES-bound PICs. 
This could be the result of interactions with tRNAiMet, or perhaps that promoting an “open” 
complex on the HCV IRES, by removing the NTT of eIF1A, drastically lowers the affinity of 
tRNAiMet for the ribosome. 
The body of eIF1A is much the same as that of IF1, though there are additional 
helical domains C-terminal of the beta-barrel. As such, much of the overlapping functions of 
the two factors could be attributed to the core of this protein. Indeed, the OB-domain 
mediates ribosome binding to the A-site (Yu et al., 2009, Passmore et al., 2007). 
At the other end of the protein is the CTT. Though distal in sequence, it appears that 
both the NTT and the CTT extend toward the P-site during initiation working cooperatively to 
facilitate translation (Aylett et al., 2015). Before tRNAiMet placement, the CTT is thought to 
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extend into the P-site and the displacement of the CTT is a necessary step in tRNAiMet- 
specific loading (Fekete et al., 2005). The CTT is also responsible for interaction with eIF5B, 
a step necessary after eIF2-TC acquisition (Marintchev et al., 2003). The interaction 
between eIF5B and the CTT of eIF1A is thought to serve two purposes; (1) it communicates 
successful start site selection to eIF5B, perhaps by CTT displacement, and (2) after subunit 
joining and eIF5B-dependent GTP-hydrolysis, the interaction with eIF5B facilitates the 
displacement of eIF1A from the 80S (Acker et al., 2006). The latter function is evident from 
kinetic experiments showing retention of both eIF1A and eIF5B in 80S ribosomes when 
eIF5B had been C-terminally truncated. Phenylalanine residues in the C-terminus of eIF1A 
(F131 and F132) are involved in the recruitment of eIF2-TC (Olsen et al., 2003), thus their 
alanine substitution reduces eIF2-binding but only in the presence of eIF1. This could be 
interpreted as impacting the binding of eIF2 directly, or because CTT mutation interferes 
with the NTT so that it no longer stabilizes incoming tRNAiMet. Unfortunately, the dynamic 
nature of the tails has impeded direct visualization in structural data, with the exception of 
one structure of the NTT. Surprisingly, this same CTT mutation causes in increase in non- 
AUG initiation (Sui- phenotype) (Fekete et al., 2005, Fekete et al., 2007). It was also 
observed that the CTT is important in determining the preference of the ribosome for an 
“open” or “closed” state in a codon- and eIF5-dependent manner (Maag et al., 2006). The 
simplest way to organize the data regarding eIF1A is to consider the importance of the 
“open” versus “closed” conformation of the ribosome. The former allows the search for start 
codons; the latter commits the present codon to initiation. Mutations to the NTT permit 
ribosomes to stay in the open state longer (more time to find the right start site), and 
mutations to the CTT accelerate commitment to the current start site (less time to find the 
right start site). The opposing roles of the tails of eIF1A are, in my mind, analogous to two 
hands manipulating a naval signal lamp; one switching the light on, a second switching the 
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light off. Coordinated motion between the two causing meaningful signals to be 
communicated to PICs (or P-I-“Sea”s). 
The duality of the NTT and CTT can be conceptualized in two ways; (1) the NTT is 
pushing “closed” complex formation and the WT CTT antagonizes it, while conversely, the 
CTT is driving toward an “open” complex by displacing tRNAs and/or eIF2-TC, or (2) the 
NTT is interfering with the “open” complex such that mutations in the NTT cause open 
complex retention and the CTT is interfering with the “closed” complex such that mutations 
in it instigate premature complex closure. While quite confusing, the interplay between these 
two states is at the heart of eukaryotic translation initiation, and visualizing eIF1A in a 
“simpler” system by removing scanning may clarify the picture. 
Viral non-IRES RNA Sequences and Structures Modulating 
Canonical Translation 
Viruses have served as invaluable tools in the study of translation, as well as the 
study of many other important cellular processes. Positive sense RNA viruses, especially, 
have evolved a number of methods to bypass different forms of translation regulation in 
response to viral infection. These methods include viral protease-mediated cleavage of 
regulatory proteins or translation factors that will not be addressed in this text but have been 
reviewed extensively elsewhere (Walsh and Mohr, 2011, Walsh et al., 2013). Also quite 
prevalent are structures in viral genomic or subgenomic RNAs that can specifically 
manipulate the ribosome or the function of eIFs. Viral genomic (g)RNAs are the molecules of 
RNA that constitute the complete genome of a virus, in the case of (+)ssRNA viruses these 
are infectious RNA molecules. Sub-genomic (sg)RNAs are shorter RNA species templated 
from viral gRNA, often serving to produce proteins from alternate reading frames. Structures 
that manipulate translation components often restrict themselves to the 5’ or 3’ UTRs of the 
g- or sgRNAs. Below, I discuss a number of known RNA structures that can manipulate the 
initiation step in translation and provide some brief examples of the viruses that use them. 
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Leaky Scanning 
Once a capped RNA is identified and the PIC has assembled, the ribosome scans 
the RNA for an AUG in good context to start translating. If an AUG is not properly 
recognized the ribosome may continue to scan (Figure 3B). Viruses have evolved multiple 
reading frames to maximize their limited coding capacity. The rate at which each reading 
frame is recognized during scanning, and thus the degree to which each AUG is used, 
depends on both the consensus strength of each AUG start site as well as its proximity to 
the 5’ end (Kozak, 2002, Berthelot et al., 2004). This happens commonly with multiple 
reading frames decoded at distances approaching 1 kb from the cap (Ftterer et al., 1996). 
Notable mammalian viruses that use this method include influenza A and B, some 
hantaviruses, and mammalian orthoreovirus (Vera-Otarola et al., 2011, Wise et al., 2009, 
Ernst and Shatkin, 1985, Williams and Lamb, 1989). 
Also relevant are non-AUG initiation events. Non-AUG codons, with special 
preference given to CUG (Figure 3B), can be decoded during initiation up to 30% of the time 
(Touriol et al., 2003). Diverse viral mRNAs can initiate from non-AUG start sites, many from 
plant viruses. An exceptional example of increasing coding capacity by manipulating 
scanning and start-site selection is the Panicum mosaic virus where up to four ORFs from a 
single sgRNA can be expressed using a combination of leaky scanning and GUG initiation 
(Turina et al., 1999). 
Ribosome Pausing Structures 
Structured RNAs must be unwound to be decoded by the ribosome. Throughout 
scanning and up to the start codon selection this is accomplished by eIF4A, DHX29, or 
some other RNA helicase and extensive structure may slow the rate of initiation. After start 
site selection, however, the PIC is committed to later steps in translation initiation and the 
PIC begins to disassemble (eIF1 loss). RNA structure adjacent to the initiation site can affect 
the rate of initiation as well (Kozak, 1990), presumably by slowing the steps following start 
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site selection down sufficiently to make sure the PIC acquires eIF2-TC or tRNAiMet by some 
other mechanism. One example is found in the later stages of infection by an alphavirus. 
Specifically, sgRNA is translated in the absence of eIF2-TC by stalling initiation at a stable 
stem loop adjacent to the start-site long enough for an alternate eIF (eIF2A not eIF2α) to 
direct Met-tRNAiMet to the initiation complex (Ventoso et al., 2006) (Figure 3C). During high 
levels of eIF2 this process is likely not important, but during periods of eIF2-limitation this 
may provide time for viral translation initiation complexes to acquire Met-tRNAiMet instead of 
being disassembled by quality control machinery. By slowing initiation with a stem-loop, 
alphaviruses can use the canonical pathway with eIF2 early during infection as well as co- 
opt a secondary pathway to translate during virus-induced translation inhibition. 
uORFs 
A special case of translation is mediated by mRNAs that contain multiple ORFs on 
the same message (mentioned above). This is quite common in bacteria, but polycistronic 
translation is somewhat rare in eukaryotes and is mostly limited to one or more small ORFs 
(<30 amino acids in length) preceding a longer regulated ORF (Figure 3D). These cases are 
interesting in that they effectively involved a form of canonical cap-dependent translation 
occurring multiple times on the same mRNA. A good example is in the ATF4 gene. In the 
case of ATF4, translation of the functional transcription factor is governed by two uORFs, 
the first of which is entirely upstream of the ATF4 ORF and the second uORF that contains 
the start site for the full-length ATF4 transcription factor (Vattem and Wek, 2004, Lu et al., 
2004). Translation of the first ORF likely proceeds normally. After termination of translation 
from short peptides, however, the 40S can often stay associated and scan further 
downstream of the uORF’s stop codon, like with the GCN4 gene in yeast (Mueller and 
Hinnebusch, 1986). This can proceed somewhat in the absence of all canonical eIFs, but 
there is some debate over the ability of eIFs to stay associated with ribosomes even after 
initiation is finished. Regardless, either with the full complement of eIFs, or with a subset, the 
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ribosome can then scan down to the second start site (the second uORF). Under conditions 
of high eIF2, there is plenty of time for a new eIF2-TC to be acquired and for translation to 
initiate at this site. However, during eIF2-limiting conditions (eIF2α-phosphorylation) there is 
not sufficient time to acquire eIF2 and so the initiation complex may keep scanning down to 
the ATF4 start site where it would be halted long enough to find eIF2-TC and initiate the 
translation of a transcription factor necessary for the expression of a number of stress 
responsive genes (Ameri and Harris, 2008). 
Other mRNAs, including other ATF genes, employ this strategy for regulated gene 
expression. There is quite a large body of literature regarding a growing list of 
experimentally-defined uORFs (Barbosa et al., 2013). I should note as well that not all 
uORFs are regulated as I mention above; rather there are a number of proposed 
mechanisms of uORF function. As a general observation, however, the situations in which 
uORFs may be most beneficial are stress conditions so that the cell can produce genes 
involved in responding to stress. Dysregulation of the expression of some uORF containing 
genes are causative in some disease states. For example, several thromboembolic 
conditions arise from a mutation that introduces an uORF in human clotting factor XII 
leading to a reduction in levels of this factor in plasma (Bersano et al., 2008). More 
examples of the manipulation of uORFs in cell biology and disease states are expertly 
reviewed by Barbosa et al. (2013). 
3’ End-dependent Translational Enhancement 
Many viral mRNAs, especially those that mature in the nucleus, are polyadenylated 
and benefit from the increased mRNA stability and translation enhancement that cellular 
mRNAs do. However, a large number of viruses do not encode their own polyadenylating 
enzyme and have evolved RNA signals that functionally replace it. RNA structure exists in 
the 3’ of many mRNAs in general but is enriched in viral mRNAs and often serves in 
translation and/or replication. Interestingly, plant viruses serve as a rich source of examples 
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of  3’ RNA structures involved in translation (Simon and Miller, 2013), though other RNA 
viruses also have them. Many methods of 3’ UTR-based stimulation of translation involve 
long-range cis-acting communication with the 5’ end of the RNA (Nicholson and White, 
2014), much like the mechanism proposed for cap:poly(A)-tail synergy (Tomek and 
Wollenhaupt, 2012). We will discuss these tactics below, but it is also worth noting that not 
only does RNA structure at the 3’ end facilitate translation, it may also function in protecting 
viral mRNA from 3’-5’ degradation (Narayanan and Makino, 2013). 
3’ CITEs 
3’ cap-independent translation enhancers (3’ CITEs) describes a number of 
structurally distinct RNA elements found in the 3’ end of a number of RNA plant viruses that 
enhance translation of gRNA and/or sgRNA (Nicholson and White, 2011). 3’ CITEs recruit 
translation components to the 3’ end rather than the 5’ end of the ORF (Simon and Miller, 
2013). It may seem somewhat strange that viral mRNAs would preferentially recruit 
translation machines downstream of the ORF they are meant to stimulate, but proposed 
mechanisms of CITE-directed translation enhancement include the subsequent rounds of 
translation by streamlining the transition from recycling to initiation, perhaps by capturing 
ribosomes that just terminated at the mRNA 3’ end and delivering them to the 5’ end again. 
Below, I discuss three general types of 3’ CITE. 
First, the Barley yellow dwarf virus contains a translation element (BTE) (Figure 4B) 
included in a number of viral genera like Luteovirus and Necrovirus (Meulewaeter et al., 
2004) and seems to be one of the most potent CITEs found (Fan et al., 2012). This CITE 
contains a conserved 17-nt motif in the 3’ UTR: GGAUCCUG-GNRNA-CAGG where the 
underlined nts form a hairpin and the GNRNA-loop must be formed (Wang and Miller, 1995). 
The overall structure can vary considerably between different viruses, but this hairpin-loop 
motif exists in all. RNA-RNA interactions between the 3’ and 5’ end of the mRNA are 
essential in most cases but may not occur within the BTE. The binding event of most 
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consequence is the high affinity binding of the BTE with eIF4G in a position that is non- 
competitive with the 4E and PABP binding (Das Sharma et al., 2015, Kraft et al., 2013). 
Second are PTEs (Panicum mosaic virus-like translational enhancer). PTEs exist in 
the Panicovirus genus and also in some carmoviruses (Batten et al., 2006). Unlike BTEs, 
they depend on a high-affinity interaction with eIF4E that does not depend on eIF4G (Wang 
et al., 2009). Surprisingly, the PTE binds eIF4E without the need for an m7G (Figure 4C). 
This RNA forms a branched helix with a C-rich bulge near the helical junction. This region 
likely base-pairs to a second G-rich motif within the main stem (Wang et al., 2011). Probing 
studies have indicated that, once folded, a G residue within the G-rich motif is flipped 
outward in a solvent-accessible position that could make it a substrate for the cap-binding 
pocket of eIF4E. Surrounding primary sequence also seems to be important for eIF4E 
binding and probably facilitates additional affinity (Liu and Goss, 2014). 
Finally, other 3’ CITEs include so-called I-shaped (ISS) and Y-shaped (YSS). 
Extended helices either singly (ISS) or three-helical junctions (YSS) represent the structural 
character of this type of CITE and both types are characterized by dependence on intact 
eIF4F (Figure 4D). Not much specific structural data is present in both cases, but the 
paradigm for other CITEs is supported in that long-range interaction with the 5’ end is 
necessary and works in conjunction with the ISS or YSS presumably to deliver eIF4F to the 
5’ end of the mRNA (Simon and Miller, 2013). 
tRNA-like Structures (TLSs) 
Some methods of translation enhancement come from plant viral genomes that 
encode a structure in the 3’ UTR that folds similarly to a tRNA (Figure 4F & G). Not only do 
these RNAs mimic tRNA structurally, they can be substrates for aminoacyl RNA synthetases 
(AARS), bind eEF1A, have affinity for the ribosome, and promote translation of the viral ORF 
(Albers and Czech, 2016, Dreher, 2010). A recent crystal structure of the TYMV TLS from 
our lab shows the unique nature of Val-tRNA mimicry (Colussi et al., 2014). While 
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maintaining an overall tRNA-like fold, the RNA solves the problem of being linked to the 
gRNA by creating a “tRNA-like face” that can be modeled onto the valyl-synthetase and the 
“divergent face” extends toward the rest of the gRNA. Multiple members of the tymovirus 
and Tobamovirus genera have aminoacylatable 3’ TLS structures but seem to only be 
aminoacylated with valine, histidine, or tyrosine perhaps due to specific features of the 
AARSs themselves (Dewan et al., 2013). TLSs seem to work synergistically with a 5’ cap to 
enhance translation (Matsuda and Dreher, 2004). Though they are aminoacylated and bind 
eEF1A, direct evidence of delivery to and participation in elongation is inconclusive 
(Matsuda and Dreher, 2006). It may happen that eEF1A-bound TLS can interact with either 
the ribosome or other components of translation and recruit them to the viral message, but 
this has yet to be definitively shown. 
Translation enhancement can also be dictated by T-shaped structures (TSS) that are 
structurally similar to TLSs but distinct in that they are 3’ UTR internal signals and therefore 
cannot be aminoacylated. Their function, at least in Turnip crinkle virus (TCV) and 
Cardamine chlorotic fleck virus (CCFV), involves direct interaction with 80S or 60S 
ribosomes (Gao et al., 2012), but does not seem to involve long-range RNA-RNA 
interactions (Stupina et al., 2008). Other TSSs form long range interactions and may act 
cooperatively with other 3’ CITEs like in the case of PEMV; which encodes both a TSS as 
well as a PTE (Gao et al., 2014). Independent elements in the 5’ UTR may also bind the 
ribosome or some associated factor to facilitate circularization. 
Reinitiation 
Once an open reading frame has been translated and the ribosome encounters a 
stop codon, eRFs associate and stimulate peptide release, tRNA release, and subunit 
dissociation (Dever and Green, 2012). Some viruses co-opt this process and translate 
bicistronic viral RNA by encoding ribosome-binding motifs within the mRNA that keep 40S 
subunits associated long enough to encounter a downstream AUG that signals the start of 
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the next ORF (Figure 4E). A well-characterized example, originally suspected to be -1 
programmed ribosomal frameshifting, comes from feline calicivirus (Neill et al., 1991). Other 
members of the Caliciviridae, including human and bovine noroviruses (NVs) and 
hemorrhagic viruses like rabbit hemorrhagic disease virus (RHDV) also share a similar 
mechanism of translating capsid protein (Meyers, 2007, Luttermann and Meyers, 2007, 
McCormick et al., 2008). Within the sgRNA of each virus is an RNA structure called the 
termination upstream ribosome binding site (TURBS) encoded within the 3’ 40-80 nt of the 
upstream ORF. This TURBS  element contains two essential RNA structural motifs. Motif 1 
is a sequence in the loop of a hairpin formed by motifs 2 and 2*. Motif 1 has 
complementarity with a specific stretch of ribosomal RNA within h26. This mRNA-rRNA 
base-pairing is sufficient to maintain the 40S subunit on the mRNA post-termination 
(Luttermann and Meyers, 2009). While still bound, the 40S can move along the mRNA to the 
ORF2 start site which is within a few nts of the ORF1 termination site but varies in exact 
distance by virus (Pyry et al., 2007). There are conflicting reports on factor requirement, but 
clearly reinitiation is streamlined in comparison to initiation (Zinoviev et al., 2015). Factor 
requirement may also be template specific. 
IRES-driven Translation Initiation 
Internal ribosome entry is a phenomenon that has been studied for some time now. It 
was first observed from the encephalomyocarditis virus and poliovirus (Pelletier and 
Sonenberg, 1988, Jang et al., 1988). An internal ribosome entry site is an RNA molecule, 
often highly structured, that can deliver translation machinery to the start site of an ORF in a 
cap- or 5’ end-independent manner (Filbin and Kieft, 2009). Since their initial 
characterizations many IRESs have been discovered in both viral families as well as in 
cellular transcripts, however, a rigorous panel of controls must be performed to define a  
bone fide IRES. Hepatitis C virus was first characterized in 1992 (Tsukiyama-Kohara et al., 
1992), though cases of viral non-A or –B hepatitis was described as early as 1976 (Purcell 
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et al., 1976). The first clone was described in 1989 (Choo et al., 1989). Shortly thereafter it 
was determined that its 5’ UTR also contained a site for internal translation initiation. It 
became clear that the method of initiation from the HCV IRES was efficient and 
mechanistically distinct from that of the picornaviral IRESs described earlier. Since then, the 
structural and biochemical characteristics of a number of viral IRESs has been characterized 
in the literature in an effort to understand viral mRNA translation, as well as general 
principles of eukaryotic mRNA translation (Lozano and Martínez-Salas, 2015). 
Most viral IRESs can be categorized into four groups based upon their general 
mechanism of initiation, e.g. the way the 40S is recruited, factor requirements, or 
dependence on scanning. Type 1 IRESs have, so far, only been observed in the 
Picornaviridae and are characterized by their dependence on all canonical eIFs except 
eIF4E, indirect recruit the 40S ribosome by IRES-bound eIFs, and their need to scan 
downstream to the authentic AUG. These IRES RNAs are relatively extended in structure 
and are longer than the more compact IRESs mentioned below. Type 2 IRESs are also 
picornaviral and operate in much the same fashion as the type 1 IRESs, though without the 
need for a scanning step before AUG recognition. Type 3 IRESs are unique in that they 
have been described in members two viral families, the Flaviviridae and the Picornaviridae, 
and are characterized by their ability to recruit the ribosome by directly binding the 40S, 
operate with only three eIFs in addition to initiator tRNA, and their independence from 
scanning to place their AUG start sites properly. Structurally, they contain somewhat 
extended secondary structures that are punctuated by a few essential, highly structured 
regions. The type 4 IRESs have so far only been found in members of the Dicistroviridae are 
characterized by their ability to bind directly to ribosomes, operate independently of all eIFs, 
and initiate from non-AUG start sites in a scanning-independent fashion. Other viral IRESs 
exist that are not categorized into those four groups. These IRESs either have not been 
studied sufficiently, or have unique mechanistic or structural characteristics that make them 
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poor candidates to join a particular group. I will briefly cover the structural and mechanistic 
characteristics of IRES types 1, 2, and 4 and briefly mention some variant IRESs below, but 
I will cover the virology, structure, and mechanism of the type 3 IRESs in much greater detail 
in its own section because HCV (and related) IRES-dependent translation initiation is the 
subject of the majority of the work of this text. 
Picornaviral (Type 1 and 2) IRES-dependent Translation Initiation 
The first internal ribosome entry sites (IRESs) that we will discuss belong to, 
primarily, picornaviruses (Figure 5A & B). Both types 1 and 2 are characteristically similar; 
structured, modular RNA domains that bind to specific components of the translation 
machinery but lack the ability to bind to the 40S subunit directly, and they are all similarly 
sized (~450 nt). They differ in dependence on scanning (type 1) or non-scanning (type 2) 
types of initiation. For general purposes I will use the poliovirus (PV) IRES (Figure 5A) and 
the encephalomyocarditis virus (EMCV) IRES (Figure 5B) as prototypes for type 1 and 2, 
respectively. It should be noted, however, that there are many other related IRESs that have 
functional deviations based on subtle structural differences. These differences are reviewed 
elsewhere (Martínez-Salas et al., 2015). 
The RNAs are divided into five domains based upon RNA secondary structure; type 
1 domains II-V, type 2 domains 2-5. A sixth domain in PV IRES separates the majority of the 
IRES from the AUG and must be unwound during scanning. These large IRES RNAs exist in 
extended conformations that make structural studies difficult, but they have been analyzed 
using genetic and chemical methods. Polypyrimidine tract binding protein (PTB) is essential 
for IRES activity presumably by framing the overall IRES structure (Kafasla et al., 2010, 
Hunt and Jackson, 1999, Kafasla et al., 2009, Borovjagin et al., 1994). PTB binds domains II 
and 2 of either type of IRES along with other polypyrimidine tracts (Yn) nearer the AUG. 
Domains IV-V and 3-4 harbor essential GNRA motifs within looped regions that serve as 
structural center points for binding sites of PTB, eIF4G, eIF4A, and seems to participate in 
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long-range interactions (Fernandez-Miragall et al., 2005, Sweeney et al., 2011, Fernández 
et al., 2011, Fernandez-Miragall and Martnez-Salas, 2003, Yu et al., 2011, Sweeney et al., 
2013). Domain V serves to bind components of the PIC, eIF4G and eIF4A. Domain 4 of type 
2 IRESs serves a similar purpose in recruiting eIF4G. Domain 5 provides binding for other 
translation factors as well (de Quinto et al., 2001). Finally, a pyrimidine-spacer-AUG motif 
(Yn-Xm-AUG) provides the 3’ boundary and the initiation site for the type 2 variety (Kaminski 
et al., 1994). The type 1 IRESs, however must scan through domain VI in an eIF4A- or 
DHX29-dependent manner to reach the appropriate AUG (Hellen et al., 1994). 
Intergenic Region (Type 4) IRES Translation 
The only known examples of type 4 IRESs are relatively short RNAs of ~200 nt that 
are found in the region between the ORFs coding the structural and non-structural proteins 
of dicistroviruses, the so-called intergenic region (IGR) IRESs. They are the most compactly 
folded IRES RNAs and can recruit ribosome subunits sequentially or as an 80S for initiation 
from a non-AUG start site (Petrov et al., 2016). The elegance in their structure comes from 
efficient use of tertiary structure (Figure 5D). There are two major functional domains whose 
structures have been solved independently by crystallography, or together in complex with 
the ribosome by cryo-EM. The first being the domain responsible for ribosome binding 
(including domains I and II) (Pfingsten et al., 2006). The second a unique domain that 
mimics the intermolecular interaction of tRNA and mRNA in the P-site by an intramolecular 
reaction (Costantino et al., 2007). As a unique consequence of this interaction the IRES 
RNA in the P-site serves to “trick” the ribosome into thinking it is elongating instead of 
relying on initiation steps. In fact, recent high resolution cryo-EM maps show initiation by 
IGR IRESs requires a translocation step to fully commit to elongation (Muhs et al., 2015, 
Fernández et al., 2014), and that the first translation step proceeds decoding of a viral 
codon (Abeyrathne et al., 2016). As such, necessary communication of an internal loop 
within domain 1 of the IRES with the elongation-associated L1 stalk of the 60S subunit likely 
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facilitates translocation (Spahn et al., 2004). Another example of the necessity for higher 
order structure is shown by the severe functional consequences upon disrupting any PK 
interaction (Kanamori and Nakashima, 2001). 
There is relatively limited information known overall about the viral life cycle save that 
they are related to the Picornaviridae (reviewed in (Bonning and Miller, 2009), but the IGR 
IRESs have provided invaluable insight into the mechanistic steps in eukaryotic translation 
and surprisingly operate as translation signals in bacteria as well (Colussi et al., 2015). 
More to our point, this class of IRESs is unique in that it is essentially unaffected by any 
known mechanism of translation regulation, which is obviously beneficial to any virus that 
uses it. 
Variant Viral IRES Translation 
The four classes of IRES mentioned above categorize well-studied examples of viral 
IRESs, but since their classification other types of IRES have been identified to exist that 
operate through mechanisms that defy easy classification. One example is found in the 
aforementioned Dicistroviridae. These viruses contain not only the type 4 IRESs in their 
intergenic region, but also another IRES at the 5’ end of the genome that drives translation 
of the upstream ORF. In contrast to the IGR IRES, this 5’ IRES appears to be  less 
structured and likely contributes to ribosome binding through polypyrimidine stretches 
(Groppelli et al., 2007); its precise mechanism of action remains unknown. Some DNA 
viruses have also been observed to contain IRESs (Yu and Alwine, 2006, Grainger et al., 
2010, Bieleski and Talbot, 2001), but like cellular IRESs, DNA virus-encoded IRESs appear 
to be largely extended in conformation and may require a confusing array of classical eIFs 
and ITAFs. The HIV-1 and the HIV-2 IRESs are other examples for special consideration. 
Like the type 1/2 IRESs mentioned, they do not form compactly folded conformations, and 
they seem to manipulate binding of eIFs rather than directly binding the 40S subunit but the 
exact factor requirement has been hard to characterize. The HIV-1 IRES operates upstream 
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of the AUG but is spliced into many different forms in the various viral transcripts (Plank et 
al., 2013). In contrast, the proposed HIV-2 IRESs fall entirely within the gag coding region 
and can initiate translation from each of three upstream AUGs (Herbreteau et al., 2005). In 
both cases though, retroviral mRNA is processed as an authentic cellular (capped) message 
so the exact contribution of cap-dependent or IRES-dependent translation is still unknown 
(Smirnova et al., 2015). 
 
 
HCV and HCV-like (Type 3) IRES Translation 
As I mentioned, the HCV IRES was one of the first originally described (Figure 5C) 
(Tsukiyama-Kohara et al., 1992). It turns out that the HCV IRES is not unique in its structure 
or mechanism of translation and other viruses were shown to contain similarly structured 
RNAs. The type 3 IRESs are related to the HCV IRES and are found in viruses from two 
different viral families, a unique characteristic thus far. This presents an interesting 
consideration when trying to interpret the function of these RNAs, and deserves to be 
addressed in greater detail. In order to understand the biological consequences of a virus 
encoding a type 3 IRES, one must first consider the replication cycle of the relevant viruses. 
Next, the in vitro descriptions of IRES function should be considered and then compared to 
what we know about the consequences of infection for translation. The interplay between in 
vitro and in vivo type 3 IRES function is a focal point for this work and is discussed below. 
Replication Cycles of Type 3 IRES-harboring Viruses 
HCV-like IRESs are all similar in that they are encoded in positive-sense single- 
stranded (+)ssRNA viruses, but the viruses that use them have different biology and 
replication kinetics. Below is an introduction to the basic replication cycles of the flavi- or 
picornaviruses. I pay special attention to that of the hepatitis C virus as it is the main focus 
of my work. It is also a member of the Flaviviridae, but specifically a hepacivirus with unique 
genomic organization as well as general virology. 
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Hepatitis C Virus 
The HCV genome is approximately 10 kilobases in length flanked by a 
triphosphorylated 5’ UTR and a 3’ UTR containing extensive RNA secondary structure but 
no polyadenylated tail (Figure 6). HCV viral particles (Scheel and Rice, 2013) are enveloped 
somewhat pleomorphic 50-80 nm wide particles that have some unique structural 
characteristics. The envelope of the virion contains two glycoproteins, E1 and E2, that form 
heterodimers studded throughout the surface of the particle and it encloses a non- 
icosahedral nucleocapsid composed of the core protein and the viral gRNA (Gastaminza et 
al., 2010). Along with the virally encoded components of the virion, the virions tend to 
associate with low-density and very-low-density lipoproteins (LDL and VLDL) to varying 
extents that fluctuate depending on growth conditions (Akazawa et al., 2011). These 
lipoviroparticles (LVPs) are likely somewhat hidden from the host immune system due to the 
close association with lipoproteins that are essential components of the blood. 
The LVPs from HCV bind to a number of cellular receptors and co-receptors through 
the E1 and E2 heterodimeric glycoprotein. At least the LDL-receptor, SR-BI, CD81, CLDN1, 
and OCLN (Lindenbach and Rice, 2013) are required for binding and entry into hepatocytes, 
but more cell-surface interactions are likely to be discovered as in vitro models develop. It 
seems that CD81 and OCLN are what restrict host species as well (Sandmann and Ploss, 
2013). I would like to also point out that while extracellular entry is an efficient method of 
infection for HCV, the infection of cells by movement of receptor complexes to tight junctions 
might be what is actually happening in the liver and cell to cell spread through tight junctions 
seems likely within an infected liver (Graw et al., 2015). After receptor binding internalization 
of the virion takes place through the clathrin-mediated endocytosis pathway and uncoating 
of the virion requires acidification of the endosome and E2-mediated membrane fusion 
(Lindenbach and Rice, 2013). Once the endosomal and viral membranes have fused, the 
capsid can enter the cytoplasm. The specific steps in the process of membrane fusion and 
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uncoating are still rather poorly understood, but perhaps the uncoating step may be linked to 
the first round of translation or a capsid ubiquitination step like from Dengue virus (Byk et al., 
2016). 
Translation of the single polyprotein ORF of HCV is driven by an IRES and will be 
covered in great detail throughout this text. Once a polyprotein is made however cellular and 
viral proteases cleave it into the mature forms of all viral proteins. The viral structural 
proteins are cleaved by ER-associated proteases, signal peptidase and signal peptide 
peptidase. After that, the non-structural proteins are auto-cleaved by either the NS2-NS3 
protease or the NS3-NS4A protease to ultimately form the replication complex comprised of 
the C-terminal peptides of the polyprotein downstream of NS3 (Scheel and Rice, 2013). 
Blockade of the NS3 protease activity of the virus has seen greater than 95% clearance rate 
in infected patients, starting with the inception of Boceprivir and Telaprivir and continuing 
with variations of these. 
Transcription of the anti-genomic strand of the viral RNA is necessary for the 
production of more positive-sense copies for viral propagation. The NS5B protein is the 
RNA-dependent RNA polymerase and acts at replication sites with the help of the other non- 
structural proteins (Moradpour et al., 2003). NS5B initiates synthesis of genomic and anti- 
genomic strands in a template-dependent fashion that seems to start by the generation of a 
dinucleotide primer (Scrima et al., 2012). As positive and negative sense strands of the virus 
accumulate infection accelerates. 
Once a sufficient amount of gRNA and core molecules have been generated, viral 
assembly can begin. The process is somewhat unique in HCV relative to other members of 
the Flaviviridae, considering virion maturation is tightly linked to host lipoprotein (Thomssen 
et al., 1992). Delivery of gRNA for nucleocapsid assembly is poorly understood, but 
effectively gRNA is loaded with core protein with the assistance of NS5A and nucleocapsid 
is extruded from the cytoplasm into the ER lumen for the maturation of virions through the 
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VLDL pathway and later steps of maturation (Syed et al., 2010). Viral particles are 
processed through the Golgi and exocytosed for release. 
 
Pestiviruses 
Pestiviral gRNA is organized much the same as the HCV case described above 
(Schmeiser et al., 2014), though it is about 20% longer in the case of the classical swine 
fever virus (CSFV, formerly hog cholera virus) (Meyers and Thiel, 1996). In fact, the 
replication dynamics are much the same as HCV, with an important difference in the final 
assembly and maturation steps. After sufficient replication and polyprotein synthesis, the 
nucleocapsid is formed and extruded into the ER lumen, but the maturation steps thereafter 
are not associated with lipoprotein synthesis. The viral particles are enveloped by ER 
membrane and simply processed through the exocytic pathway and released without the 
association of lipoprotein (Murray et al., 2008). 
Picornaviruses 
Picornaviral gRNAs contain IRESs and are a repository of the first three types of 
IRESs mentioned. This presents an interesting question; how does the picornaviral 
replication cycle accommodate multiple modes of translation within their virological 
framework? The answer to that question has not really been addressed but understanding 
the general mechanism of picornavirus replication can help us speculate. This group of 
viruses, including enteroviruses, rhinoviruses, hepatitis A virus, etc. are formed in 
icosahedral ~30 nm capsids. The viral genome itself is only 7-9 kilobases in length. Like 
many (+)ssRNA viruses, the virus encodes a single polyprotein in its ORF that is flanked by 
extensive 5’ and 3’ UTRs (Figure 6). The 5’ UTR can be anywhere from 500-1500 
nucleotides in length but universally contains a covalent viral protein (VPg) modification to 
the 5’ end in place of an m7G-cap structure (Flather and Semler, 2015). The 5’ UTR also 
contains essential replication signals while also containing an IRES to facilitate protein 
production in lieu of a cap (Lyons et al., 2001, Barton et al., 2001). The 3’ end is generally 
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shorter (approximately 50-350 nucleotides) and contains necessary replication signals as 
well as a polyadenylated end (Rohll et al., 1995). 
Surface receptors responsible for picornaviral entry are quite diverse, not surprisingly 
considering the large number of picornaviruses, but they tend to include inmmunoglobulin 
superfamily proteins, integrins, membrane-bound glycoproteins, as well as sialic acid 
residues (Tuthill et al., 2010). 
Entry of picornaviruses generally requires either clathrin- or calveolin-mediated 
endocytosis, though poliovirus enters independently of those two pathways (Tuthill et al., 
2010, Pelkmans et al., 2004). In most cases endosomal acidification facilitates viral 
uncoating, but not all picornaviruses require this step. In some cases receptor binding is 
sufficient to trigger conformational changes in the capsid (so-called A particle formation in 
poliovirus) (Curry et al., 1996). Through mechanisms unknown, however, a second 
conformation change leads to the release of viral RNA into the endosome, perhaps triggered 
from the N-terminus of VP1 and the generation of an empty capsid intermediate at low pH 
(Tuthill et al., 2009, Tuthill et al., 2006). Once released the RNA must find a way to breach 
the membrane, but again, data informing this process are scant. 
Like all sense-strand viruses, the first step once released in the cytoplasm must be to 
translate. This is accomplished by one of three types of IRESs depending on the virus and 
leads to the production of a polyprotein containing three regions, P1, P2, and P3. The 
polyprotein is auto-cleaved first in one step by (in poliovirus) the 2A protease to release the 
structural (P1) and non-structural (P2 and P3) proteins. Subsequent processing steps are 
performed by the 3C(D) protease (Blom et al., 1996, Banerjee et al., 2004). Once cleaved 
and released viral proteins can begin replication first through negative strand synthesis by 
the 3D polymerase (primed by uridylated VPg) and the formation of replication complexes. 
Once infection has taken hold and replication complexes are hard at work, structural 
proteins accumulate along with sense gRNAs. Virion formation occurs in the cytoplasm and 
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incorporates VPs 1-4 into a 60-unit (240-protein) capsid that is fit for packaging viral RNA 
(Zhu et al., 2015). Packaging is still somewhat mysterious, but it is clear that there are 
metastable intermediates of the capsid between initial assembly, RNA packaging, and 
release (Veesler and Johnson, 2012). There are important, sometimes proteolytic, steps that 
lead to final maturation of a virion. The viral particles are then released during cell lysis as 
150S particles after they have accumulated throughout infection (Guttman and Baltimore, 
1977). 
In Vitro Model of HCV IRES-Mediated Translation 
The structure of HCV and similar IRESs have been mapped out extensively using 
chemical and enzymatic RNA probing methods. The resultant structure of the HCV, CSFV, 
and SPV-1 IRESs are shown (Figure 7). Portions of the HCV IRES have been solved 
independently using NMR and X-ray crystallography (reviewed in (Filbin and Kieft, 2009), 
but only recently have high resolution structures of intact IRES been solved using cryo-EM, 
specifically in the case of HCV and CSFV (Hashem et al., 2013b, Spahn et al., 2001, Quade 
et al., 2015, Yamamoto et al., 2014). The RNA molecules that function in internal translation 
initiation are approximately 330 nucleotides in length in the case of HCV and closer to 400 in 
some like GBV-B. The RNAs must fold in a very specific tertiary pattern to operate 
efficiently. This includes three independently folded domains (II, III, and IV). Within the 
extended stem-loop that is domain II, the A-form helix is often interrupted by bulges that 
dictate binding sites for cellular proteins like PKR (Toroney et al., 2010), provide contacts 
with the translation machinery, and cause the RNA to fold into a conformation (~60˚ bend) 
necessary for function (Lukavsky et al., 2003, Spahn et al., 2001, Filbin et al., 2012, Filbin 
and Kieft, 2011). Within dIII are three-way and four-way junctions that are essential for 
presenting the binding surface for both eIF3 and the 40S subunit (Kieft et al., 2002, Kieft et 
al., 2001, Kieft et al., 1999). Domain IV is somewhat variable among the related IRESs in 
that it starts with pseudoknotting on dIIIf and an adjacent stem-loop containing the ORF start 
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site or a single stranded region containing the start site (Berry et al., 2011, Berry et al., 
2010). Some type 3 IRESs, like the SPV IRESs, are not predicted to form an AUG- 
containing stem-loop (Hellen and de Breyne, 2007). The ultimate importance of this 
distinction in dIV has yet to be fully characterized though mutations that disrupt dIV lead to a 
moderate increase in IRES activity (Honda et al., 1996). Ultimately, it seems reasonable that 
subtle structural differences like this relate to IRES-specific tuning of activity. 
Recently, advances in detection and data processing from cryo-EM has yielded 
detailed structural insight into the specific molecular contacts necessary for IRES function 
on the ribosome. Most studies focus on the HCV IRES but essential, similarly structured 
viral IRESs from pestiviruses and picornaviruses exist as well (Hellen and de Breyne, 2007, 
Martínez-Salas et al., 2015, Lozano and Martínez-Salas, 2015). The RNA folds into two 
major domains (dII and dIII) with a smaller domain IV sometimes containing a pseudoknot 
(PK) and stem-loop with the AUG. Solution structures for dII (Lukavsky et al., 2003), crystal 
structures for portions of dIII (Kieft et al., 2002) and low resolution cryo-EM reconstructions 
of the 40S-IRES have existed for some time (Boehringer et al., 2005, Spahn et al., 2001, Yu 
et al., 2007), but we now have near atomic resolution data that provides remarkable insight 
into why this IRES structure is so effective (Quade et al., 2015, Yamamoto et al., 2014). 
DII is a dynamic irregular helix that, when ribosome bound, bends at angles close to 
90° (Quade et al., 2015) and up to 120° (Yamamoto et al., 2014) to facilitate roles in AUG 
placement, tRNA binding, and ribosome conformation transitions preceding elongation 
(Filbin et al., 2012) while interacting with a number of small ribosomal subunit proteins (rpS). 
An important example is interaction in the E-site with rpS25 as it has consequences for 
overall IRES activity (Landry et al., 2009). An interesting note is the remarkable evolutionary 
diversity in the overall length and flexibility of type 3 IRES dII’s. This domain in HCV is ~80 
nt, while it can encompass as little as 30 nt in the porcine teschovirus (PTV) IRES or as 
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many as 130 nt with multiple independently folded stems in the GB virus-B (GBV-B) IRES 
(Hellen and de Breyne, 2007). 
DIII is a larger domain with multiple subdomains that form an essential 4-way 
junction (dIIIabc) with high affinity for eIF3 (Kieft et al., 2001, Hashem et al., 2013b) as well 
as short stem-loop which is absolutely essential for high affinity ribosome binding (dIIId) 
(Kieft et al., 2001). In fact, biochemical and structural data have indicated necessary base- 
pairing between a CCC triplet in the apical loop of expansion segment 7 (ES7) in helix 26 
(h26) of the 18S rRNA and an essential GGG triplet in dIIId of all known type 3 IRESs 
(Matsuda and Mauro, 2014) as well as an essential motif for unrelated modes of translation 
discussed below. DII and dIII are joined by a 3-way helix and PK (dIIIef) that serves as the 
anchor point to the PIC. DIII recruits viral mRNA to the 43S PIC with multiple high affinity 
interactions. The most closely related IRES to HCV belongs to classical swine fever virus 
(CSFV). They behave quite similarly biochemically, but have an obvious structural difference 
in the presence of a second hairpin in dIIId. The exact function of the additional domain is 
unknown but does seem to appear in multiple IRESs in this group. Type 3 IRES structure 
and function is the focal point of my dissertation and, appropriately, will be addressed in 
much greater detail throughout the remainder of the text. 
IRES RNA structure and function are inextricably linked (Lukavsky, 2008). 
Comprehensive mutational analysis has shown us that the conserved secondary structure 
mentioned above is essential for function. dIII and dIV comprise the 40S binding site on the 
IRES (Kd = ~3 nM) while the junction dIIIabc is required for tight binding to eIF3 (Kd = ~34 
nM) (Kieft et al., 2001). Most models predict that the assembly of initiation complexes on 
these IRESs starts with the high affinity interaction with the 40S. The interaction itself is 
primarily mediated by an essential GGG triplet in dIIId that base pairs with 18S h26 
expansion segment (ES)7 and an interaction that requires dIIIc of the dIIIabc junction 
(Matsuda and Mauro, 2014). The remaining (dIIIef-dIV) portion of the ribosome binding sight 
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is arranged near the exit of the decoding groove in the platform region and places the 
coding mRNA in the decoding groove with the P-site filled by the AUG. This step, as 
mentioned, is mediated by dII but upon binding this mRNA forms a stable complex in the 
ribosome, evidenced by toe-printing and chemical probing experiments. This binary complex 
is poised, then, for the acquisition of eIF3. The Mg2+-dependent fold of the dIIIabc four way 
junction interacts with the core of the eIF3 mediated by eIF3 subunits a, b, d, and f (Cai et 
al., 2010, Prard et al., 2008, Collier et al., 2002, Sizova et al., 1998). An eIF3 subunit, eIF3j, 
is also important to mention in the formation of a productive initiation complex on the HCV 
IRES. As with translation of typical mRNAs, eIF3j must be displaced from the E-site of the 
40S to allow full accommodation of coding RNA onto the decoding groove (Fraser et al., 
2009). This process in HCV IRES-mediated translation seems to be facilitated by dII, in a 
proximal binding position, and conformational rearrangements that take place in the 40S 
and/or eIF3. 
The HCV IRES has no inherent affinity for eIF2, and its assembly (thus Met-tRNAiMet 
delivery) on IRES-bound initiation complexes is thought to be stimulated by eIF2-TC’s 
binding capacity for eIF3 (Ji et al., 2004, Valsek, 2002). Coordinately associated with eIF3, 
eIF2-TC then can be placed onto the decoding site of the 40S to form a 48S* complex (* 
denoting is atypical nature in relation to cap-dependent 48S formation) and through eIF5- 
mediated GTP-hydrolysis, deposit tRNAiMet. The placement of the AUG, placement of eIF2, 
and stimulation of GTP-hydrolysis all seem to be mediated in some fashion by dII, though 
whether it is doing all of this through direct manipulation or through some allosteric 
communication network in the ribosome is unclear. Upon GTP-hydrolysis eIF2 and eIF5 are 
likely displaced and a tRNAiMet, eIF3, IRES-bound 40S is then of the proper composition and 
in the proper conformation to facilitate subunit joining. Type 3 (mostly HCV and CSFV) 
IRES-bound 48S* have been analyzed extensively by toe-print analysis to determine 
efficiencies of formation, overall stability of IRES 48S*, and factor composition (Hellen and 
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Pestova, 1999, Newcomer and Givens, 2013, Locker et al., 2007, Kolupaeva et al., 2000). 
Summarily, it is often said that eIF2-TC and eIF3 (in the manner described above) are 
necessary and sufficient for 48S preinitiation complex formation in type 3 IRES initiation. 
After tRNAiMet is acquired, all that is left to transition to elongation is subunit joining. 
The joining step is the last general mechanistic step before elongation can proceed, 
but there are subtle manipulations that occur between 80S formation and elongation that 
seem to be facilitated by dII (Filbin et al., 2012). Subunit joining is mediated by eIF5B, as in 
canonical translation (Yamamoto et al., 2014, Terenin et al., 2008, Pestova et al., 2000). 
Once a 48S* has been formed eIF5B encounters it and binds near the A-site surface of the 
40S in a position that allows contact with the initiator tRNA, coding RNA, and the A-site 
proximal surface of the 60S subunit as well (Yamamoto et al., 2014). As in cap-dependent 
translation, the actual recruitment of a large subunit to the 48S is stimulated by eIF5B alone. 
GTP-hydrolysis, however, is required for the eventual dissociation of eIF5B. Hydrolysis or 
simply the dissociation of eIF5B is sufficient to stimulate changes in the 80S that make it 
accessible for elongation since 80S can form without eIF5B (Fringer et al., 2007), though 
these ribosomes may not be competent for elongation. 
At this point, my technical definition of IRES-mediated initiation is complete, but this 
seems like a useful time to describe some IRES related events that must still happen. One 
fundamental question that exists in the study of the HCV IRES is, when and how does the 
IRES  dissociate  from  the  40S  after  such  a  high-affinity binding  step?  Similarly, a 
fundamental unanswered question in the field of translation initiation in general is, how and 
when does eIF3 leave an initiated ribosome? My suspicion, due to the nearly as high 
affinity of the IRES for eIF3 (Kieft et al., 2001) is that this process is coupled, but there has 
been no real experimental insight into this process. 
53  
Translation of viral RNA driven by the HCV IRES during Viral Infection 
Immediately after entry, or early in infection, the cell has not signaled that it is 
infected yet and has not had the opportunity to control translation. The first step toward 
productive infection for a (+)ssRNA virus is the translation of its mRNA. Assuming a cell has 
been infected during the G1 stage of the cell cycle, translation is minimized during other 
stages (Tanenbaum et al., 2015). There would be abundant resources for translation, but 
the HCV IRES would likely need to compete with cellular messages for ribosomes. 
Late-Stage infection causes the development of replication complexes and an 
infection-induced antiviral state (Reineke and Lloyd, 2013). Translation occurs at these 
replication complexes associated with the ER. Infection induces the expression of interferon 
stimulated genes (ISGs) through an interferon receptor-mediated signaling cascade (Li et 
al., 2015). Briefly, the recognition of viral replication intermediates in the form of double- 
stranded (ds)RNA are sensed by intracellular RNA helicases that trigger IRF signaling, 
phosphorylation, and transport to the nucleus for trans-activation of interferon promoter 
regions. The enhanced expression of IFN mRNA leads to an increase in extracellular 
interferon that can bind the IFNAR-1 and -2 receptors, trigger the Jak/STAT pathway, and 
culminate in an ISG production/IFN production loop (Haller et al., 2006). One such gene of 
importance is eIF2 kinase, PKR (Hovanessian, 1989). Late stage infection means high 
levels of HCV protease and core protein that are known to regulate this cascade by 
proteolytic cleavage of many of the signaling components (Horner and Gale, 2013), but 
often this results in a global shutoff of translation mediated by both mTOR signaling and 
eIF2-kinase activation. Thus, the translational landscape late during infection is much 
different than upon initial infection. This means that there are less cellular messages to 
compete with, but resources for translation are scarce, including functional eIF2 and free 
ribosomes (many are trafficked to stress-granules) (Kimball et al., 2003). The enrichment of 
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ribosomes in stress granules may be the reason HCV effectively co-opts them at replication 
sites (Ariumi et al., 2011). 
Liver-specific miRNA-122 is suggested to facilitate viral replication and translation 
from the 5’ end (Roberts et al., 2011). As mentioned above, miRNA is often targeted to the 
3’ UTR of cellular messages to stimulate translation repression or mRNA degradation. The 
HCV genome contains two tandem miR-122 binding sites that are critical for HCV replication 
and stabilization of the genome by protecting the 5’ triphosphorylated end. miR-122 binding 
in an AGO complex likely influences translation by protecting the 5’ end from degradation 
while not interfering with internal ribosome entry because the IRES recruits the 40S directly 
to the start site without the need for scanning (Goergen and Niepmann, 2012). Interestingly, 
a recent study suggested the predominant role for miRNA binding may well be to act as a 
miR-122 “sponge” to remove micro RNA from cellular messages that are repressed by 
binding (Luna et al., 2015). This may be important for persistence of infection by the 
deregulation of lipid metabolic genes (miR-122’s primary targets). 
Cellular IRES trans-acting protein factors (ITAFs) are implicated in further levels of 
control. Type1 or type 2 IRESs are more often associated with ITAFs, in large part because 
while specific mechanistic information is scarce, they are often thought to act as RNA 
chaperones in order to modulate or stabilize IRES folds to enhance translation (Spriggs et 
al., 2005, King et al., 2010). The HCV IRES case, however, is more limited in that the La 
autoantigen (Shimazaki et al., 2002), hnRNP L (Hwang et al., 2008), the ribosome- 
associated RNA-binding factor NSAP1 (Park et al., 2011), hnRNP D (Paek et al., 2008), and 
the LSM1-7 complex (Roberts et al., 2014) facilitate HCV IRES-dependent translation. 
Again, the precise functions of ITAFs are unknown aside from general stimulation of 
translation. It is possible that these factors are simply passengers on ribosomes and that 
proper initiation complex assembly is really the step that is enhancing HCV IRES translation. 
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Incongruities Between in vitro and in vivo IRES-mediated Translation Initiation 
In vitro systems are useful for defining key components in biology, but there are 
fundamental limitations to describing function in a purified system versus within the context 
of a cell. These failures represent complications and caveats for both systems. 
eIF2-independent translation in cells is a hallmark of the HCV and CSFV IRES 
despite the necessary function of eIF2 in vitro (Pestova et al., 2008, Robert et al., 2006). 
Evidence for eIF2-independent translation appeared as early as 2002 (Koev et al., 2002). 
Since that time, other studies have supported that finding and added some possible 
mechanisms by which this takes place. The earliest observations suggested that PKR 
activation stimulated HCV IRES-dependent translation while inhibiting translation from an 
unrelated IRES (Rivas-Estilla et al., 2002). Follow-up studies suggested that the IRES itself 
was inhibiting PKR, by directly interacting with it (Vyas et al., 2003). The specific observation 
that the IRES was operating in the absence of eIF2-TC came a few years later and was 
based upon a small molecule screen published a couple years before it (Robert et al., 
2006). The result of that study was to effectively state that the HCV IRES was capable of 
preferential recruitment of the eIF2-TC during conditions that caused a reduction in available 
amount of eIF2. This observation makes sense given the biochemical need for the factor, 
but does not explain preferential recruitment other than to say that eIF2-TC has a higher 
affinity for initiation complexes with an AUG in the P-site (Peterson et al., 1979). Multiple 
publications have described alternative eIFs and their ability to stimulate binding of 
aminoacylated tRNAs to the P-site of the 40S. These factors have no inherent tRNA binding 
properties but are somehow capable of stimulating tRNA (usually tRNAiMet) binding. eIF2A 
was the first identified, though eIF2D (also called ligatin) was likely present in samples of 
natively purified eIF2A as they co-migrate by SDS-PAGE. These factors have the capability, 
in vitro, of stimulating tRNAiMet binding to HCV 48S complexes in an eIF2-independent 
manner (Zoll et al., 2002, Dmitriev et al., 2010). They have a similar effect on some 
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scanning-dependent messages as well suggesting that they are part of a cellular response 
to translation shut-off by stimulating translation by a subset of mRNAs. The most convincing 
functional characteristic of eIF2A is its function in the translation of CUG-start codon mRNAs 
for MHC class I peptide presentation (Starck et al., 2012). eIF2A is implicated in the efficient 
eIF2-independent translation of Sindbis virus sgRNA translation late in infection (Ventoso et 
al., 2006). A recent publication also claimed that eIF2A was specifically responsible for 
efficient HCV RNA translation during infection (Kim et al., 2011), though the IRES dIIId- 
eIF2A binding reported by that study is of dubious quality. eIF2D has no reported translation 
initiation function in vivo, but eIF2D and the binary complex of the oncogenic protein MCT-1 
and DENR can stimulate eIF2-independent tRNAiMet delivery to viral mRNAs in vitro and 
seem to be involved in ribosome recycling (Skabkin et al., 2010). Interestingly, the C- 
terminus of eIF2D and the DENR protein contain SUI1 domains. SUI-domains are named 
after the scanning enhancer elements of eIF1, suggesting that they may be most functional 
in the context of scanning mRNAs not IRESs like HCV’s. 
The function of eIF5 in HCV IRES-mediated translation is implicit rather than explicit. 
eIF5’s main function is to facilitate GTP-hydrolysis on eIF2 once an AUG has been found. Its 
activity is regulated by a somewhat complex network of interactions governed by eIFs 1, 1A, 
and 2 (Nag et al., 2016, Luna et al., 2013, Nanda et al., 2013, Luna et al., 2012). Most of the 
dependence of HCV, and related, IRES(s) on eIF5 is inferred by their dependence on eIF2. 
Locker et al. attempt to investigate this, but is based on an RRL translation system. They 
argue that since the endogenous levels of eIF5 are low, they add almost a 2000-fold excess 
of eIF5 to get the desired results. They ultimately conclude that dII of HCV and CSFV 
mediate eIF2 release during subunit joining (Locker et al., 2007). 
There is a significant question regarding the availability of factor-free ribosomes for 
IRES•40S binary complexes. As I discussed above, ribosomes are associated with factors 
throughout the translation cycle. There may be a period during cellular stress in which 40S 
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subunits may not be recycled effectively (Robert et al., 2006), and may lead to an increase 
in unbound 40S that is concomitant with an increase in CrPV IRES activity . This may also 
be co-opted by the HCV IRES to perform 48S assembly in accordance with the 
biochemically-proposed pathway (Otto and Puglisi, 2004). 
Dissertation Hypotheses and Synopsis 
In this section, I outline some key points relating to the progression of my PhD 
training. My previous scientific training was based in general microbiology; mostly bacterial 
pathogenesis and prokaryotic biology. The specialty of the Kieft lab, as I saw it upon 
entering, was determining structural characteristics of viral RNAs at play in eukaryotic 
systems. Needless to say, I was presented with an exciting, albeit sometimes frustrating, 
opportunity to develop expertise in RNA biology. As a result, and like many other PhD 
candidates, my initial expectations entering the lab and my proposed topic of study were 
quite different from what I actually ended up doing and learning about. 
During his postdoctoral fellowship, Dr. Kieft was instrumental in determining some of 
the early structural characteristics of one of the most useful, and earliest discovered, viral 
internal ribosome entry sites. I use the word “useful” because it has provided valuable 
insight into the fundamental characteristics of eukaryotic translation initiation complexes. 
Insight that will be discussed further in my conclusions. The HCV IRES project was one that 
he brought with him into his lab when it was established. Other lab members have picked up 
this project at various points, most notably Dr. Megan Filbin-Wong during her PhD work. She 
provided fundamental insight into the mechanistic capabilities of a region of the IRES that I 
will discuss considerably, domain II. From the work of the previous Kieft lab members, and a 
large body of literature, a great deal was known about the translation initiation 
characteristics of the HCV IRES, but it was becoming increasingly clear that the paradigm 
that existed to describe its function was not complete. There were incongruities in the data 
generated from reconstituted translation systems and the overall function of the IRES during 
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infection or simply when operating in tissue culture systems. Recent studies had galvanized 
my interest in understanding how the HCV IRES was operating in cells, and I was 
specifically interested in the prospect of the function of “alternative” eIFs and their role 
during HCV infection. Below, I will describe first the series of events that I had planned for 
during the first year of my graduate work, and second I will describe the questions I actually 
ended up testing. 
I had three general questions, relating to translation from the hepatitis C virus IRES 
during viral infection: 
1. Were alternative initiation factors, specifically eIF2A or eIF2D, facilitating 
HCV IRES-mediated Translation during viral infection? 
The discovery of non-canonical factors that can stimulate tRNAiMet binding to the 
ribosome is not new. During the original purification and characterization of eIFs 
some interesting factors were discovered that could possibly be delivering tRNA 
to initiation complexes. I had a number of specific questions regarding this 
phenomenon (1) Are any of these factors essential for HCV IRES-dependent 
translation? (2) Are alternative eIFs present in viral replication complexes? (3) 
Are there unknown proteins that can facilitate translation more efficiently during 
virus-induced stress? 
2. Are there specific regions of the IRES that are enacting eIF2-independent 
translation either through recruitment of alternative eIFs or manipulating 
the ribosome during infection? One of the earliest observations regarding the 
function of the HCV IRES was that it adopted a fold that allowed tight binding to 
both the 40S and eIF3 and that binding was essential for function. (1) Are there 
other translation factors that interact specifically with the HCV IRES during viral 
infection? (2) Are there portions of the IRES that are required specifically during 
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translation under cellular stress or infection? (3) Is the ribosome recruited 
differently during stress, perhaps with different factors bound? 
 
3. Given the abundance of post-transcriptional modification of cellular RNAs, 
is the HCV IRES modified similarly and is that modification important for 
function during infection? Post-transcriptional modifications of tRNAs and 
rRNAs are highly prevalent and occur with high diversity. These modifications are 
important for the overall binding stability and decoding capacity of both 
ribosomes and tRNAs. mRNA modifications seem to be less abundant and more 
restricted in the types that occur. (1) The HCV ORF has been shown to contain 
simple modifications, does this extend to the IRES RNA? (2) Are modifications to 
IRES RNAs dynamic, do they change in response to cellular stimuli like 
stresses? (3) Are site-specific modifications important for the maintenance of 
IRES translation during stress and/or viral infection? 
 
 
The initial question I was curious to ask were rooted in my desire to study, 
specifically, HCV IRES activity during viral infection. This topic of study turned out to be both 
ambitious and unfortunately not quite fruitful, but my attempts at answering the first two 
questions are what diverted my attention to my ultimate topic of study. The third question 
was a completely unexplored area of study that was rife with technical difficulties, but at the 
very least taught me some methodological considerations in dealing with chemical changes 
in RNA species that I applied in the Appendix. Below are the questions that I will discuss 
testing during the meat of my dissertation along with specific hypotheses that I generated as 
the questions arose. 
1. Does the HCV IRES indeed continue to function effectively during cellular 
stress? I hypothesized that the HCV IRES would continue to function for viral 
mRNA translation under the majority of cellular stresses as had been published 
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in different contexts previously. I was simply attempting to replicate previously 
published data so that I could further examine the system. 
2. Further, is the HCV IRES the only related RNA that can perform a similar 
feat of eIF2-independent translation? I expected that they would perform 
almost identically given the biochemical similarities of the IRESs from the type 3 
group, and that the sequence and structural differences in the IRESs would be 
served as virus infection-specific differences that would not be evident in reporter 
experiments. 
3. What  proteins  interact  with  the  type  3  IRESs  and  are  alternative  eIFs 
involved? I had hypothesized that a number of unexpected proteins would 
associate with IRESs, likely through their interaction with the 40S. Specifically I 
had expected that alternative eIFs would be associated with the ribosome, but 
would not bind the IRES directly as had been suggested previously. 
4. Do  type  3  IRESs  actually bind  40S  subunits in the  model  proposed  by  Otto 
and Puglisi (2004)? Polysome analysis of cell lysates with physiological salt 
concentrations showed that eIFs and 40S subunits co-migrate suggesting that 
there is not a significant pool of free ribosomes to be bound by type 3 IRESs. I 
expected that IRESs would bind to assembled initiation complexes and would not 
“search” for apo-40S subunits. 
5. Does eIF1A have a legitimate function in the activity of type 3 IRESs?  eIF1A 
is a known component of the 43S PIC and has essential functions in canonical 
translation. I hypothesized that eIF1A being present on type 3 IRES complexes 
was simply a by-product of its close association with 40S subunits. 
6. Do post-scanning functions of eIF1A facilitate stable tRNA Met binding on 
 
non-scanning initiation complexes? After determining that eIF1A did have a 
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legitimate function in IRES-driven translation, I suspected that it was influencing 
tRNA on the initiation complexes. 
 
7. Is tRNA Met delivery to IRES preinitiation complexes factor-independent? 
 
Factor-independent delivery of initiator tRNA is generally accepted as possible in 
bacterial systems but is not in eukaryotic systems, likely due to the requirement 
for eIF2 in most translation and certainly bacteria do not seem to have a 
dedicated tRNA-delivery factor. I would hypothesize that future studies will show 
that factor-free tRNAiMet is quite abundant in eIF2-limited cells and that it can 
readily associate with initiation complexes that have placed an AUG in the P-site 
of the ribosome. 
8. Are  type  3  IRES-containing  viruses  excluding  eIF2  from  translation 
factories? I would expect that viruses that co-opt stress granules are likely to 
specifically exclude eIF2 from their replication complexes, since stress granules 
seem to be limited in eIF2 abundance anyway. Because type 3 IRESs exist in 
diverse viruses, however I would hypothesize that not all type 3 IRES-containing 
viruses would operate similarly with respect to eIF2 exclusion. 
These questions have been the driving force behind the majority of my thesis work 
and have ultimately allowed me to provide insight into the specific function of viral IRESs. 
Moreover, testing these questions have shaped my perception of the importance of the 
further study of initiation events and their fundamental regulation. As I have mentioned 
above, regulation of translation is often perceived as protein- and pathway-based (e.g. 
interferon stimulated expression of a protein kinase (PKR) that inactivates eIF2). Studies like 
mine are important in that they provide the framework for a unique mode of translation that 
bypasses most translation regulation steps. It also shows evolutionarily conserved functions 
of eIFs that were previously unappreciated. To summarize this thought, my work may be 
important from the perspective of IRES-dependent translation, but its most important 
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contribution is that it suggests a unique mechanism for tRNA acquisition to translation 
initiation complexes in eukaryotes. If a viral IRES can operate in a special way, then surely 





Figure 1: Cap-dependent Translation Initiation. 
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Figure 1: Cap-dependent Translation Initiation. 
Translation initiation is a process that couples the eIF-based preparation of 40S subunits to 
coding mRNAs and culminates in the joining of 40S and 60S and the transition to elongation. 
Recycled ribosomes are pre-loaded with eIF1, 1A, 5, 3, and eIF2-TC (43S PIC). mRNAs are 
preloaded with eIF4F in a cap- and poly(A)-tail-dependent manner (eIF4F: eIF4E, 4G, 4A/4B, 
PABP (not shown), MNK). mRNAs are recruited to 43S PICs by interactions between eIF3 
and eIF4G. mRNA is loaded into the decoding groove of the ribosome and codon composition 
is investigated sequentially in a 5’-3’ manner. Once a proper start site is placed in the P-site 
of the ribosome, GTP-hydrolysis on eIF2 deposits Met- tRNAiMet in the P-site and locks the 
complex in place in a transition from an “open” (scanning) to a “closed” (arrested) complex. 
Some eIFs leave, while the remaining complex awaits the binding of a 60S, accelerated by 
eIF5B. GTP-hydrolysis in a second step switches the ribosome into another conformation that 
allows the release of eIF1A and eIF5B, while Met- tRNAiMet remains. 
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eIF1 Promotes start site fidelity, directs eIF2-TC binding, promotes scanning 
with eIF1A, stabilizes the “open” ribosome conformation, decreases the 
rate of eIF5-mediated GTP-hydrolysis on eIF2 
eIF1A Stimulates eIF2-TC binding with eIF3 and eIF1, cooperates with eIF1 to 
promote scanning, senses codon:anticodon base-pairing, 
communicates with eIF5 for PIC assembly, communicates tRNAiMet 
accommodation to eIF5B for subunit joining, assists eIF5B dissociation 
after 80S formation 
eIF2 A heterotrimer complex that associates with tRNAiMet and GTP to form 
the eIF2-TC, binds to 40S in an eIF-dependent manner and delivers the 
specialized initiator tRNA. 
eIF2A Alternative eIF, implicated in promoting eIF2-independent tRNA 
delivery for initiation, acts during nitrogen stress in IRES-mediated 
translation, promotes non-AUG initiation during antigen presentation 
eIF2B Pentameric complex that acts to exchange GDP for GTP on eIF2, has 
increased affinity for the phosphorylated form of eIF2 
eIF2D Alternative eIF, implicated in eIF2-independent tRNAiMet delivery to the 
ribosome, may operate as part of the ribosome recycling machinery 
eIF3 13 subunits, binds 40S, eIF1, and eIF2-TC, and eIF4G to assemble 
mRNA on PICs, prevents premature association of ribosome subunits 
eIF4A ATP-dependent RNA helicase involved in resolving mRNA secondary 
structure during scanning 
eIF4B RPB that operates as a co-factor of eIF4A and can travel with eIF4F 
eIF4F Cap-binding complex that consists of eIF4E, eIF4A, eIF4G, mediates 
attachment of mRNAs to the 40S through eIF3 
eIF4G Acts as a scaffold for eIF4E, eIF4A, eIF3 and PABP and mediates the 
attachment of the complex to PICs by binding eIF3 
eIF4H RPB homologous to eIF4B, enhances the helicase activity of eIF4A 
eIF5 GTPase-activating protein that stimulates GTP-hydrolysis of eIF2-TC 
after start codon recognition, interacts with eIF3, eIF1, and eIF2 
eIF5A Resolves polyproline-induced ribosome stalling 
eIF5B Mediates ribosome subunit joining in a GTP-dependent manner 
eIF6 Prevents premature subunit association by binding 60S 
DHX29 DExH box protein that promotes ribosome scanning on mRNAs with 
extensive secondary structure 
PABP Binds to polyadenine stretches at the 3’ end of mRNAs, associates with 
eIF4G and enhances binding of the cap to eIF4F, 
Met A structurally specialized tRNA that recognizes AUG start codons and 
delivers the first methionine of most proteins 
 
Table 1: Eukaryotic Initiation Factors. 


















































Figure 2: “Open” Versus “Closed” Preinitiation Complexes 
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Figure 2: “Open” Versus “Closed” Preinitiation Complexes 
Cryo-EM structures of two states of the yeast PIC from Llácer et al. (2015) (PDB: 3JAP, 
3JAQ). Figure shows a 43S viewed from the inter-subunit face for orientation (top) the 
decoding groove is labeled (dashed box). The bottom figures show a view from the A-site 
“side” of the 43S PIC with identical RNA or protein chains colored the same between states. 
The head of the “open” conformation has moved away from the body to allow greater access 
to the decoding groove during mRNA association and scanning. The head in the “closed” 
complex has rotated closer to the body to constrict the decoding groove after a start codon 
has been found and scanning of the PIC has arrested. There are subtle conformational 
differences in the position of eIFs and tRNAiMet between each structure, but the position of the 
head between the two states (red arrow) is the only highlighted rearrangement. Colors were 
randomly assigned to chains of individual protein or RNA domains, but are consistently 
colored between all three panels. 
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 Figure 3: Unstructured 5’ UTRs in Initiation 
Reading frame can be influenced by only the sequence and/or minimal structures of the 5’ 
UTR. (A) A standard mRNA containing a m7G-cap, a relatively unstructured 5’ UTR and an 
AUG start codon (ORF depicted as yellow block). (B) Alternate, AUG or non-AUG start open 
reading frames can be decoding at low frequencies when Kozak context is suboptimal; Sui- 
phenotypes are often associated with this event (alternate ORF depicted as green block, Y= 
C or U and represents departure from purines necessary for good context). (C) Small stem- 
loops immediately downstream of an AUG can cause ribosomes to delay sufficiently to acquire 
an alternative eIF for tRNAiMet delivery. This can occur during alphavirus-induced cell stress 
that limits eIF2-TC availability. (D) uORFs (purple, green) can be translated during conditions 
of high eIF2-TC and lead to the decreased expression of downstream  ORFs (yellow). 
Suboptimal eIF2-TC levels lead to scanning through uORFs and the translation of 
downstream coding regions. 
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Figure 4: 3’ End-dependent Translation Enhancement. 
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Figure 4: 3’ End-dependent Translation Enhancement. 
RNA structures at the 3’ end of mRNAs modulate translation. (A) Typical cellular mRNAs are 
often polyadenylated and relatively unstructured. (B-D) Highly structured plant virus 3’ UTRs 
can bind eIFs at the 3’ end of the viral mRNAs and deliver them to the 5’ end for translation 
initiation by long-range base-pairs between the 5’ and 3’ ends of the RNA. BTE (Barley yellow 
dwarf virus-like translation enhancer), PTE (Panicum mosaic virus-like translation enhancer), 
ISS and YSS (I- and Y-shaped structures). (E) Termination-upstream ribosome binding sites 
(TURBS) direct reinitiation of translation at downstream (adjacent) ORFs (orange) directed by 
structures at the 3’ end of the terminating (yellow) ORF. (F) tRNA-like structures (TLS) are 
aminoacylated and bind eEF1A, they also facilitate 3’ end-dependent translation 
enhancement. (G) TLSs exist at internal sites of the 3’ UTR and bind ribosomes, because 
they do not have a free 3’ OH, they do not get aminoacylated. 
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Figure 5: The Four Types of Viral Internal Ribosome Entry Sites. 
Viral IRESs are classified into four groups. (A) There are picornaviral scanning-dependent 
IRESs (Type 1, e.g. Poliovirus), (B) picornaviral non-scanning IRESs (Type 2, e.g. 
Encephalomyocarditis virus), (C) flavi- and picornaviral ribosome-binding IRESs (Type 3, e.g. 
Hepatitis C virus), and (D) dicistrovirus intercistronic IRESs (Type 4, e.g. cricket paralysis 
virus). Secondary structure cartoons are shown along with the codon of the first coded amino 
acid. RNA domains are labeled with the nomenclature used in this text. Grey bars denote 




Figure 6: Genome Organization of Generic Flavivirus and Picornavirus. 
Members of the hepacivirus and pestivirus genera encode a large ORF in their genomes that 
is processed into structural and non-structural proteins at the N-terminal and C-terminal end 
of the polyprotein, respectively. The hepaciviruses and pestiviruses have a triphosphorylated 
5’ end, a departure from the capped 5’ end of flaviviruses. The 3’ end of the hepaciviruses 
lacks a poly(A)-tail and often terminates in secondary structure that may protect the 3’ OH 
from degradation. HCV is used as an example here, with structures of its 5’ and 3’ end inlaid. 
Picornavirus RNA genomes are organized similarly, in that they contain a polyprotein that is 
processed into 5’ structural proteins and 3’ non-structural proteins. Significant differences 
include the extremely long 5’ UTR, 5’ VPg capping, and 3’ polyadenylation. 
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Figure 7: Secondary Structures of Representative Type 3 IRESs. 
Structures of the HCV and CSFV IRES (A and B) have been validated biochemically and 
structurally. (C) The SPV-1 IRES predicted secondary structure is shown. Greyed boxes 
represent highly variable regions between type 3 IRESs. Variable regions, dII, dIIId, and dIV 
are important for the manipulation of the ribosome and dictating the composition of IRES- 
bound PICs. 
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 Figure 8: Existing Model of HCV IRES-Driven Translation Initiation. 
Biochemical analyses of HCV IRES function suggest the formation of an IRES•40S binary 
complex through high affinity binding of IRES dIId to 18S ES7. eIF3 and eIF2-TC are recruited 
independently. GTP-hydrolysis on eIF2 deposits Met- tRNAiMet and allows the eIF5B-GTP- 
dependent subunit association and formation of 80S elongation-ready complexes. eIF2- 
independent translation has been suggested to proceed through the action of eIF2A-, eIF2D- 




EIF2-INDEPENDENT TYPE 3 IRES ACTIVITY 
 
Study Rationale 
The overarching goal of my studies revolves around a further characterization of the 
in vivo mechanism of type 3 IRES-dependent translation. Understanding of the specific 
mechanism of translation from medically and agriculturally relevant viruses gives us insight 
into possible antiviral strategies. Also important is understanding the full breadth of the 
mechanisms that promote translation initiation, not only from viral RNAs, but from cellular 
messages as well. Viruses have served as invaluable tools for understanding cellular 
pathways that can be co-opted, manipulated, or altered. My ambition was for these studies 
to provide valuable insight into a mode of translation initiation that is important for a wide 
array of viruses, and also direct interest in identifying cellular messages that can use a 
similar pathway for enhanced gene expression. 
This chapter is specifically tailored to expand our understanding of the breadth of 
eIF2-independent translation from type 3 IRESs and the conditions that promote it. In fact, 
under specific circumstances the HCV IRES can function without any eIFs (Lancaster et al., 
2006). Despite more than a decade since the observation of specifically eIF2-independent 
translation on the HCV IRES (Koev et al., 2002, Robert et al., 2006), we have yet to 
understand how it proceeds in a complex system like a cell. Alternative eIFs have been 
proposed to function in this capacity (Kim et al., 2011, Dmitriev et al., 2010), but their 
function has been met with some skepticism. Indeed, some are actually quite unstable 
during stress conditions supposing poor functionality for IRES-mediated translation during 
stress (Komar et al., 2005). The type 3 IRESs, also called HCV-like IRESs, have grown into 
a large group of IRESs from prevalent (+)ssRNA viruses from different viral families (Hellen 
and de Breyne, 2007), the only known viral IRES group that spans multiple viral families. 
This observation alone plays at the high utility of HCV-like IRESs to control translation. The 
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HCV IRES’ ability to drive translation during eIF2-limiting conditions has been examined 
previously (Robert et al., 2006, Koev et al., 2002), but to what extent other type 3 IRESs 




The HCV IRES Continues to Function during Cellular Stress States 
The starting point for understanding how the HCV IRES manipulates the translation 
machinery was to confirm the observation of eIF2-independent translation. Both the HCV 
and CSFV IRESs facilitate translation efficiently during limitation of the eIF2•GTP•Met- 
tRNAiMet ternary complex (eIF2 TC) (Koev et al., 2002, Pestova et al., 2008). Most studies 
revolve around the use of translation lysate systems, though some cell culture studies exist. 
I first created reporter mRNAs containing two ORFs; the first encodes the Renilla luciferase 
gene (Rluc) driven by cap-dependent (eIF2-dependent) translation, the second encoding the 
Photinus luciferase gene (Fluc) driven by IRES-dependent translation (Figure 9A). These 
mRNAs were then used to transfect Huh 7.5 human hepatoma cells that had been 
pretreated with different chemical inducers of eIF2α-phosphorylation, a hallmark of cellular 
translation regulation and requisite step in the inactivation of the eIF2 TC (Figure 9B). After 
translation for 2 hours at 37˚C, the cells were lysed and the lysate subjected to luciferase 
activity analysis. I found that under any tested stress, the HCV IRES was not significantly 
affected in its ability to drive translation, while the translation of the cap-driven message was 
inhibited to varying extents (Figure 10A). eIF2-dependent translation was affected least by 
tunicamycin (an N-linked glycosylation inhibitor isolated from the bacterium Streptomyces 
clavuligerus (Takatsuki et al., 1977) treatment, then thapsigargin (a non-competitive 
sarco/endoplasmic Ca2+ pump inhibitor derived from the plant Thapsia garganica (Hakii et 
al., 1986) treatment, and most effectively inhibited by dithiothreitol (DTT; reducing agent 
disrupts ER integrity and causes accumulation of unfolded protein) treatment. Conversely, 
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HCV IRES-dependent translation was not significantly inhibited as previously reported, and 
surprisingly was even stimulated near 3-fold after treatment with DTT (Figure 10A). In Huh 
7.5 cells the activity of the HCV IRES was highest when there was a higher relative level of 
eIF2α phosphorylated (P-S51, inactivated) compared to total eIF2α (Figure 10B). 
Furthermore, we tested the efficiency of HCV IRES driven translation relative to cap- 
dependent translation in both HeLa and HEK293 cells (Figure 10C & D). Though a similar 
panel of chemical treatments was not applied to every cell type, HCV IRES-mediated 
translation was never significantly inhibited. Tunicamycin treatment, though potent in eIF2- 
inactivation, came the closest to decreasing IRES activity, it is likely that this was a 
consequence of the high toxicity of this drug (Wei et al., 1998). 
These studies are predicated on understanding IRES function as it operates without 
eIF2. It has been reported that during the course of HCV infection there is not a notable 
increase in the level of eIF2α-phosphorylation (He et al., 2001). Indeed, there are 
mechanisms by which HCV infection specifically limits activation of eIF2-specific kinases 
and the interferon signaling pathway (He et al., 2001, Qashqari et al., 2013, Arnaud et al., 
2010, Toroney et al., 2010).However, the opposite result has also been published and is 
more consistent with the consequences of infection by many other RNA viruses (Garaigorta 
and Chisari, 2009, Kim et al., 2011). I decided to test the activity of reporter RNAs with 
concurrent viral infection. I infected Huh 7.5 cells with HCV isolate JFH-1 lab construct JC-1 
(Gottwein et al., 2011) at an MOI of 0.1. I further transfected cells with reporter mRNA at 72 
hpi, then harvested cells and analyzed translation activity (Figure 11A). Though I was able 
to confirm infection by RT-PCR analysis relative to a mock treated sample (Figure 11B), 
activity was not largely affected for cap- or IRES-driven translation. 
IRESs within the Type 3 Group Have Variable Activities during Stress 
I have mentioned above that the HCV IRES RNA is not unique in its fold or general 
mechanism of action. It is the archetype of a group of IRESs called the type 3 IRESs. The 
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existence of multiple related RNAs poses the question of whether or not all of them are 
similarly eIF2-independent, in spite of the biochemical characterizations that defined them. I 
cloned the IRES sequences from classical swine fever virus (CSFV), GB-virus B (GBV-B), 
porcine teschovirus (PTV), and simian picornavirus type-1 (SPV-1, greater than 98% similar 
to the SPV-9 IRES) into dual luciferase reporter constructs and produced mRNAs similar to 
those made with the HCV IRES. Though there are notable structural differences between 
them (Figure 12A, highlighted) my expectation was that the activity of these IRESs would be 
similarly eIF2-independent to HCV. The unrelated cricket paralysis virus (CrPV, type 4 
Figure 5D) IRES and the encephalomyocarditis virus (EMCV, type 2 Figure 5B) IRES were 
used as negative and positive controls for eIF2-dependence, respectively (Figure 12B). 
Diagrammed in Figure 9, I transfected IRES reporter mRNAs into Huh 7.5 cells that had 
been pretreated with thapsigargin or mock treated with DMSO. Luciferase activity was 
measured after 2 hours and the results were graphed relative to mock treated activities of 
the cap- or IRES-driven luciferases. As expected cap-driven translation was inhibited by 
chemical stress. Similarly, the EMCV IRES was unable to continue functioning efficiently 
during stress, and conversely the CrPV IRES operated independent of chemical stress. The 
battery of type 3 IRESs tested, unexpectedly, had quite variable activities. The HCV IRES 
performed as expected, but the CSFV was inhibited by greater than 50%, while the SPV-1 
IRES activity more than doubled with stress. The GBV-B and PTV IRES luciferase activities 
were variable resulted in ~80% and ~60% IRES activity, respectively. These results 
suggested that the structural differences between IRESs of a similar type are related to 
ability to function in stress conditions, and that each IRES evolved to “fine-tune” its activity in 
its host species. 
I chose to use, for a number of future studies, the CSFV, HCV and SPV-1 IRESs to 
represent the highest activity to lowest activity (also highest to lowest dependence on eIF2) 
of the IRESs I have tested. I next wanted to understand what chemical stresses did to the 
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rate at which the IRESs acted. Specifically, does chemical treatment simply impede 
translation from the beginning, or does translation slow later during the time course of the 
translation assay? Using reporter mRNAs I transfected cells as described above, but now 
harvested them during a time course to qualitatively compare the rate of translation from 
each IRES (Figure 13). As expected, the rate of HCV IRES-mediated translation was 
unaffected by thapsigargin pretreatment (Figure 13A). CSFV (Figure 13B) was simply 
translated at a slower rate when chemically stressed, while SPV-1 translated similarly while 
unstressed and stressed through the majority of the time course when the rate increased 
toward the later time points (Figure 13C). An increase in the rate could be attributable to the 
removal or exhaustion of some factor slowing translation, possibly explaining SPV-1 
translation enhancement and also HCV IRES enhancement during DTT treatment (Figure 
10A). 
Cell Type Affects the Capacity for Translation on Type 3 IRESs 
As mentioned, there is variability in the capacity of different IRESs to translate in the 
same system during thapsigargin treatment. I was curious to discover how translation 
proceeds during induced stress from other chemicals when comparing the HCV, CSFV, and 
SPV-1 IRESs, the IRESs chosen above to represent variable dependence on eIF2. Using 
bicistronic mRNA reporters again I transfected Huh 7.5 cells that had now been either left 
untreated, thapsigargin treated again, DTT stressed, or treated with tunicamycin (Figure 
14A). Treatment with thapsigargin affected cap and HCV IRES-driven translation as shown 
in Figure 10. DTT treatment also significantly inhibited cap dependent translation while 
substantially increasing HCV IRES translation. Interestingly, DTT treatment allowed the 
CSFV IRES to translate near untreated levels, unlike thapsigargin treatment. The SPV-1 
IRES translation was further enhanced by DTT treatment over thapsigargin treatment. 
Tunicamycin treatment seemed to be the most poorly tolerated treatment for IRES 
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translation as it led to a decrease in HCV and CSFV IRES activity, while only a moderate 
increase in the activity of the SPV-1 IRES. 
Up to this point, I have used Huh 7.5 cells to study translation since they are cells 
that are permissible for HCV infection. The variability of translation between IRES and cell 
state caused me to speculate that individual IRESs may have adaptations for better 
translation in their host species, or cell stress that most mimics the consequences of their 
respective viral infection. I next tested the activity of the HCV, CSFV, and SPV-1 IRES in 
either PK-15 (porcine kidney) or Vero (simian kidney) cells (Figure 14B & C). In PK-15 cells, 
thapsigargin treatment cased an almost uniform increase in all IRES translation, while DTT 
treatment resulted in translation similar to the unstressed condition. In Vero cells, however, 
both thapsigargin and DTT treatment resulted in decreases in HCV and CSFV IRES 
translation, while SPV-1 IRES translation was largely unaffected. This result, suggests that 
each IRES is adapted to a given cell type to maintain, rather than increase or decrease, 
translation during stress. Also, a general observation between cell types would suggest that 
the maximal translation mediated by these IRESs occurs during conditions that cause 
significant eIF2α phosphorylation (Figure 14D), DTT in Huh 7.5 and thapsigargin in PK-15. 
The activities of the IRESs in Vero cells confuses this observation, but it may be that since 
there is already a relatively high level of eIF2α phosphorylation (Figure 14D, bottom) the 
IRESs are already functioning at their maximal level before chemical stress. 
It is worth noting that alternative eIFs, eIF2A and eIF2D, have been implicated in 
 
eIF2-independent tRNA Met delivery on ribosomes bound by the HCV IRES (Kim et al., 2011, 
 
Dmitriev et al., 2010). I western blotted for each factor in each cell type under all tested 
conditions (Figure 14E), and there is not an alteration in expression pattern that reflects the 
difference in IRES activity. However, this only really means that alternative eIFs are not 
differentially expressed during these stresses, not that they are not being used for IRES- 
dependent translation. 
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Alternative Initiation Factors are not Necessary for HCV IRES-mediated Translation 
Although I showed that alternative eIF2A and 2D levels are not changing, I next 
wanted to test if these alternative eIFs function in HCV IRES-driven translation, particularly 
during stress. I chose to do this by using siRNA to knock down expression of eIF2A and 
eIF2D. I pretreated Huh 7.5 cells with 20 nM siRNA targeting the alternative eIFs (eIF2A KD, 
eIF2D KD, or Dbl KD) or a non-targeting control (Ctrl) for 48 hours prior to mRNA reporter 
transfection and luciferase activity measurement (Figure 15A). I reported activity relative to 
the HCV IRES Fluc activity that was pretreated with the Ctrl siRNA and left unstressed 
(Figure 15B, grey bar). There was no significant change in IRES activity when either factor 
was depleted. I was able to show by western blotting that the knock down of the factors was 
quite robust either singly or in tandem (Figure 15C). These results strongly suggest that 
translation mediated by the HCV IRES in Huh 7.5 cells is not dependent on either eIF2A or 
2D, as previously suggested (Kim et al., 2011, Skabkin et al., 2010, Dmitriev et al., 2010). 
Efficient Translation Mediated by Type 3 IRESs becomes More AUG-Dependent during 
Stress 
I have examined the ability of different type 3 IRESs to translate in an eIF2- 
independent manner by chemically inducing a stressed cell state that results in inactive 
(phosphorylated) eIF2. The main purpose of eIF2 is to deliver tRNAiMet to PICs so that 
codon:anticodon base-pairing can occur. Given the eIF2-independent nature of type 3 IRES 
translation I wanted to do determine if translation during stress still proceeds primarily 
through the use of an AUG start codon. Most translation requires an AUG, but there are 
many examples of non-AUG initiation events, particularly at CUG codons (Starck et al., 
2012). The HCV IRES, however, has been reported to be refractory to start codon mutation 
under standard culture conditions in HepG2 cells (Rijnbrand et al., 1996). I made mutations 
to the start codons of each IRES bicistronic reporter and tested the ability of these mRNAs 
to translate during thapsigargin-induced stress in Huh 7.5 cells. Wild type (AUG) HCV IRES 
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activity during unstressed conditions was considered 100% activity and activities of mutant 
IRESs with either CUG, AUA, AUU, UAA, or UAC were graphed relative to AUG reporter 
(Figure 16A). Start codons are well tolerated by the HCV IRES, as has been reported 
previously (Rijnbrand et al., 1996). What we learned, however, is that codon mutants are no 
longer well tolerated during thapsigargin-induced stress (Figure 16A), likely because eIF2- 
TC has been limited. This could be by a mechanism where the eIF2-TC forces delivery and 
placement of tRNAiMet in or near the P-site of the 40S. Similar trends are observed with the 
CSFV (Figure 16B) and SPV-1 (Figure 16C) IRESs though there are nuances to each IRES’ 
function that are mirrored by the WT IRES activity during stress. The CSFV IRES does not 
tolerate start codon mutation well, except CUG, and tends to be more eIF2-dependent in 
Huh 7.5 cells. The SPV-1 IRES is able to tolerate start codon mutations even during stress, 
especially codon AUU that only differs from AUG at the wobble position (Figure 16D). 
Mutations to the Type 3 IRES have Specific and Stress-Dependent Effects on Overall 
Translation 
Through my work and the work of others, it is clear that mutations to various HCV 
IRES domains can have detrimental effects on translation (reviewed in (Lukavsky, 2008, 
Filbin and Kieft, 2009)). I further examined the effect of specific IRES mutations on HCV 
IRES-dependent translation during stress (Figure 17). I stressed Huh 7.5 cells with DTT 
treatment and compared the translation capabilities of various IRES mutants (highlighted in 
Figure 17A). The wild type HCV IRES, as shown in Figure 10, increases activity 
substantially when cells are pretreated with DTT. A mutation to three conserved G’s in dIIId 
(dIIId_GGG-CCC) removes high affinity binding of the IRES to the 40S subunit (Kieft et al., 
2001, Jubin et al., 2000) and as expected lowers translation activity to background levels 
with or without DTT treatment (Figure 17). A truncation of dIIIb is responsible for decreased 
affinity of the IRES for eIF3 and results in a significant decrease in IRES activity (Kieft et al., 
2001), though that activity is partially restored after DTT treatment. A mutant with its entire 
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dII deleted (ΔdII) is defective in codon placement, GTP hydrolysis by eIF2, and post- 
initiation steps in translation is also similarly reduced in activity and that reduction is 
unaffected by DTT treatment (Filbin et al., 2012, Filbin and Kieft, 2011). When dII was, 
instead, truncated down to dIIa (dIIIa_UUCG) it functioned as inefficiently as the ΔdII mutant 
but was able to partially restore activity during stress. A mutation to the apical loop of dII 
(dII_ΔGCC) that specifically affects dIV unwinding and start codon placement (Filbin and 
Kieft, 2011, Berry et al., 2011), is decreased only about 50% relative to wild type, but upon 
DTT treatment is able to increase activity to near WT stressed activity (200% unstressed). 
Finally, a start codon mutant (AUG-CUG) during DTT treatment behaves similarly to 
thapsigargin treatment.(compare to Figure 16). What is most interesting about these 
mutants is that, during stress, I observed a trend that implicated the presence of RNA from 
dII in the ability of an IRES to translate more efficiently during DTT-induced eIF2 depletion 
(Figure 17B, navy, cyan, and red bars). Anytime structured RNA is in the position of dII (near 
the E-site in the decoding groove), the HCV IRES can function better in the absence of eIF2. 
A complete removal of dII prevents that from happening, as does a non-AUG codon. 
Together, we can surmise that dII manipulates steps in translation to facilitate tRNAiMet 
delivery to the start codon of IRES•PICs. 
Discussion 
I have summarized and recapitualted data that shows the HCV (and related) IRES(s) 
are able to direct translation under conditions that significantly limit the availability of eIF2- 
TC for the delivery of the first tRNA to initiation complexes. This phenomenon is not new, but 
has remained enigmatic because the majority of data on this topic is resticted to two IRESs 
(from HCV and CSFV) in translationally competent lysates, often RRL. I have expanded 
these studies by investigating translation dynamcs within multiple cell types and using 
multiple IRESs to encompass a spectrum of dependence on eIF2. These data will be useful 
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for the comprehensive understanding of IRES-driven translation within a cellular 
environment rather than within reconstituted systems. 
This work highlights the presence of evolutionary adaptations that seem to exist for 
IRES RNAs from different viruses, and presents an interesting perspective on the translation 
environment from cell types from different species. Thus, I suggest that the cellular 
environment has more overt control over type 3 IRES-mediated translation than has 
previously been appreciated. As I have mentioned, eIF2-independent translation from the 
HCV IRES is not a new observation (Koev et al., 2002), but the body of literature 
surrounding it has largely left it as just an observation. A large portion of data surrounding 
the function of IRESs involves rigorous and detailed biochemical and biophysical 
characterizations (reviewed by Lukavsky, 2008), but seems to underappreciate the dynamic 
nature of cellular conditions that ultimately dictate the rate of translation. 
eIF2-independent Translation Mediated by Type 3 IRESs is Dynamic 
The first pieces of data generated for this thesis were done so as proof-of-concept to 
recapitulate eIF2-independent translation in my hands because my initial hypotheses 
supposed that alternative initiation factors were what drove translation from the HCV IRES. 
Regardless, my first experiments were to determine, by translation reporter assay, that the 
HCV IRES could continue to function in cells. Other labs have reported eIF2-independent 
translation within cells using various stresses including chemical ER stress induces, 
oxidative stress, and interferon treatment (Kim et al., 2011, Shimoike et al., 2009, Terenin et 
al., 2008, Robert et al., 2006, Koev et al., 2002). I tended to use chemical ER stress 
inducers due to the large burden that HCV infection places on the ER (Li et al., 2009). HCV 
combats interferon production by the induction of PKR and subsequent eIF2α- 
phosphorylation (Kim et al., 2011, Garaigorta and Chisari, 2009, Arnaud et al., 2010), 
though reports that suggest HCV limits PKR activation do exist (Yan et al., 2007, Toroney et 
al., 2010). PERK is likely activated as a consequence of NS4B-dependent rearrangement of 
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the ER (Li et al., 2009), and there are likely low levels of PKR activation despite dII- 
dependent sequestration. 
I have shown that HCV IRES-driven translation is maintained after chemical 
treatment in Figures 10-17 and it is not unique to a single cell type. What was most 
interesting, though, is that under certain conditions IRES activity was enhanced. Stimulation 
only occurred during conditions that severely limited translation from a cap-dependent 
reporter. Increased eIF2α-phosphorylation (Figure 9B) negatively affects cap-dependent 
translation, suggesting that high levels of cap-dependent translation and/or high levels of 
eIF2-TC are imposing some sort of stringency on IRES-driven translation. Cap-dependent 
translation requires eIF2 because it stabilizes tRNAiMet on the PIC until a proper start codon 
has been selected in a scanning step that is bypassed by IRES-binding to the 40S (Pestova 
et al., 1998b). Translation by a reporter was even unaffected by HCV infection, though 
further experiments are required to validate this observation (Figure 11). 
There are a group of IRESs that have been either biochemically demonstrated or 
predicted to function in a similar fashion to the HCV IRES (Hellen and de Breyne, 2007). 
The CSFV IRES has been studied extensively and behaves virtually identically to the HCV 
IRES in vitro (Locker et al., 2007, Kolupaeva et al., 2000, Sizova et al., 1998). Other 
pestiviral IRESs, like from bovine diarrhea virus (BVDV) and GBV-B, have also been tested 
(Kieft et al., 2001) (Figure 12). Similar RNAs also exist within the Picornaviridae family (de 
Breyne et al., 2007, Hellen and de Breyne, 2007). Those from either simian picornaviruses 
(SPV-1, -9) or porcine teschovirus (PTV), or avian encephalomyelitis virus (AEV) also 
contain similar RNAs (Hellen and de Breyne, 2007) (Figure 12). Ultimately, I was curious if 
these RNAs were really “created equal” as they are from very different viruses. It seemed 
likely that there was at least some variation between them within the confines of a reporter 
system. That ended up being the case. Figure 12 highlights that exact principle since even 
very similar IRESs have very different responses to cellular stress. The only drug tested in 
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this manner was thapsigargin, though more in depth studies are warranted to determine 
what specific differences are actually responsible for translation variability, both response to 
stress as well as the overall activity (each IRES activity is adjusted independently). There 
are a number of IRES RNAs that I did not test, but my observations from Figure 12 suggest 
that their activity may also be variable between cell types and the type of stress induced. 
Further studies were carried out using the CSFV and SPV-1 IRES in addition to the HCV 
IRES because the three represented a dependence on, indifference to, and independence 
from eIF2 (in Huh 7.5 cells pretreated with thapsigargin). Variability in the activity of related 
IRESs could result from the rate of initiation changing in response to chemical treatment or 
changing during the course of the experiment due to some other factor. The time courses I 
carried out showed that the translation with or without stress behaved differently for each 
IRES. 
I suggest that an IRES can function without eIF2-loaded ribosomes in three possible 
ways based on data from this chapter. IRESs either can continue translating with or without 
eIF2-TC as efficiently, drive translation more efficiently in the presence of eIF2-TC, or directs 
translation more efficiently without eIF2-TC. To discuss the above conclusion, two important 
biophysical characteristics of eIF2 must be stated. First, a necessary step in eIF2 depletion 
is that it needs to be used (GTP-hydrolysis) to be sequestered by eIF2B (Pavitt et al., 1998). 
Second, is that as eIF2 becomes limited, it reduces its affinity for tRNAiMet implying that 
during severe stress there are higher concentrations of unbound tRNAiMet in the cell (Kapp 
and Lorsch, 2004). These two observations could explain the three different trends seen for 
the rate of IRES-driven translation in Huh 7.5 cells (Figure 13). An IRES like HCV’s uses up 
the rest of the eIF2 efficiently and transitions to an eIF2-independent mode easily (Figure 
13A). The CSFV IRES is slow from the start because eIF2 is scarce its mode of action 
prefers eIF2-TC. In contrast, the SPV-1 IRES operates more efficiently without any eIF2 and 
as more eIF2-TC-deficient ribosomes become available if functions more efficiently perhaps 
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because it can stabilize initiator tRNA on IRES-bound ribosomes (de Breyne et al., 2007). 
These conclusions are generalized based on the data presented in this chapter and need to 
be further validated 
As it turned out, variability in eIF2 dependence really resulted from the specific 
cellular condition tested. Under certain conditions like in a cell type from its host species, 
even CSFV operated independently of eIF2 (Figure 14B, PK-15 cells, thapsigargin 
treatment) suggesting that there was some condition that was driving the ability of these 
IRES to function effectively. Or, as mentioned above, some concentration of eIF2 or free 
tRNAiMet had to be reached to promote optimality for each IRES. Any specific treatment was 
not sufficient to dictate how an IRES would function since what was optimal for Huh 7.5 cells 
(DTT) was not optimal in PK-15 cells (thapsigargin). These data suggested that IRES-driven 
translation was not just eIF2-independent but was actually stifled by high eIF2 levels; 
supposing a level of negative regulation that might limit the speed at which a virus can 
amplify itself. This conclusion is based on the assumption that chemical stress limits 
translation because eIF2 is inactivated, one that is often made in regard to IRES-driven 
translation (reviewed by Lozano et al., 2015). That idea presents an interesting perspective 
when considering that Pestiviruses and picornaviruses tend to be cytopathic while HCV is 
not and has much longer replication kinetics (White et al., 2011, Gottwein et al., 2011), but 
there is no clear connection and warrants further investigation before any conclusions could 
be made. 
Alternative Factors cannot explain the Resilient Nature of Type 3 IRES Function 
In some of the earliest characterizations of translation factors there were proteins in 
addition to eIF2 were identified that had the ability to stimulate the binding of tRNAiMet to a 
ribosome. This function did not include specific tRNAiMet binding like eIF2, but promoted 
tRNAiMet through means unknown. These included eIF2A, a 65 kDa protein co-purified with 
the eIF fraction from RRL (Zoll et al., 2002). Another was eIF-4C (Goumans et al., 1980), 
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which will be discussed later. And later on came eIF2D (Dmitriev et al., 2010), originally 
annotated as Ligatin (Jakoi et al., 1989), and a binary complex of the proteins MCT-1/DENR 
that shared homology to the N- and C- terminal domains of eIF2D, respectively (Skabkin et 
al., 2010). Factors eIF2A, 2D, and MCT-1/DENR have been suggested to deliver tRNAiMet to 
initiation complexes on HCV-like IRESs or other eIF2-independent means of translation in 
reconstituted systems (Skabkin et al., 2010). eIF2A has been shown to function in non-AUG 
initiation events in MHC-I peptide presentation (Starck et al., 2012), and in translation from 
Sindbis virus subgenomic RNA translation (Ventoso et al., 2006). To this end, I tested the 
dependence of the HCV IRES on either eIF2A or 2D by siRNA-dependent knock down. 
There was no observable effect on the translation of RNA containing this IRES, in direct 
conflict with published data showing that eIF2A was necessary for HCV IRES translation 
(Kim et al., 2011). eIF2D was also not required, but despite its in vitro contribution to 
tRNAiMet binding its primary function may be in ribosome recycling as presented by Skabkin 
et al. (2010). While I did not test dependence on MCT-1/DENR, it has recently been shown 
to stimulate reinitiation events that are mechanistically distinct from IRES-driven initiation 
(Zinoviev et al., 2015, Horvath et al., 1990). There may be some, as of now, uncharacterized 
factor that may be directing HCV IRES-driven translation, but current data did not provide a 
clear course of study regarding factor dependence after these results. 
Efficient  Translation  during  Stress  Requires  communication between  the  AUG  and 
Domain II 
Many early studies have characterized the nature of  HCV IRES•40S binary 
interactions and the ability of 40S binding to place the AUG into the P-site of the ribosome 
(Honda et al., 1996, Wang et al., 1995). This binding event obviates the need for any 
scanning, and supported the notion that scanning factors were not necessary for type 3 
IRES-dependent translation (Pestova et al., 1998b, Otto and Puglisi, 2004). It has been 
known also, somewhat contradictorily, that for translation from the HCV and CSFV IRESs 
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mutation of the conserved AUG start sites does not hinder translation as seriously as a start 
codon mutation on scanning messages (IRES translation from ~30-60% compared to <10% 
during canonical translation). What was unknown was what happens to a start codon mutant 
during cellular stress, since I had observed that translation from wild type IRESs could be 
enhanced in the absence of eIF2. Non-AUG initiation events from these IRESs required 
eIF2 and activity fell below 10% when the cells were stressed. Two things were clear; first, 
that the retention of IRES activity after start codon mutation was likely due to eIF2 forcing 
tRNAiMet onto non-cognate codons, a phenomenon eliminated by decreasing eIF2-TC 
concentration. Second, that despite independence from any known tRNAiMet delivery factors, 
tRNAiMet was required even under conditions of severe stress. It is also worth noting that in 
the case of SPV-1, a near-cognate mutation (AUU) was still quite active, perhaps because it 
differed from an AUG only at the wobble position and tRNAiMet delivery was somehow more 
efficient for this IRES under these conditions. 
In the absence of a specific factor to examine at this point, I turned to the IRES itself. 
It has long been appreciated that the function of these IRESs is absolutely linked to their 
three-dimensional fold (Lukavsky, 2008) and that the association of type 3 IRESs can 
influence the conformation of the ribosome and eIF3 (Hashem et al., 2013b). I reasoned that 
the ability to continue translation during stress was a function of a specific IRES domain. It 
quickly became clear that while overall activity can be dramatically altered by mutation to the 
IRES, increased translation requires domain II. DII is known to induce conformational 
changes in the ribosome and IRES RNA configuration in the decoding groove (Filbin et al., 
2012, Hashem et al., 2013b). Furthermore, as I show in Figure 17 the optimal translation 
efficiency of the HCV IRES is dependent on both dII and an AUG start codon. Overall, my 
conclusion from this was that there was some interplay between stress, dII, and an AUG 




The most pertinent experiments I have yet to do on this topic include finer time 
courses on the translation mediated by type 3 IRESs. I have only examined three IRESs 
under one condition. A number of cellular states promote the inactivation of eIF2 (Jiang et 
al., 2006). Here I have only really tested three (thapsigargin, DTT, and tunicamycin). These 
treatments provide clues to the way that translation is driven by these IRESs, but more 
comprehensive analyses must be performed to make stronger conclusions. For instance, 
would the CSFV IRES activity in PK-15 cells treated with thapsigargin have a curve that 
mirrors the one shown for SPV-1, or would the initial rate be increased instead of a late time 
point acceleration of translation? My hypothesis would be that there are only those three 
instances where, as I suggest, an IRES is competing with/for eIF2 (CSFV), eIF2 is 
inconsequential (HCV), or an IRES operates more efficiently once eIF2 levels drop below a 
certain point. 
More studies will be required to develop a comprehensive list of how type 3 IRESs 
can function during certain stress conditions. By performing translation assays that can be 
carried out in cells from many species I could begin to understand the real nature of the 
evolutionary tuning that these RNAs have been subject to. Further, since eIF2 is not 
essential, but tRNAiMet still is, I would be interested to quantitate the levels of tRNAiMet in 
each cell type by RT-PCR or deep sequencing and comparing that to the amount of eIF2 
available to define the ratio of tRNAiMet to eIF2 that is optimal for these IRESs, and 
determine if this ratio changes significantly during stress that stimulates IRES-dependent 
translation. Though not specific to my studies, it would also be worth starting to quantitate 
levels of eIFs relative to ribosomes in some cell types to help advance our understanding of 
the potential rates, and true rate limiting steps in translation initiation. Only in lysates and in 
yeast have these types of quantifications been done. A related point is that, despite decades 
of research the timing of eIF2-TC association with 48S PICs (before or after mRNA 
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association) has not been clearly determined. Understanding, at the very least, the 




Figure 9: Diagram of Translation Reporter Constructs and Translation Assays. 
(A) Translation reporter assays used throughout this text are designed either as bicistronic 
(cap-driven Renilla luciferase and IRES-driven Firefly luciferase) or as monocistronic IRES- 
driven (triphosphorylated, not polyadenylated) or cap-driven (m7G-capped and 
polyadenylated). (B) Standard translation assay workflow shown for either cell culture (left) or 
from in vitro translation lysates (right). Cells were chemically stressed as indicated in Materials 
and Methods for 1 hour before being transfected with reporter RNAs and analyzed for 
luciferase activity at two hours post transfection. Lysate translation assays were performed 
according to manufacturer’s conditions unless recombinant protein or aptamer was added 
before reporter mRNAs were added. Translation was allowed to proceed for 20-30 minutes 
before being analyzed for luciferase activity. 
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Figure 10: HCV IRES Maintains Activity During Stress in Multiple Human Cell Lines. 
Bicistronic HCV IRES reporter mRNAs were transfected into (A) Huh 7.5 cells, (C) HeLa cells, 
or (D) HEK293 cells. Cap and IRES activities were analyzed individually with 100% 
representing the luciferase activity from unstressed cells. Huh 7.5 cells were pretreated with 
300 nM thapsigargin, 2 mM DTT, or 2 ng/mL tunicamycin. (B) Relative levels of 
phosphorylated eIF2α in Huh 7.5 cells are shown by western blot and compared to total eIF2α. 
Data are presented as the mean activity relative to the unstressed control for at least 3 
independent experiments. Error bars represent the standard error of the mean. 
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Figure 11: HCV IRES Mediates Translation from Reporter mRNAs efficiently during Viral 
Infection. 
(A) Bicistronic HCV IRES reporter mRNAs were transfected into Huh 7.5 cells that had been 
mock infected or infected with HCV strain JC-1 at an MOI of 0.1. Transfections were 
performed 72 after infection. Cap and IRES activities are graphed independently with activity 
in mock-treated cells representing 100%. (B) RT-PCR analysis of total RNA isolated from 
mock-infected or HCV-infected Huh 7.5 cells. Three sets of primers were used targeting the 
ORF (HCV1 and 2) or the 3’ UTR (HCV 3). GAPDH was used as a positive control. Data are 
presented as the mean activity relative to the unstressed control for at least 3 independent 
experiments. Error bars represent the standard error of the mean. 
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 Figure 12: HCV-like IRES have Variable Activities during Stress in Huh 7.5 cells. 
There are a number of related RNAs that drive translation of viral mRNA in diverse viruses. 
(A) Cartoon secondary structures of the HCV and CSFV IRESs, and predicted secondary 
structures of GBV-B, PTV, and SPV-1. Variable regions are highlighted in pink boxes. (B) 
Translation assays in Huh 7.5 cells with bicstronic reporters constructred to contain the 
indicated IRES in the intergenic region. Control IRES reporter mRNAs for eIF2-independent 
translation (CrPV) or eIF2-dependent translation (EMCV). Type 3 IRESs tested reported 
variable relative levels of translation during thapsigargin (300 nM) stress. For each IRES, cap 
and IRES activities were reported independently. 100% activity represents the activity in 
unstressed cells. Data are presented as the mean activity relative to the unstressed control 
for at least 3 independent experiments. Error bars represent the standard error of the mean. 
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Figure 13: Type 3 IRESs Facilitate Translation at Different Rates During Stress. 
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Figure  13:  Type  3  IRESs  Facilitate  Translation  at  Different  Rates  during  Stress. 
Representative IRES reporter mRNAs, HCV IRES (A), CSFV IRES (B), or SPV-1 IRES (C) 
were transfected into Huh 7.5 cells after 1 hour pretreatment with thapsigargin (300 nM, red 
line) or mock treatment (DMSO, black line) and were harvested at the indicated time after 
transfection. Relative activity is presented as fraction of the IRES activity in unstressed cells 
at 360 minutes. Data are presented as the mean activity relative to the unstressed control for 




Figure 14: Type 3 IRES have Variable Activities between Cell Types. 
(A) Huh 7.5 cells were transfected with bicistronic reporter RNAs harboring representative 
type 3 IRESs. Translation assays were performed during cell stress induced with the indicated 
chemical. (B) PK-15 (porcine kidney) cells were transfected with IRES reporter mRNAs after 
pretreatment with thapsigargin (3 μM) or DTT (2 mM). (C) Vero cells were transfected with 
IRES reporter mRNAs after pretreatment with thapsigargin (1 μM) or DTT (2 mM). (D) Relative 
levels of phosphorylated-eIF2α after chemical treatment were compared to total eIF2α by 
western blot visualization. (E) Levels of alternative eIFs (2A and 2D) after chemical treatment. 
Chemicals stress does not affect the abundance of these factors. Translation data are 
presented as the mean activity relative to the unstressed control for at least 3 independent 
experiments. Error bars represent the standard error of the mean. Statistically significant 




Figure 15: Alternative eIFs are not essential for HCV IRES Activity. 
Alternative eIFs were depleted from cells to determine their contribution to HCV IRES- 
mediated translation. (A) Workflow of the siRNA-mediated knock down of eIF2A and eIF2D. 
siRNAs were added at 10 nM and cells were transfected 48 hours later with reporter mRNAs. 
(B) HCV IRES activity in either unstressed or thapsigargin stressed cells that had been 
pretreated with non-targeting (Ctrl) or siRNAs targeting alternative eIFs singly or in 
combination. (C) Western blotting showing the efficient knockdown of alternative eIFs relative 
to a β-actin loading control. Data are presented as the mean activity relative to the unstressed 





Figure 16: Type 3 IRESs are Highly Dependent on AUG Start Codons during Stress. 
(A) Translation activities of HCV IRES bicistronic reporter mRNAs with mutated start codons 
(WT= AUG) in unstressed or thapsigargin (300 nM) pretreated Huh 7.5 cells. (B) Translation 
activities of CSFV IRES start codon mutant reporter mRNA. (C) Translation activities of 
SPV-1 start codon mutant reporter mRNA. Data are presented as the mean activity relative to 
the unstressed control for at least 3 independent experiments. Error bars represent the 




Figure 17: HCV IRES Domain II is Necessary for Increased Translation during Stress. 
(A) Schematic of the HCV IRES and the location of the indicated mutants. (B) Translation 
activities of HCV IRES domain mutants in Huh 7.5 cells unstressed (solid) or stressed with 
DTT (2 mM, shaded). Colors represent the corresponding mutants shown on the cartoon in 
(A). Data are presented as the mean activity relative to the unstressed control for at least 3 
independent experiments. Error bars represent the standard error of the mean. Statistically 





TYPE 3 IRES RNAS ASSEMBLE INITIATION COMPLEXES BY AN UNEXPECTED 
PATHWAY 
Study Rationale 
The purpose of this chapter is to challenge the model for the initial steps of HCV 
IRES-dependent translation. The formation of a binary complex between a 40S subunit and 
an IRES is an easy inference to make when using a reconstituted system, but recent 
advances in our understanding of the cyclical nature of the function of ribosomes would 
suppose that they are always factor associated. They would be bound by accessory factors 
from the first co-transcriptional processing event of the 47S rRNA transcript, to the 
programmed degradation of a retired ribosome. With that information in mind, I investigated 
the factors accompanying an IRES in cell lysate to a limited extent. It is important to 
determine the actual complex formed by IRES binding, in that it shows exactly what is 
available for use in initiation by viral RNAs. It is clear that the minimal requirements (in vitro) 
and the optimal requirements (in vivo) can be comprised of a very different set of factors. 
This phenomenon is not unique to translation.For example, RNA polymerase can transcribe 
RNAs in vitro with the assistance of transcription factors, but the actual rate of transcription 
is modulated by a whole host of modulatory and signaling factors that manipulate the 
polymerase and the DNA for efficient access (Shandilya and Roberts, 2012). 
Further, we address the physical role of dII in navigating the assembly of HCV IRES- 
bound initiation complexes. The stimulatory nature of IRES dII has been characterized 
extensively by mutagenesis (Bhat et al., 2015, Filbin et al., 2012, Berry et al., 2011, Filbin 
and Kieft, 2011, Locker et al., 2007, Lukavsky et al., 2003, Kalliampakou et al., 2002). It 
affects binding steps, ribosome conformation, and manipulates the switch between initiation 
and elongation. It is also an especially flexible RNA domain, and that flexibility is critical to 
its function. It would be simple to say that dII is flexible so any conflict with eIF2-TC that has 
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been indicated by structural data regarding IRES•40S•eIF2-TC would be solved by flexibility. 
My attention was drawn to the steric conflict imposed by the simultaneous binding of IRES 
and eIF2 suggested by recent cryo-EM structures (Filbin et al., 2012, Llácer et al., 2015, 
Quade et al., 2015, Yamamoto et al., 2014). There has been longstanding confusion 
regarding how dependent type 3 IRES-mediated translation actually is on eIF2. It turned out 
that conflict with eIF2 may be somewhat limiting on type 3 IRES-mediated translation and 
that dII may need the departure, or inhibited binding, of eIF2 to function properly. 
Finally, studies of this nature also provided insight into the actual composition of 
PICs as they exist in mammalian cells. Understanding the composition of translation 
complexes is a fundamental aspect of biology that, in my opinion, is often overlooked. I have 
begun examining PICs under different cellular states and a comprehensive analysis of the 
factors bound is the next real step. The HCV IRES has, once again, provided a useful 
paradigm to consider. From my studies, it is clear that even a “minimal” translation signal 
like the HCV IRES can manipulate ribosomes bound to an extensive amount of protein 
factors to serve its own purpose. This poses an important question for future studies; do 
specific mRNAs assemble, or preferentially bind, PICs of a distinct composition? 
Results 
 
HCV IRES dII May Compete with eIF2 During Initiation 
Translation directed by type 3 IRESs in an eIF2-independent fashion presents a 
number of problems addressed above. Study of IRES function has been mostly biochemical 
as structural information has been somewhat elusive, and it is clear that eIF2 delivers 
tRNAiMet for these IRESs in a reconstituted system. Recently though, single particle cryo-EM 
reconstructions have shown a clearer picture of where IRESs are assembled on ribosomes 
(Quade et al., 2015, Yamamoto et al., 2014), though a structure of a fully assembled HCV 
IRES 48S complex still has not been solved.  In spite of this, interesting observations can be 
made based on related structures. The most obvious problem with the current models of 
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IRES function is that for every structure solved containing eIF2 bound to 40S ribosomes, the 
position of a helical segment of eIF2α is in direct steric conflict with the binding position of dII 
in the HCV•40S binary complex solved by Yamamoto et al. (2014) (Figure 18A). This is a 
problem yet the structure of the HCV IRES bound to an 80S•eIF5B• tRNAiMet shows 
significant rearrangement of dII that could accommodate eIF2 (Figure 18B, left:40S 
right:80S). It could be that the dynamic nature of dII allows the resolution of the steric clash I 
mentioned, but I showed in the previous chapter that a mutation to dIIb facilitated a large 
increase in translation specifically in the absence of eIF2 (Figure 17B, red bars). The 
functional importance and apparent flexibility of dII prompted me to examine, in more detail, 
the effect of dII mutations on eIF2-independent translation initiation mediated by the HCV 
IRES. 
I made multiple mutations to the apical loop of HCV IRES dII. The loop GCC 
nucleotides were either deleted (dII_ΔGCC), mutated to a UUCG tetraloop (dII_GCC- 
UUCG), deleted for a single nucleotide (dII_ΔapexC), or I introduced a transversion mutant 
(dII_GCC-AUU). Mutant IRES dual luciferase reporters were transfected into Huh 7.5 cells 
that had been pretreated with thapsigargin (Figure 19A) and analyzed for their ability to 
mediate translation in the absence of eIF2. Function of the WT IRES was unabated as 
expected, and for every dIIb mutant tested translation continued equally, if not more 
effectively during cell stress, though still to a lesser extent than WT IRES activity. The CSFV 
IRES has a similar dIIb apical loop while SPV-1 has a different sequence (UGU, the 
secondary structure in Figure 7C has not been as rigorously validated as those of the HCV 
and CSFV IRES). I made deletions of the dIIb apical trinucleotides for each IRES and 
compared the capacity of each construct for translation in Huh 7.5 cells pretreated with DTT 
(Figure 19B). Similar to the HCV IRES dII_ ΔGCC mutant, the CSFV IRES dII_ΔGCC 
mutant completely rescued IRES activity is DTT stressed cells. Surprisingly, the SPV-1 
mutant (dII_ΔUGU) was not able to increase translation after stress, though it maintained 
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WT IRES activity. Two possible explanations for this are; first, that the secondary structure 
drawn is incorrect (Figure 7C) and the mutations I made cause unforeseen structural 
problems; second, that since the SPV-1 dII lacks the GCC-loop predicted in many other type 
3 IRES dIIs (Hellen and de Breyne, 2007) its “WT” is effectively acting as the “ΔGCC” 
mutant from HCV or CSFV IRESs and further deletion is detrimental for other structural 
reasons. Clearly, dII is manipulating translation from these IRESs but I suggest that these 
mutants translate less efficiently in the presence of eIF2 because they are less capable of 
resolving the conflict with eIF2 than their WT counterparts, a problem that is of no 
consequence when eIF2 has been limited by cellular stress. 
The HCV IRES Assembles Initiation Complexes in Cell Lysate 
Studies of IRES-dependent translation are often predicated on the first binding event 
in IRES-driven initiation forming a binary complex of the IRES and the 40S subunit. It is 
increasingly clear that the function of ribosomes in translation proceeds as a cycle rather 
than a unidirectional pathway (Figure 20) (Aitken and Lorsch, 2012, Dever and Green, 
2012). As translation termination seems to be tightly linked to initiation through a recycling 
step it seems unlikely that apo-40S subunits exist in high proportion during cell growth. This 
observation, and those made earlier regarding eIF2 dependence and binding caused me to 
revisit the composition of IRES-bound initiation complexes, this time from cell lysates rather 
than reconstituted in vitro systems. 
I used 5’ biotinylated HCV IRES immobilized on streptavidin-coated agarose beads 
incubated in Huh 7.5 cell lysates to test what factors would associate with the HCV IRES. I 
used lysates that were left untreated or pretreated for 3 hours with DTT (workflow Figure 
21A). I used two control conditions to determine if interactions were specific, the first was a 
background binding measurement by using beads without IRES RNA (beads) and the next 
as a positive control for ribosome binding but negative control for eIF binding (CrPV, high 
affinity binding to the 40S but operates eIF-free). I incubated unbound or IRES-bound beads 
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with cell lysate then extensively washed the beads before subjecting to SDS-PAGE and 
western blotting analysis for core components of the 43S PIC, a 40S ribosomal protein 
(rpS6), eIF1, 1A, 2 (2α), and 3 (3B). I also tested for the presence of the phosphorylated, 
inactive form of eIF2 (p-2α) to determine if only active eIF2 was associated with these 
complexes (Figure 21B). The negative and CrPV IRES controls performed as expected for 
both unstressed (-) and stressed (DTT) lysates, meaning that the beads had little 
background binding while the CrPV IRES primarily recruited just the 40S subunit, though 
there was some eIF2, and 3 bound likely due to their inherent ability to associate with 40S 
subunits. The HCV IRES pulled down the ribosome as well as eIF2 and 3 as expected. 
Interestingly, eIF1A was associated with the IRES sample though eIF1 was not. Pull down 
of eIF1A required the ribosome as shown by the use of an IRES mutant that does not bind 
the ribosome (dIIId_GGG-CCC) (Figure 21B). This pattern of eIF association was surprising 
since, biochemically, eIF1A is not required for IRES function. The association of eIF2 in 
unstressed lysates was expected, but eIF2 was also associated with the HCV IRES in DTT- 
stressed lysates. During DTT treatment there is also an increase in p-2α binding to the 
complex (Figure 21B, “-“ versus “DTT” panels). These findings suggest that the eIF2 that is 
bound may not be productively bound. This further calls into question the nature of the 
eIF2 bound in the unstressed sample. Is it possible that the eIF2 associated in both cases is 
bound simply because of its affinity for eIF3? 
HCV IRES Initiation Complex Composition is directed by RNA Subdomains 
I had previously shown that domain mutants of the HCV IRES negatively affect 
translation driven by the HCV IRES (Figure 17B), specifically during stress. I was curious if 
this unexpected pattern of eIF pulldown was unique to the WT IRES or if it could be altered 
by different mutations. I used biotinylated mutant HCV IRESs similar to those used for 
translation assays in Figure 17 and incubated them in unstressed Huh 7.5 cell lysate (Figure 
22A). When compared to the WT HCV IRES, a mutant with reduced affinity for eIF3 
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(dIIIb_trunc) pulled down less eIF3 and similar levels of eIF2, but still retained eIF1A. A 
deletion of dII (ΔdII) pulled down eIF3 and eIF2 as well as WT, but had a reproducible defect 
in eIF1A binding. The dIIb mutant (dIIb_ΔGCC) used in translation assays behaved similar 
to wild type though was did not retain eIF2 to a similar extent, perhaps owing to eIF2- 
dependent translation defects noted in Figures 17 &19. While domain mutations have 
significant effects on translation efficiency, another important requirement for the formation 
of translation-ready IRES PIC complexes is RNA in the decoding groove. It has been well 
documented that both an AUG and at least the first 30 nucleotides of the HCV ORF 
constitute a fully functional IRES (Reynolds et al., 1996, Nomoto et al., 1995). I was curious 
if the presence of decoding groove RNA affected the composition of IRES-bound PICs. To 
this end, I made truncations to the 3’ end of the WT IRES (3-372) that either ended 
immediately following the AUG (3-344) or lacked the stem-loop containing the AUG entirely 
(3-330) and tested their ability to pull down initiation components (Figure 22B). These two 
mutants had RNA filling the P-site and no RNA in the decoding groove respectively. There 
was no observable difference in the occupancy of the eIFs tested for the length mutants. 
The ability of IRES mutants to not only affect the overall function of the IRES, but to 
specifically manipulate the composition of the PIC posed interesting questions. Does eIF1A 
function in IRES-mediated translation or is it simply a passenger on the 40S subunit? Is the 
IRES really recruiting the ribosome and necessary factors independently as the literature 
suggests, or is the IRES being recruited to a ribosome preloaded with eIFs, perhaps the 
product of recycling events shown in Figure 20? The first question is addressed in detail in 
Chapter IV, while the second question I address in the following sections. 
The CSFV and SPV-1 IRESs Assemble Similar Initiation Complexes in Lysate 
There are clear similarities in function of the CSFV and SPV1 IRES compared to the 
HCV IRES, in vitro. However, my data also highlights some differences when they operate in 
cells. Their similarities extend to biochemical characteristics as well as some trends in 
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domain function in translation. I used the CSFV and SPV-1 IRESs in a similar pull down 
experiment to determine if they bind PICs in the same fashion as the HCV IRES. I use WT 
IRES and compared them to mutant IRESs discussed previously that had either been 
deleted for dII, or had the trinucleotides in dIIb deleted (Figure 22C). Like the HCV IRES, the 
CSFV and SPV-1 IRES both pulled down eIF3 (not shown) and eIF2. Both IRESs also 
pulled down eIF1A but to varying extents. Perhaps variable eIF1A levels are a consequence 
of the overall stability of the PIC for each IRES, or suggesting a variable dependence on 
eIF1A. 
Natively Purified 43S PICs are Suitable Substrates for HCV IRES Binding 
My observation that unexpected PICs assemble on type 3 IRESs could possibly be 
explained by coincidence, any non-essential factors bound to the IRES are a consequence 
of eIF association with the 40S subunit. Recent data providing a dynamic link between the 
termination/recycling steps in translation and the requisite factor-loading steps that precede 
common types of initiation, however, suggest another possibility. Do IRESs load onto 40Ss 
preloaded with eIFs as a result of recycling instead? To test this, I modified standard 
ribosomal subunit preparation protocols to purify intact 43S PICs. 
Most preparations of ribosomal subunits involve the use of near 0.5 M KCl for the 
dissociation of factors associated with the subunits as well as dissociation of 80S particles 
(Sadnik et al., 1975). Using much lower concentrations of KCl, such as 0.025 M KCl, I 
intended factors to remain bound to the 40S subunit so that they more closely mimicked the 
state of small subunits that an HCV IRES might encounter in the cell. After lysis of cells 
either unstressed or stressed by DTT treatment, I pelleted total ribosomal fractions and 
resuspended them before subjecting them to a sucrose gradient that would resolve 80S 
from 60S from 43S PICs (Figure 23A, left graph). The PICs obtained in this fashion could 
then be incubated with IRES RNAs and run over a second sucrose gradient that would then 
resolve what stays bound to the 40S or is released upon IRES binding (Figure 23A, right 
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graph). When comparing the no RNA sample to the sample with HCV IRES incubated with 
the PICs (Figure 23B) there are subtle differences in the occupancy of certain eIFs, much 
like what I saw with the IRES pulldowns (Figure 21). eIF3 stays bound, as does eIF1A, but 
when comparing the bound and released fractions we can see trends in the displacement of 
eIF1 and 2 that would indicated that IRES binding destabilizes those eIFs, though there is 
significant variability in the stability of eIFs on 40S subunits when no IRES RNA is added. 
The altered composition of the PICs bound by the HCV IRES supports a hypothesis that it 
manipulates the PICs that it assembles in solution. This could be a result of directly 
remodeling a preassembled 43S PIC, or that it is selecting complexes that have 
stochastically lost eIFs it does not need. 
HCV IRES Subdomain Mutants Affect PIC Composition 
The PICs I have purified are large complexes that include the 40S subunit, but 
include a large number of other factors as initially purified (a limited list of these proteins is 
shown in Table 2). In that large number are eIFs responsible for 43S formation as well as 
recycling factors and AARSs. These samples could further be bound by WT HCV IRES to 
manipulate the complexes as shown in Figure 23, but two questions could examined in a 
similar way. Do IRES RNA subdomains individually manipulate the composition of the PIC? 
Is PIC remodeling GTP-dependent? 
43S samples were incubated with IRES mutants mentioned previously; dIIIb_trunc, 
ΔdII, dIIb_ΔGCC, and AUG-CUG then compared to the no RNA and WT IRES controls 
(Figure 24A). Ribosomal protein content was constant, the same input for each reaction, 
and eIF3 content remained largely the same except for the dIIIb_trunc mutant, though the 
effect was subtle. eIF3 should largely remain bound as it has high affinity for the 40S when 
eIF3j is also present (Fraser et al., 2007), as it presumably is in these samples. Again, eIF2 
is displaced by WT IRES and to a similar extent the dIIIb-trunc mutant. eIF2 loss for the dIIIb 
mutant may be a consequence of the loss of eIF3 as they tend to be stable on ribosomes 
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together (Sokabe and Fraser, 2014). The domain II and start codon mutants were not able 
to displace eIF2, suggesting that eIF2 displacement is a result of dII-dependent 
conformational changes and/or the correct placement of coding RNA. eIF1 is the most labile 
of the eIFs while eIF1A is stably bound in all complexes. Perhaps this occurs because the 
PICs purified tend toward a conformation that more closely mirrors the “closed” conformation 
of a post-scanning ribosome (Zhang et al., 2015). eIF1 and eIF1A are known to bind 
together and that eIF1 enhances eIF1A binding only when the ribosome is in an “open” 
scanning-competent conformation, as seen before start codon selection (Pestova et al., 
1998a, Passmore et al., 2007). The opposite is true after a start codon is found. Why a PIC 
purified in this fashion might tend toward a “closed” conformation without a bound mRNA is 
unknown. The most interesting trend is that the dIIb_ΔGCC and AUG-CUG mutants actually 
stimulate eIF1 binding relative to the no RNA control (Figure 24A, lanes 5 and 6 reflected in 
the released from 40S panel lanes 11 and 12). It is possible that a defect in eIF1 release 
contributes to translation defects for these mutants. Finally, eIF5B is associated with PICs. It 
is interesting because eIF5B is often depicted as traveling with or independently from 60S 
subunits in many models, but its presence in these samples suggests that eIF5B may be 
sampling 43-48S PICs regularly to determine if they are ready for subunit joining. Though 
much more labile without 60S present, eIF5B binding is stabilized on IRES-bound PICs with 
the highest translation activity in cell-based reporters; WT HCV, dIIb_ΔGCC, AUG-CUG 
(Figure 24A, lanes 2 and 5). 
An important consideration for this experiment, specifically in regard to eIF2 and 
eIF5B association, is that there are two critical, GTP-dependent steps in canonical 
translation initiation. The first is from the eIF2-TC (stimulated by eIF5) and occurs after AUG 
recognition and triggers the departure of phosphate while further promoting conformational 
changes in the 48S PIC that allow partial or full release of eIF2 and/or eIF1 (Saini et al., 
2014). The second involves eIF5B-GTP and occurs when the ribosome is in a joining- 
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competent conformation (promoted by eIF1A) (Fringer et al., 2007, Acker et al., 2006). To 
determine what effect GTP is having on IRES-based remodeling of the PIC, we pre- 
incubated cell lysates, prior to ribosome pelleting, with a non-hydrolyzable GTP analog 
(GMP-PNP). After treatment, I purified PICs in the same manner and treated those samples 
with the same panel of mutant IRESs to compare (Figure 24B). The patterns of eIF 
occupancy were almost indistinguishable from those of the untreated sample, with the 
exception of less eIF1A bound to the ΔdII IRES PIC sample which more closely mimics the 
pulldowns from Figure 22. Further, eIF5B was now no longer associated with the 40S in any 
condition (Figure 24B, top “bound to 40S” panel). I confirmed the efficiency of GTP to GMP- 
PNP exchange by performing a ribosome assembly assay in HEK293F lysate with either 
radiolabeled capped β-globin leader RNA or HCV IRES. I compared the ability of these 
labeled RNAs to migrate with either 40S or 80S subunits, and it was obvious that with GMP- 
PNP pretreatment both RNAs do not progress to 80S complexes, which requires GTP for 
both cap- and IRES-driven translation (Figure 25). This indicates that GTP analog treatment 
was efficient, with functional consequences 
I have shown that many IRESs function more efficiently during conditions of stress 
that limit eIF2. I was prompted to examine first the content of PICs from cells that had been 
stressed, as well as determining the composition of PICs from stressed cells after IRES was 
bound. To do this, I pretreated cells with DTT for 3 hours before harvesting the cells I would 
use to isolate ribosomes and ultimately 43S PICs. I then used these samples and tested the 
same panel of HCV IRES mutants used for the other PIC samples (Figure 26). The most 
notable difference is that the PICs from stressed cells contain very little eIF2 relative to the 
unstressed samples and that any eIF2 associated is not phosphorylated (Figure 26A). While 
eIF2 was no longer present on these PICs eIF3, 5B, and 1A were all present in the same 
trend as with other PIC samples tested. An important highlight is that in stressed PIC 
samples the eIF1A binding defect noted for the ΔdII mutant is exacerbated (Figure 26B). Not 
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unexpectedly, this implies that eIF2 does not play a role in IRES and 40S association, but 
what it does suggest is that the majority of PICs from stressed cells do not contain functional 
eIF2. This further supports the idea that translation is proceeding in the absence of eIF2 
rather than from the remaining pool of PICs that contain eIF2 as might be possible during 
translation in cells. The maintenance of eIF1A throughout all tests performed above also 
suggests even more strongly the importance of the factor in IRES-driven translation. 
“43S PICs” Include a Large Number of Associated Cellular Proteins 
Since the 40S subunits I have been purifying are not salt washed, they co-purify with 
a number of eIFs that I tested in response to HCV IRES binding. Also important, is that eIFs 
and translation factors are not the only things to associate with ribosomes within a cell. I 
used mass spectrometry to determine what other proteins were bound to the samples I used 
for my remodeling experiments. I first tested the unstressed or DTT-stressed samples that I 
was using as my input for IRES binding. Further, since salt washing is used to remove 
auxiliary factors from subunit preps, I salt treated samples with increasing doses of KCl 
(0.025 M, 0.05 M, 0.1 M, 0.2 M, 0.3 M, and 0.4 M) to determine which factors were the most 
stable, and by extension perhaps most closely associated with ribosome function. I 
subjected samples to sucrose gradient centrifugation after salt treatment and the resulting 
40S associated proteins are displayed by spectral count (Table 2). A number of translation 
factors were associated, as expected. A large number of cellular components like tubulin, 
proteosome components, mitochondrial components, dynamin, and some metabolic 
enzymes were also associated, again, highlighting “ribocentricity” of the cell. Also 
associated, were components of the aminoacyl tRNA synthetase complex (AARS-complex) 
(Raina et al., 2012) and interestingly, in the DTT sample a hallmark of stress granules, 




The composition of IRES-bound PICs, so-called 48S* complexes, has been 
repeatedly diagrammed as containing only eIF3, eIF2-TC, and the 40S subunit (highlited by 
Otto and Puglisi, 2004). Many studies have described the composition, the rates of IRES 
binding, and outlined the mechanism of IRES-dependent initiation (reviewed by Lukavsky, 
2008). In fact, these studies have described that eIF2 and eIF3 are necessary and sufficient 
for IRES 48S complex formation (de Breyne et al., 2007, Pestova et al., 1998b). Two 
problems remain in spite of these studies. First, it is obvious from the results in Chapter II 
and numerous other groups that eIF2 is not, in fact, necessary for translation mediated by 
the HCV and CSFV IRESs in cells. Second, the ribosome is a huge megadalton sized 
molecular machine that is associated, at any given time, with cellular factors, 
translation/recycling factors, and AARS-complexes. These statements taken together make 
it clear that translation from a type 3 IRES happens in a much more complicated 
environment than the HCV IRES-dependent translation model would suggest. 
IRES Domain II Provides Clues to the Mechanism of eIF2-independent Translation 
For much of the time that the HCV IRES has been studied, high-resolution structures 
were elusive. Crystallographic resolution of IRES•40S complexes have yet to be 
determined, but single particle cryo-EM reconstructions have shed some light on the nature 
of the binding events that lead to IRES-driven initiation (Hashem et al., 2013b). The first 
reconstruction of the HCV IRES bound to the 40S ribosome subunit came in at around 20 Å 
more than 15 years ago (Spahn et al., 2001) and since have been refined to near 9 Å in an 
80S complex (Yamamoto et al., 2014) and below 4 Å in a binary complex with the 40S 
subunit (Quade et al., 2015). Most apparent from the structural data was the conflict in IRES 
binding with the binding positions noted for what should be necessary factors eIF3 and eIF2. 
A map of the yeast 43S PIC with most factors loaded came at 6 and 4.9 Å for the open and 
closed states of the PIC, respectively (Llácer et al., 2015). eIF3 must be displaced by IRES 
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binding. It has been suggested that eIF3 is sequestered from PICs by the IRES in one study 
(Hashem et al., 2013b) and that it binds the IRES independently of the 40S by others 
(Collier et al., 2002). More to my point, it became clear that dII must displace eIF2 or 
otherwise resolve a positioning problem presented by the cryo-EM maps (Figure 18). This, 
with data showing increased translation without eIF2 (Figure 17B), suggested that eIF2 may 
actually be inhibitory rather than stimulatory at least when operating in cells. 
The interplay between dII and eIF2 is shown best by Figure 17. Mutations to the 
HCV IRES dII cause increases in translation specifically during stress, though they are 
limited during normal cell conditions. Even when the WT IRES does not increase efficiency, 
dII mutants cause at least a partial rescue of activity. Two things can be concluded from that 
data. First, that mutations to dII are defective because they do not communicate with eIF2 
effectively when it is present (unstressed, lower activity). Second, the presence of eIF2 is 
inhibitory for these mutants as well as wild type (stressed by thapsigargin and DTT). The 
mutations I used for the HCV IRES dII (dIIb_ΔGCC) are already known to affect IRES- 
dependent translation by affecting the unwinding and placement of dIV RNA in the decoding 
groove of the ribosome (Filbin and Kieft, 2011), and do so through the ribosomal RNA or 
ribosomal proteins, indirectly. It is possible that, in the presence of eIF2-TC, improperly 
arranged coding RNA slows the rate of eIF2-dependent translation, likely because stable 
start codon selection contributes significantly to eIF2-TC affinity for PICs. Without eIF2, 
however, PICs can acquire tRNAiMet but do not have to accommodate a tripartite protein 
complex like eIF2. Further, I have found that dII-eIF2 interplay is not unique to the HCV 
IRES and likely describes a general mechanism for type 3 IRES translation, but small 
evolutionary adaptations seem to cause changes in the ability of dII to “deal with” eIF2. 
IRES RNAs are Associated with Unexpected 40S-bound Complexes 
I was curious what was actually being assembled on the HCV IRES from cell lysates 
because there was an obvious difference in what was required in vitro and what was used in 
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a more complicated translation system. If the above assumptions are correct, eIF3 should 
only bind with an intact dIII, and eIF2 should only be bound in the absence of dII. Of course 
this was not the case as both bound significantly with or without these HCV IRES domains. I 
had initially performed IRES-based pulldowns to determine all factors that were associated 
with the PICs, but as a proof of concept had begun by testing for the presence of 43S- 
associated eIFs. The most striking result up to this point was the stable and 40S-specific 
association of eIF1A. eIF1A has often been tested in vitro to determine its effect on IRES 
initiation complex formation, and has been deemed unnecessary and, in concert with eIF1, 
deleterious to IRES 48S PIC formation (Locker et al., 2007, Sizova et al., 1998, Pestova et 
al., 1998b). The presence of eIF1A on these initiation complexes is what diverted my 
attention from determining what unknown factors were associated to understanding how the 
IRES 48S was really assembled. 
When the first models of IRES-driven translation were presented, the complex and 
coupled nature of translation termination and recycling was not as well understood. It 
became clearer, however, that since all steps in translation are coupled, an IRES may be 
better suited to find the product of a step in recycling than finding a ribosome free of factors. 
This made more sense when one considers the nature of MFC loading to the 40S as a final 
step in recycling to displace recycling factors (Nrenberg and Tamp, 2013). If one imagines 
that ribosomes start as factor-loaded PICs then the differences in factor association make 
more sense. eIF1A could be present as a byproduct PIC assembly. eIF1 loss could be a 
product of IRES binding-induced conformational changes. eIF2 retention on IRES-bound 
complexes from lysate could be a result of its association with eIF3. eIF3 is always present 
due to its affinity for the 40S as well as HCV IRES dIII, except when dIIIb is truncated. 
Finally, eIF5B is present in the PIC samples and can be stable once it encounters a 
ribosome in the right conformation. It has been shown that only eIF3 and the 40S have 
specific affinity for an HCV IRES (Kieft et al., 2001), all other factors are likely associated 
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with the IRES PIC indirectly. Given that mutations to subdomains of IRES cause 
conformational changes to the 40S (Filbin et al., 2012, Hashem et al., 2013b), the subtle 
changes to eIF stability in Figures 22 are more consistent. For example, dII promotes a 
“closed complex” and its deletion would likely destabilize a factor that is more stable in a 
closed complex, eIF1A. 
43S PICs are Bound and Manipulated by IRESs 
Standard preparation of ribosomes and ribosomal subunits involves a pelleting step 
that separates heavy particles (ribosomes) from other soluble components. The pellet is 
then “salt washed” at 0.5 M or higher monovalent salt concentration to dissociate all protein 
factors from the ribosomal subunits. Salt washing effectively allows the separation of 
individual subunits in addition to generating a translation factor fraction that can be further 
manipulated for native purifications of translation factors for reconstituted systems etc. This 
was also the manner in which many eIFs were first characterized and named. As the field 
gains momentum in understanding the coupled nature of recycling and initiation it became 
clear to me that an IRES would be poised to bind a 40S that had been loaded with eIFs as a 
consequence of recycling. I purified those complexes instead of salt washed ribosomes by 
leaving out the salt washing step in an attempt to isolate a more “natively” assembled 
complex (Figure 23) then using that to analyze IRES binding. As expected, the IRES was 
still able to bind to the ribosomes in these samples (Figure 23B). More to the point, the IRES 
was perfectly capable of manipulating these complexes by directly influencing factor 
composition or by selecting for partially stochastically disassembled initiation complexes. 
Subtle differences in the composition of the PICs from unstressed cells resulted from 
IRES and/or IRES mutant binding. More importantly, the changes to the PIC are not GTP 
dependent and seem to be a direct consequence of IRES binding and the subsequent 
conformational changes in the ribosome that binding induces (Figures 24-26). The position 
of IRES binding is interesting to consider because with the exceptions of the displacement 
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of eIF3 and the conflict with eIF2 mentioned above, the IRES should not come in conflict 
with other eIFs. eIF1 is the next closest factor to the IRES, bound near the E-site and near 
dII. eIF1 does not stay stably bound with or without the IRES and is probably less stable due 
to changes or dynamics in ribosome conformation that lead to its release. That is not 
unexpected as eIF1 tends to be the first eIF that leaves after it has performed its function in 
scanning (Maag et al., 2005). eIF1A is bound near the A-site of the ribosome in a position 
that allows it to interact with the P-site and the tRNA and mRNA present. It is also one of the 
last factors to leave during initiation and can be bound simultaneously with eIF5B as 
subunits are being joined (Acker et al., 2006). It does, however, require a specific ribosome 
conformation to remain stably bound in the absence of eIF1. This is effectively the same 
conformation induced by IRES binding. 
The cellular condition that is most conducive to IRES-driven translation, in my 
experiments, is one where the cells have been stressed and eIF2 has been limited (inferred 
from high levels of eIF2α-phosphorylation). Up to this point, the chemical treatment of cells 
and subsequent inactivation of eIF2 has been supposed by previous literature and 
significant relative increases in eIF2α phosphorylation. When isolating native 43S PICs it 
became clear that at least in the case of HEK293F cells, DTT treatment is effectively 
removing any detectable eIF2 from the 40S bound fractions, thus confirming our supposition 
that eIF2 was effectively depleted under certain conditions. In the absence of eIF2 the 
modulation of the PIC as the IRES was bound was effectively unchanged from the 
unstressed condition; a result in accordance with the observation that eIF2-TC is 
peripherally bound and is only stabilized once an AUG has been found. This result 
suggested that eIF2 is really not necessary for IRES-driven translation, rather than 
remaining eIF2 being used more efficiently by IRESs as global translation is limited. It also 
suggested that, at least at the 48S stage, there is not a significant increase in eIF5B 
association that may be responsible for delivering tRNAiMet in the absence of eIF2, as eIF5B 
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been previously suggested to be the major player in tRNA delivery in the absence of eIF2 
(Terenin et al., 2008). Using the DTT-treated samples also highlighted some of the changes 
based on IRES RNA subdomain specifically that the deletion of dII resulted in a reduced 
capacity for eIF1A binding. Given that the ΔdII mutant is the only mutant with an AUG that 
was not able to at least partially rescue activity during stress it became the first real link 
between eIF1A and the optimal function of type 3 IRESs. 
The HCV IRES Binds Ribosomes Efficiently Despite Hundreds of Extra 40S-associated 
Proteins 
The 40S-associated complexes I had purified were analyzed minimally to determine 
what eIFs were bound. I looked specifically at eIFs because their presence would be 
indicative of the overall translation initiation capacity of the complex. I was curious, however, 
what other factors co-purified because it has been well established that ribosomes are focal 
points of cellular biology and have many binding partners. They associate with the ER, 
interact with cytoskeletal machinery, and associate with the AARS-complex to name just a 
few. Beyond curiosity, it was also important to determine the extent of the factors bound to 
the PIC to show that an IRES can find its way to its binding site despite all the traffic 
surrounding the ribosome. This observation further strengthens my argument that an IRES 
has evolved to bind ribosomes in a cellular milieu and so does not require free ribosomes or 
unbound eIF3. There are a number of factors associated with ribosomes, many of them 
function directly in translation but others may increase local concentrations of factors that 
facilitate translation. Case in point, aminoacyl tRNA synthetases in close proximity to an 
elongating ribosome would thus increase the elongation proximal concentration of 
aminoacylated tRNAs to increase the rate of translation. Translation elongation factors as 
well as recycling factors (ABCE1) are also in the samples I have prepared. Association of 
ABCE1 with preinitiation complexes has already been published (Pisarev et al., 2010), 
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where it was suggested to facilitate recycling and thus promote initiation by increasing the 
rate of PIC formation, a function that would be co-opted by type 3 IRESs as well. 
The distinction between the models presented for type 3 IRES-mediated translation 
and one where an IRES binds a PIC coated in cellular factors may seem small, but 
ultimately it implies that binding is not hindered by the associated factors on ribosomes. The 
streamlined mechanism proposed and biochemically characterized in many related 
publications grants us detailed views on the binding and translation characteristics of an 
IRES when it does not compete with other cellular factors and/or mRNAs. The real purpose 
of my study is to determine what the most likely mechanism of translation initiation in the 
opposite scenario; the relevant one where, especially early in infection, the IRES must 
compete for cellular translation machinery. 
Future Directions 
The interplay between eIF2 and dII warrants further study as the competition seems 
to be integral to the overall kinetics of translation. I would like to do real competition 
experiments with eIF2 and various IRESs to see if the IRES binding is slowed by eIF2 or if 
eIF2 binding is lowered in the presence of dII. Which backs down first? Filter bind 
experiments could be used to test this, but to really get at the kinetics of the competition, 
FRET experiments with labeled dII and labeled eIF2 could be designed to measure 
rearrangements between the two. Pulldown experiments can be used easily to test for the 
presence of individual factors by western blotting. A more comprehensive approach would 
be to analyze the IRES-bound complexes in a similar way to the PICs. Mass spectrometry 
on the IRES-bound samples would be a way to determine if the IRES is able to pull out 
“lighter” 40S particles from lysate or if all IRES-bound ribosomes are the same flavor as the 
PICs I used in the latter half of the above chapter. Another interesting question posed by the 
pulldown experiments is why is eIF2 pulled out of the stressed lysates? The PIC analysis 
shows that eIF2 does not associate with PICs after sucrose gradient ultracentrifugation, but 
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why is it pulled out of lysates? Characterizing the interaction of inactivated eIF2 (p-eIF2α) 
with IRES-bound complexes would answer that. I would expect that it is being pulled down 
as a result of its inherent binding to eIF3, but looking at that specifically through an eIF3- 
based pulldown in the presence of IRES, or crosslinking experiments would finally answer 
that question. To further understand the rearrangement of the PIC architecture, mass 
spectrometry experiments should be done in the presence or absence of IRES in addition to 
the salt washing steps that I have described here. 
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Figure 18: Structural Evidence Suggests a Steric Clash between eIF2 and IRES Domain 
II on PICs. 
(A) Superimposed models (bottom) of the HCV IRES•40S binary complex (top, left, PDB: 
5A2Q) and eIF2α bound to the yeast PIC in the “open” conformation (top, middle, PDB: 3JAP) 
or “closed” conformation (top, right, PDB: 3JAQ) shows that the position of IRES dII (magenta) 
is in conflict with the position of eIF2α in both the “open”  (green) and “closed”  (blue) 
conformations. Yeast PICs have been stripped for all factors except the 40S and eIF2α. (B) 
Two cryo-EM structures of the HCV IRES bound to a 40S (left) or bound to an 80S (left, PDB: 




Figure 19: IRES Domain II Mutants Function more Efficiently during Stress. 
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Figure 19: IRES Domain II Mutants Function more Efficiently during Stress. 
(A) Mutations were made to the GCC triplet in the apical loop of dIIb in the HCV IRES as 
indicated. Mutant IRESs were placed in bicistronic reporter mRNAs and their activity during 
stress was monitored. (B) Analogous mutations were made to the apical loops of CSFV 
(dIIb_ΔGCC) or SPV-1 (dIIb_ΔUGU) and compared to the activity of the HCV IRES and its 
dIIb deletion mutation (dIIb_ΔGCC).100% activity is the luciferase activity from unstressed 




Figure 20: The Translation Cycle. 
The cyclical nature of ribosome function. Starting with 43S PICs loaded with eIFs (grey circle), 
mRNAs with eIF4F bound associate with 43S PICs. eIF2-TC directs Met-tRNAiMet to 43S PICs. 
The precise timing of eIF2-TC association may vary by message (TC + dotted lines). 48S 
complexes scan the 5’ UTR to find the proper start site (AUG). GTP-hydrolysis irreversible 
commits the complex to initiation. Associated eIFs depart with subunit association catalyzed 
by eIF5B. The only factors remaining at the 80S stage are eIF5B and eIF1A and eIF5B GTP- 
hydrolysis allows their release. The ribosome transitions to elongation, encounters a stop 
codon, and terminates using eRFs. Peptide release precedes subunit dissociation and 
tRNA/mRNA release facilitated by ABCE1. The full recycling of subunits and the displacement 




Figure 21: The HCV IRES Assembles an Unexpected Initiation Complex in Cell Lysates. 
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Figure 21: The HCV IRES Assembles an Unexpected Initiation Complex in Cell Lysates. 
(A) Workflow for biotinylation of IRES RNAs and isolation of IRES-bound complexes. After 
incubation in lysate the precise stage of translation is unknown (e.g. complexes may include 
48S or 80S particles). (B) Western blotting showing the factors associated with 43S PICs that 
associate with IRES RNA. Background binding (beads) was assessed compared to an eIF- 
independent mode of translation (CrPV, type 4 IRES). Factors bound to the WT HCV IRES 
were compared to those bound to a ribosome binding-deficient HCV IRES (dIIId_GGG-CCC). 
The composition of factors was also compared from unstressed (-) Huh 7.5 cell lysates or 




Figure 22: Type 3 IRES Mutants Pull Down Variable Initiation Complexes from Lysates. 
(A) Biotinylated IRES pulldowns were used to assess the composition of PICs on mutant HCV 
IRESs by western blot. The mutation in each lane are color coded and their positions 
diagrammed in the cartoon at the right. (B) The HCV IRES was sequentially deleted from full 
length (3_372, minimal IRES includes 30 nucleotides downstream of the AUG), deleted 
directly after the AUG (3_342, contains AUG in the P-site when ribosome-bound), or deleted 
for dIV (3_330, no RNA available for binding the decoding groove. (C) Western blot 
comparison between CSFV and SPV-1 IRES-associated complexes. Mutations to dII (deleted 
completely ΔdII) or deletion of the apical loop (dIIb_ΔGCC or ΔUGU) for these related IRESs 
were tested as well. 
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 Figure 23: Intact 43S Particles can be purified by Sucrose Gradient Ultracentrifugation. 
(A) Workflow for the isolation of intact 43S PICs from HEK293F cells. A representative A254 
trace for each of the centrifugation steps is shown below each step. (B) Western blot of 43S 
samples with or without the addition of the HCV IRES prior to the second centrifugation step. 
Blots on the left are from the 40S-associated peak (bound) and the blots on the left are from 




Figure 24: Natively Isolated 43S PICs are Remodeled by HCV IRES Binding. 
Native 43S PICs were analyzed for their factor composition by western blot after they had 
been incubated with WT or mutant HCV IRES. (A) 43S samples from unstressed cells were 
incubated with WT, a dIII truncation (dIIIb_trunc), domain II deletion (ΔdII), apical loop deletion 
of dIIb (dIIb_ΔGCC), or a start mutant (AUG-CUG) IRES before the second centrifugation 
step from Figure 22. Factor retention or displacement is shown by the Bound to 40S or Reased 
from 40S panels. (B)Unstressed HEK293F lysates were incubated with 1.5 mM GMP-PNP 
prior to ribosome pelleting and sucrose density gradient ultracentrifugation. IRES RNAs were 
incubated with these 43S PICs the same as in (A). GMP-PNP treatment was performed to 
monitor any contribution of GTP-dependent remodeling of PICs. 
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Figure 25: GMP-PNP Treatment Inhibits 80S Formation in RRL. 
WT HCV IRES (bottom) or a β-globin leader RNA (bottom: capped, contains the first 79 
nucleotides of the human beta-globin gene) was added to RRL that had been untreated or 
pretreated with 1.5 mM GMP-PNP. Reactions were run on a sucrose gradient to determine if 




Figure 26: Stressed Cells contain 43S PICs that Lack eIF2. 
(A) Western blotting of eIF2α in PIC samples either unstressed, unstressed but treated with 
GMP-PNP, or stressed by DTT. A phosphorylated-eIF2α blot is shown to represent that these 
samples do not co-purify with kinase-deactivated eIF2. (B) 43S PICs from stressed (DTT) 
cells were treated with HCV IRES constructs. The composition of 40S-associated complexes 
(bound to 40S) and the unbound factors (released from 40S) are shown by western blot. 
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Table 2: 43S-associated proteins 
Number of Unique Peptides 
Unstressed 43S DTT-stressed 43S 
Gene MW Input 0.025 M 0.1 M 0.2 M 0.4 M Input 0.025 M 0.1 M 0.2 M 0.4 
M 
RS3A 30 kDa 41 54 65 86 87 67 79 169 253 126 
RS3 27 kDa 31 67 79 102 100 73 101 197 313 96 
RS4X 30 kDa 30 48 55 73 70 44 66 130 175 80 
RS2 31 kDa 19 40 43 55 57 34 51 99 129 103 
RS8 24 kDa 27 42 55 71 70 49 80 121 170 69 
RS5 23 kDa 22 57 68 79 76 47 58 83 124 84 
RS18 18 kDa 21 26 41 48 42 29 49 135 208 61 
RS10 19 kDa 13 23 46 50 46 22 46 59 67 44 
RRP12 144 kDa 19 42 58 74 77 10 20 59 49 52 
RS16 16 kDa 27 39 42 44 45 26 50 99 151 86 
RS9 23 kDa 11 23 29 39 42 29 34 85 113 59 
RS11 18 kDa 14 20 29 43 28 19 32 58 105 59 
RS6 29 kDa 16 28 24 40 42 34 26 96 113 59 
RSSA 33 kDa 18 35 43 51 51 38 65 65 81 54 
RS13 17 kDa 11 23 26 32 33 25 27 50 0 54 
RS19 16 kDa 18 22 34 32 29 18 28 74 111 63 
RS7 22 kDa 14 23 27 28 28 14 23 65 62 34 
HNRPU 91 kDa 43 32 30 11 0 29 20 32 0 10 
RS17 16 kDa 13 23 27 31 31 18 25 63 108 27 
RS15A 15 kDa 0 14 17 22 18 0 22 41 62 50 
RS14 16 kDa 14 21 24 25 28 24 31 59 89 46 
RM37 48 kDa 10 28 23 29 29 9 19 25 0 29 
RPC1 156 kDa 12 45 36 9 8 18 27 13 0 0 
RM15 33 kDa 15 28 25 34 31 0 14 0 0 34 
RM44 38 kDa 12 21 26 31 30 7 13 0 0 0 
RS24 15 kDa 0 0 0 0 0 0 0 0 0 21 
RM39 39 kDa 16 29 23 34 32 0 18 13 0 25 
RS26 13 kDa 0 0 0 0 21 0 0 36 0 0 
RM03 39 kDa 11 16 20 19 17 0 10 25 27 15 
RM38 45 kDa 10 16 17 23 23 0 13 0 0 17 
RPC2 128 kDa 11 33 39 0 0 24 28 23 0 0 
RM11 21 kDa 8 17 19 25 19 11 17 31 24 25 
RS25 14 kDa 0 0 15 14 0 0 0 41 73 0 
RS23 16 kDa 0 14 16 17 17 0 15 47 70 27 
RM28 30 kDa 0 13 12 25 20 0 7 0 0 15 
RM13 21 kDa 12 14 19 18 16 0 0 0 30 25 
RM16 28 kDa 6 12 18 19 13 0 9 0 0 0 
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Number of Unique Peptides 
Unstressed 43S DTT-stressed 43S 
Gene MW Input 0.025 M 0.1 M 0.2 M 0.4 M Input 0.025 M 0.1 M 0.2 M 0.4 
M 
HNRPQ 70 kDa 11 23 11 0 0 45 28 27 0 0 
RM04 35 kDa 10 17 15 22 20 0 0 0 0 19 
RM01 37 kDa 11 15 17 21 18 0 13 0 0 13 
RM22 24 kDa 0 13 15 14 0 0 0 0 0 0 
RM47 29 kDa 0 16 20 20 17 0 8 0 0 10 
RS27A 18 kDa 9 0 11 16 10 0 18 23 0 29 
RM09 30 kDa 9 11 10 16 13 0 0 18 30 25 
LARP1 124 kDa 0 5 13 17 0 8 10 16 0 0 
RM24 25 kDa 0 10 0 12 14 0 0 0 0 19 
RT30 50 kDa 4 15 12 18 17 0 0 0 0 27 
RM02 33 kDa 6 10 8 14 12 0 0 0 0 0 
RM19 34 kDa 0 0 0 9 10 0 0 0 0 15 
RM45 35 kDa 6 11 11 20 13 0 0 0 0 21 
RPB2 134 kDa 8 8 9 13 19 0 7 0 0 19 
HNRPR 71 kDa 0 25 17 0 0 41 38 0 0 0 
RS12 15 kDa 0 12 18 12 0 0 12 0 38 15 
RL3 46 kDa 0 0 0 13 13 0 0 0 40 17 
RL7 29 kDa 0 0 0 9 7 0 0 0 0 0 
RL4 48 kDa 0 0 0 13 15 0 0 0 22 27 
RM46 32 kDa 0 10 8 11 10 0 0 0 0 0 
HNRPC 34 kDa 6 7 6 0 0 10 14 18 0 0 
RL7A 30 kDa 0 0 0 13 15 0 0 16 30 31 
RL5 34 kDa 0 0 0 12 16 0 0 0 0 17 
RM27 16 kDa 0 0 0 0 0 0 0 0 0 0 
RPC3 61 kDa 7 18 12 0 0 11 11 0 0 0 
RPC5 80 kDa 7 19 15 0 0 8 14 0 0 0 
RPAC1 39 kDa 0 11 12 0 0 0 13 0 0 0 
RM17 20 kDa 0 7 11 7 7 0 7 0 0 0 
RL13 24 kDa 0 0 0 0 13 0 0 20 38 17 
RM18 21 kDa 0 8 7 12 7 0 0 0 0 0 
HNRPD 38 kDa 17 0 0 0 0 20 0 0 0 0 
PRPS1 35 kDa 0 0 0 0 0 28 0 0 0 0 
RLA0 34 kDa 0 0 0 12 12 0 0 0 0 13 
RL8 28 kDa 0 0 0 0 9 0 0 0 0 0 
RM21 23 kDa 0 8 10 8 8 0 0 0 0 0 
PRP8 274 kDa 0 5 10 9 9 5 0 0 0 0 
RM49 19 kDa 0 9 8 9 0 0 0 0 0 0 
RL18 22 kDa 0 0 0 0 0 0 0 0 35 19 
RM20 17 kDa 0 0 0 0 8 0 0 0 0 0 
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Number of Unique Peptides 
Unstressed 43S DTT-stressed 43S 
Gene MW Input 0.025 M 0.1 M 0.2 M 0.4 M Input 0.025 M 0.1 M 0.2 M 0.4 
M 
RS21 9 kDa 0 0 0 0 0 0 0 0 0 19 
RL6 33 kDa 0 0 0 0 8 0 0 0 0 17 
RPC4 44 kDa 0 9 0 0 0 0 10 0 0 0 
HNRPK 51 kDa 31 0 0 0 0 21 0 0 0 0 
RM41 15 kDa 0 7 7 0 0 0 0 0 0 0 
HNRPL 64 kDa 22 0 0 0 0 24 0 0 0 0 
RM14 16 kDa 0 0 9 7 0 0 0 0 0 0 
RL10 25 kDa 0 0 0 0 0 0 0 0 0 21 
RM48 24 kDa 0 0 7 0 0 0 0 0 0 0 
GRP75 74 kDa 7 0 8 10 11 0 0 0 0 0 
RL26 17 kDa 0 0 0 0 0 0 0 0 0 0 
SERPH 46 kDa 0 0 0 0 0 0 6 0 0 0 
RL23 15 kDa 0 0 0 0 6 0 0 0 0 0 
RM53 12 kDa 0 0 0 0 0 0 0 0 0 0 
RM40 24 kDa 0 0 0 0 0 0 0 0 0 0 
RL23A 18 kDa 0 0 0 0 0 0 0 0 0 15 
RL10A 25 kDa 0 0 0 0 0 0 0 0 0 15 
RPC6 36 kDa 0 9 0 0 0 0 8 0 0 0 
KPRB 41 kDa 0 0 0 0 0 19 0 0 0 0 
HNRPM 78 kDa 8 0 0 0 0 0 0 0 0 0 
RT27 48 kDa 6 0 0 0 0 0 0 0 0 0 
EIF3A 167 kDa 166 267 232 124 103 208 274 138 4 7 
EIF3C 105 kDa 68 104 81 40 41 100 109 49 0 9 
EIF3B 92 kDa 59 97 85 37 43 110 98 61 0 2 
EIF3L 67 kDa 55 74 62 33 30 95 92 37 4 0 
EIF3E 52 kDa 46 75 47 24 19 80 75 46 0 0 
EIF3D 64 kDa 52 79 60 28 29 58 70 29 0 0 
EIF3M 43 kDa 43 76 49 20 15 53 58 9 0 0 
EIF3H 40 kDa 30 49 28 19 16 34 46 22 0 0 
EIF3I 37 kDa 39 47 36 25 16 53 59 37 7 0 
IF4A1 46 kDa 54 76 25 3 4 59 37 0 0 7 
EIF3F 38 kDa 22 39 25 14 10 38 43 26 0 0 
IF4G1 175 kDa 42 40 2 0 0 44 62 2 0 0 
EIF3G 36 kDa 24 43 28 11 7 31 40 9 0 0 
EIF3K 25 kDa 14 25 18 10 6 15 27 6 0 0 
IF2G 51 kDa 17 15 10 0 0 9 7 5 0 0 
IF4G2 102 kDa 27 21 0 0 0 0 0 0 0 0 
EIF3J 29 kDa 3 7 2 0 0 2 15 2 0 0 
IF2A 36 kDa 13 10 4 0 0 8 6 3 0 0 
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Number of Unique Peptides 
Unstressed 43S DTT-stressed 43S 
Gene MW Input 0.025 M 0.1 M 0.2 M 0.4 M Input 0.025 M 0.1 M 0.2 M 0.4 
M 
IF4A2 46 kDa 29 41 0 0 0 28 27 0 0 0 
IF2B 38 kDa 5 7 4 0 0 7 4 0 0 0 
IF1AX 16 kDa 2 5 1 0 0 5 5 0 0 0 
EI2BD 58 kDa 0 0 2 0 0 2 0 0 0 7 
IF4G3 177 kDa 8 7 0 0 0 0 0 0 0 0 
IF4B 69 kDa 5 0 0 0 0 0 0 0 0 0 
IF4A3 47 kDa 8 0 0 0 0 8 0 0 0 0 
EIF2D 65 kDa 0 0 0 0 0 4 0 0 0 0 
IF2P 139 kDa 4 0 0 0 0 0 0 0 0 0 
IF4E 25 kDa 0 0 0 0 0 0 1 0 0 0 
IF5 49 kDa 2 0 0 0 0 0 0 0 0 0 
EI2BE 80 kDa 0 0 0 0 0 2 0 0 0 0 
EIF2A 65 kDa 1 0 0 0 0 0 0 0 0 0 
ABCE1 67 kDa 29 24 12 6 4 25 25 14 13 13 
MTEF3 48 kDa 0 0 0 1 1 0 0 0 0 0 
ERF1 49 kDa 2 0 0 0 0 0 0 0 0 0 
SYEP 171 kDa 131 21 61 68 71 31 15 12 0 7 
SYIC 145 kDa 96 14 50 44 47 25 7 12 0 6 
SYMC 101 kDa 72 11 41 39 29 28 11 12 2 2 
SYRC 75 kDa 70 10 43 39 40 22 8 6 0 6 
SYLC 134 kDa 81 12 36 23 11 31 6 0 0 0 
SYDC 57 kDa 57 9 29 32 28 19 8 6 0 7 
SYK 68 kDa 45 5 16 12 10 2 2 0 0 0 
SYQ 88 kDa 66 4 17 12 12 7 0 0 0 0 
AIMP1 34 kDa 34 3 12 15 16 2 2 0 0 0 
AIMP2 35 kDa 14 5 10 9 9 13 6 3 0 2 
ICT1 24 kDa 6 7 9 9 8 0 4 5 2 19 
RTCB 55 kDa 8 0 0 0 0 4 2 0 0 0 
NSUN2 86 kDa 0 0 0 0 2 2 3 0 0 0 
TRM2A 69 kDa 0 1 0 3 1 0 0 0 0 6 
SYHC 57 kDa 5 0 0 0 0 0 0 0 0 0 
SYTC2 93 kDa 2 0 0 0 0 0 0 0 0 0 
SYCC 85 kDa 2 0 0 0 0 0 0 0 0 0 
SYYM 53 kDa 0 0 0 0 0 0 0 0 0 0 
ACTG 42 kDa 21 13 22 19 23 32 21 28 57 35 
ACTZ 43 kDa 23 26 25 13 12 24 10 0 0 0 
DCTN1 142 kDa 33 29 18 7 7 28 4 0 0 0 
G45IP 25 kDa 7 12 14 19 16 5 7 0 0 6 
AIMP1 34 kDa 33 3 12 15 16 0 0 0 0 0 
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Number of Unique Peptides 
Unstressed 43S DTT-stressed 43S 
Gene MW Input 0.025 M 0.1 M 0.2 M 0.4 M Input 0.025 M 0.1 M 0.2 M 0.4 
M 
AIMP2 35 kDa 13 5 9 8 9 13 6 0 0 0 
CAZA1 33 kDa 4 5 0 0 0 5 0 0 0 0 
DCTN4 52 kDa 6 4 0 0 0 5 0 0 0 0 
ARP10 46 kDa 0 0 0 0 0 4 0 0 0 0 
CAPZB 31 kDa 4 0 0 0 0 0 0 0 0 0 
TBA1B 50 kDa 234 252 240 257 283 336 393 281 260 162 
TBB2B 50 kDa 222 234 218 223 233 224 279 379 481 265 
TBB5 50 kDa 253 266 243 248 266 295 348 450 562 306 
TBB4B 50 kDa 234 249 235 236 254 262 289 412 534 291 
TBA1C 50 kDa 158 176 166 187 187 244 290 0 0 0 
TBG1 51 kDa 22 17 14 5 0 8 12 10 0 0 
TBB6 50 kDa 82 105 94 101 104 126 149 0 0 136 
TBB4A 50 kDa 205 0 203 202 222 0 252 0 0 246 
TBB3 50 kDa 124 0 0 0 0 168 208 0 0 196 
GCP2 103 kDa 10 5 4 0 0 0 5 0 0 0 
GCP3 104 kDa 12 6 3 0 0 0 0 0 0 0 
Table 2: 43S-Associated proteins. 
43S Samples isolated from Unstressed or DTT-stressed cells were analyzed for peptide 
content by Orbitrap MS/MS. Samples of 43S were run through a second sucrose gradient in 
the presence of increasing concentrations of KCl in Buffer B. Samples were concentrated and 
prepared for SDS-PAGE before in-gel tryptic digest and mass spectrometry. Proteins in Table 
2 are an abbreviated list organized in the order of ribosomal proteins, eukaryotic translation 
initiation factors, translation recycling factors, actin genes, and tubulin genes. CRITERIA FOR 
PROTEIN IDENTIFICATION-- Scaffold (version Scaffold_4.6.2, Proteome Software Inc., 
Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide 
identifications were accepted if they could be established at greater than 95.0% probability by 
the Scaffold Local FDR algorithm. Protein identifications were accepted if they could be 
established at greater than 99.0% probability and contained at least 2 identified peptides. 
Protein probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii et al., 2003). 
Proteins that contained similar peptides and could not be differentiated based on MS/MS 




THE SCANNING-ASSOCIATED INITIATION FACTOR EIF1A IS NEEDED FOR 
OPTIMAL IRES ACTIVITY 
Type 3 IRES and eIF1A Function in vitro 
48S complex formation on type 3 IRESs historically has been determined to be 
facilitated only by eIF2-TC and eIF3 (Otto and Puglisi, 2004, Fraser et al., 2009). One of the 
reasons for this has been that very early on, it was determined that the 5’ UTRs of these 
IRESs contain multiple in-frame AUGs, but they are not used for translation. Without 
scanning, the contribution of eIFs involved in scanning seems remote, thus the model for 
translation initiation on type 3 IRESs excluded eIF4F, 1 and 1A. Often, experiments relating 
to the factor requirements of translation initiation complexes include ribosome toe printing. 
The experiment is predicated on primer extension inhibition by the leading edge of a 
ribosome complex (Kozak, 1998, Hartz et al., 1988). Ribosomes are a known size with a 
known length of coding RNA being protected from transcription, and deviations in the length 
of RT products can be inferred as changes to the location, stability, efficiency, or 
composition of initiation complexes. 
Early characterizations of HCV IRES translation were simply that, translation assays 
validating internal initiation, describing the start site, and determining relative efficiencies of 
HCV IRESs between genotypes. Insight into the specific mechanism of action of the IRES 
only came out 5-6 years after it was originally described by Tsukiyama-Kohara et al. (1992). 
Only in 1998 were eIF-dependencies evaluated for the HCV IRES starting with its interaction 
with eIF3 (Sizova et al., 1998). Very early on, it was determined by toe printing that eIFs 3, 
4F, and 2 were dispensable for the binding of both the HCV and CSFV IRESs to the 40S 
(Kolupaeva et al., 2000, Hellen and Pestova, 1999, Sizova et al., 1998, Pestova et al., 
1998b). Further, it was noted that addition of eIF2-TC was sufficient for the formation of 
48S-specific toe prints, and that eIF3 was necessary for the formation of 80S ICs. As early 
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as 1998 the basic model of IRES to 40S binding for initiation was proposed (Hellen and 
Pestova, 1999). 
The first test of the contribution of eIF1 and eIF1A to type 3 IRES-dependent 
translation came in 1998, where the CSFV IRES was used as a model for the independence 
of these two factors (Pestova et al., 1998b). Addition of both to toe printing reactions 
resulted only in a modest decrease in toe print intensity relative to eIF3 and eIF2 alone 
(Pestova et al., 2008). Direct influence of eIF1 and eIF1A on type 3 IRES PIC formation 
came a few years later where it was determined that eIF1 has a general destabilizing effect 
on 48S PICs on the SPV-9 IRES, but eIF1A actually enhances the toe prints independently 
of eIF2 (de Breyne et al., 2007). Interestingly, SPV-9 can stimulate tRNAiMet binding in the 
absence of other eIFs and can form stable toe prints with only tRNA and eIF1A added. This, 
so far, is unique to the SPV IRESs in that the addition of eIF1A to the CSFV (Locker et al., 
2007) or HCV IRES has no effect. In vitro however, there is no strict dependence on eIF1A 
in any case, and the conclusion from multiple studies is that eIF2-TC and eIF3 are 
necessary and sufficient for 48S PIC formation (Hellen, 2009, de Breyne et al., 2007). 
Study Rationale 
The function of eIF1A is both critical and mysterious to initiation. The dynamic nature 
of the evolutionarily expanded N- and C-terminal tails makes study of the molecular motions 
that govern its function quite difficult. Insight into this problem might be presented by a type 
of initiation that removes the scanning step and allows us to examine the duties of eIF1A 
after a start codon has been found. Previous characterization of the function of eIF1A in type 
3 IRES-mediated translation is quite limited, and it is considered unnecessary largely 
because it is associated with scanning, and type 3 IRESs do not scan. I have observed 
eIF1A on PICs bound to type 3 IRESs, but its role in that regard has not been tested. The 
purpose of this chapter is to determine if eIF1A is present on PICs as a passenger or if it is 
performing a specific function. Further, what would the function of eIF1A be on these 
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complexes? Examining those general questions was the subject of a significant effort on my 
part, but understanding them would give us greater detail in understanding the surprisingly 
mysterious mechanism of action of an essential initiation factor. 
Results 
 
A SELEX-Generated Aptamer Specifically Removes eIF1A from PICs 
My results suggest, overall, that translation by type 3 IRESs proceeds from an IRES 
binding event that associates it with a factor-loaded PIC that subsequently gets remodeled 
to an “ideal” particle for IRES-dependent translation. IRESs operate independently of eIF2 
and may translate more efficiently without eIF2, likely because there is no need to resolve a 
substantial steric conflict between dII and eIF2. Unexpectedly, eIF1A is stably bound in 
these complexes and its presence, according to published 43S PIC and HCV IRES•40S 
binary complex structures, may not cause any steric or conformational conflict with IRES, 
coding RNA, and tRNAiMet binding (modeled in Figure 27). However, since its loading onto a 
40S is coupled to recycling and eIF3 and eIF1 loading, it may not be functional despite 
being present. 
The first step in testing the function of eIF1A in type 3 IRES-mediated translation was 
to take advantage of a kind gift from Akihiro Oguro and Yoshikazu Nakamura at the 
University of Tokyo. They generated an RNA aptamer by SELEX that specifically targets 
eIF1A and removes it from initiation complexes. It was generated in a similar fashion to 
aptamers targeting eIF4E, eIF4G, and eIF4A (Miyakawa et al., 2006, Oguro et al., 2003, 
Mochizuki et al., 2005). A secondary structure prediction of the aptamer is shown (Figure 
28A), while experimental validation is shown (Figure 28B) using a bicistronic reporter mRNA 
with a cap-driven Rluc ORF (lower band) and an HCV IRES driven chloramphenicol 
acetyltransferase ORF (CAT, upper band) translated in RRL in the presence of 35S- 
methionine and visualized by radiography of an SDS-PAGE gel. The treatment of lysates 
with an α-eIF1A (apt) aptamer compared to a no aptamer RNA (no RNA) or a randomized 
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RNA (N40) decreases the production of protein. We also tested the effect of aptamer 
depletion on translation assays from either a capped monoluciferase mRNA (positive 
control) or an Fluc mRNA led by the CrPV IRES (negative control, requires no eIFs) (Figure 
29A). As expected, luciferase activity from the capped reporter was significantly decreased 
relative to the AS control in both RRL as well as HeLa IVT lysate. Also, the CrPV IRES- 
driven reporter was unaffected by eIF1A depletion, and even markedly (~4 fold) increased 
by reducing the amount of eIF1A-bound PICs (Figure 29B). These data, as well as 
biophysical validations provided by our collaborators (supplied for publication in Jaafar et al.) 
show that the aptamer used in my studies is potent and specific in the inactivation of eIF1A. 
Type 3 IRESs have Variable Dependence on eIF1A in Rabbit and Human Translation 
Lysate Systems 
Aptamer treatment has consequences for both peptide synthesis and luciferase 
activity from lysates. Further, it can be seen easily via western blot that if biotinylated HCV, 
CSFV, or SPV-1 IRES is used for ribosome pulldowns (as in Figure 21) from Huh 7.5 cell 
lysates that had been either pretreated with the anti eIF1A (α-eIF1A) relative to the 
antisense (AS) RNA control there was an almost complete reduction in the amount of eIF1A 
associated with 40S ribosomes (rpS6) but no change in the occupancy of the other eIFs 
tested (Figure 30A) indicating efficient, and specific, eIF1A depletion from PICs, as 
expected. I next tested the effect of eIF1A depletion on the ability of type 3 IRESs to 
translate firefly luciferase. The HCV, CSFV, and SPV-1 IRES all pulled down ribosomes that 
had eIF1A bound, though to a variable extent (Figure 22). I used either a capped and 
polyadenylated Fluc reporter (positive control) or IRES-led Fluc reporters with no poly-A tail. 
In RRL, for every IRES tested, eIF1A depletion was detrimental to overall translation (Figure 
30B). I saw mostly the same case when using HeLa IVT lysates (Figure 30C), though the 
pattern of eIF1A dependence for the type 3 IRESs was slightly different than in RRL. The 
dependence on eIF1A very closely reflected the eIF1A levels from the aforementioned 
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pulldowns; e.g. CSFV pulled down the most eIF1A and was most affected by eIF1A 
depletion in HeLa lysate. This overall trend again highlights the subtle differences in the 
function of related IRESs, but most interestingly in each case the dependence of the HCV 
IRES on eIF1A was most closely related to the dependence of a capped message. Again, it 
is worth noting that eIF1A has been tested for its influence on the function of the HCV IRES 
in reconstituted systems and has no notable effect (Hellen and Pestova, 1999, Pestova et 
al., 1998b, Sizova et al., 1998). Most data supplied to this end however, was based upon 
toeprinting experiments that used IRES•40S complex inhibition of a reverse transcription 
reaction as a proxy for the efficiency of initiation events. Moreover, PICs are likely more 
dynamic in cells, or at least when assembled natively, and may have quite different behavior 
than fully purified components. 
eIF1A is Required for Full HCV IRES Activity in Cell-based Assays 
The variable dependence of the HCV, CSFV, and SPV-1 IRES on eIF1A in 
translationally competent lysates is surprising given the current data regarding the 
mechanism of action of these IRESs. I used siRNA-mediated knock down of eIF1A in a cell- 
based translation assay to further support my claim that, at least, the HCV IRES requires 
eIF1A for full activity. These experiments were carried out in the same fashion as those 
performed previously (Figure 15A). I compared the activity of the HCV IRES during eIF1A 
knock down to its activity during treatment with a scrambled siRNA control (Ctrl) or with 
double knock down of eIF2A and eIF2D (eIF2A + eIF2D) (Figure 30D & E). eIF1A-targeting 
siRNA treatment has a modest but reproducible effect on the translation of the HCV IRES 
reporter RNA (Figure 30E, blue bars). This effect was consistent in unstressed, thapsigargin 
treated, or DTT treated Huh 7.5 cells. It is worth mentioning that the siRNA treatment in here 
was 10 nM (compared to 20 nM in Figure 15). There was not complete knock down of any 
factor at this concentration as shown by western blot (Figure 30D). 10 nM siRNA was used 
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because higher doses of eIF1A siRNA caused noticeable cell death by the time of reporter 
mRNA transfection (48 hrs). 
 
The  Defect  in  Cap-  and  IRES-driven  Translation Initiation  from α-eIF1A  Aptamer 
Treatment is Specific to eIF1A Function 
I have shown that eIF1A depletion results from aptamer treatment, but it is possible 
that removal of eIF1A causes pleiotropic effects that are, themselves, responsible for the 
defects in translation. While it is beyond the scope of my studies to determine physical 
consequences of eIF1A removal to the PIC, I needed to determine if the eIF1A was the 
specific factor needed for restoration of activity. I chose to do this by purifying recombinant 
human eIF1A and adding it back to depleted translation systems. I purified WT eIF1A (with 
an N-terminal 6X histidine tag and thrombin protease cleavage site) along with individual 
deletion mutants of eIF1A’s essential N-terminal tail (NTT), and C-terminal tail (CTT). These 
tails (Figure 31A), while unstructured are essential for eIF1A function and viability in yeast 
(Fekete et al., 2007). To determine the baseline effect of eIF1A protein addition to 
translation assays, I added a capped message to RRL that had been supplemented with 
additional WT eIF1A, the ΔNTT mutant, and the ΔCTT mutant. The addition of WT had no 
effect on translation, but the addition of the ΔNTT mutant had a marginal increase in overall 
activity relative to the buffer only control (Figure 31B). This is somewhat confusing, but the 
alanine substitutions of residues 7-16 in the NTT increase leaky scanning and cause 
premature initiation events (Fekete et al., 2007), and perhaps on an optimal (unstructured 
UTR, AUG in good context, or HCV IRES that places an AUG upon binding) start site 
operates more efficiently. Further, the addition the ΔCTT mutant had a dramatic negative 
effect on all tested types of translation (Figure 31C, note: log scale). This effect is likely due 
to the inability of C-terminally truncated eIF1A to be released from ribosomes (Nag et al., 
2016, Fringer et al., 2007), and so this mutant was not used in further studies. 
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I used bicistronic mRNAs with type 3 or mutant IRESs in order to have an internal 
positive control for eIF1A dependence (Figure 32A). Again, using the capped portion of each 
message and the CrPV IRES I had good controls for the dependence on and independence 
from eIF1A. Compared to the AS control, simply depleting eIF1A negatively affected cap- 
driven translation while increasing CrPV IRES activity (compared to no change in 
monoluciferase experiments presented previously). This aligns well with suggestions that 
the IGR IRESs operate differentially during infection, getting more active as cellular 
translation decreases. Addition of WT eIF1A after depletion partially restored cap-driven 
translation while simultaneously restoring CrPV IRES activity back to normal levels (Figure 
32B). The addition of the ΔNTT mutant fully restored cap activity while returning CrPV IRES 
activity near the activity in the buffer only control, showing a strong relationship between 
eIF1A and modes of translation that require or operate independently from it. 
When eIF1A was added back to translation reactions containing HCV IRES reporter 
mRNA, its activity increased similarly to the capped message (Figure 32C, HCV WT green 
bar). However, addition of the N-terminal mutant did not fully restore activity suggesting the 
HCV IRES is more dependent on eIF1A’s NTT. Unexpectedly, the CSFV IRES only was 
able to partially restore activity without the NTT of eIF1A. An opposite trend was observed 
with the SPV-1 IRES, the addition of WT eIF1A caused a near full restoration of activity, 
though eIF1A depletion caused less of a defect than other IRESs. The addition of the ΔNTT 
had no effect on this IRES. Overall, these data suggest that the dependence of a given 
IRES on eIF1A is in part due to the specific function of the NTT. 
I chose next to test the most interesting HCV IRES mutants in terms of overall 
activity. The dIIb_ΔGCC mutant and the AUG-CUG start mutant (Figure 32C, right end). 
Both had translation defects under eIF2-replete conditions, but had opposite responses to 
eIF2-independent translation; they increased to WT levels or could not translate without 
eIF2, respectively. The dII mutant had an interesting phenotype in that depletion of eIF1A 
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decreased activity, but it could not be rescued by recombinant eIF1A addition. This is 
confusing and may have something to do with the amount of eIF2 present in RRL relative to 
the amount of IRES, but I have no good explanation for it. The AUG-CUG HCV IRES mutant 
behaved unexpected when used for translation in lysates pretreated to inhibit eIF1A. 
Depletion of eIF1A increased translation from this mutant. Further, the addition of any form 
of eIF1A decreased activity back to lower than the AS control. Again, one function of eIF1A 
is that it works with eIF1 to select start codons during scanning-dependent translation 
events. My data suggest that eIF1A is functioning in IRES translation to facilitate tRNAiMet 
and start codon recognition in the absence of eIF1. That hypothesis correlates with an 
earlier observation by de Breyne et al. (2008) that the SPV-9 IRES could facilitate tRNAiMet 
delivery in the absence of factors, perhaps reflected here by its lower dependence on eIF1A. 
eIF1A Queries the Start Codon to Direct tRNAi Binding 
I had hypothesized that eIF1A was functioning in HCV IRES translation because of 
its ability to direct the codon:anticodon interaction, much the same as its post-scanning 
duties in canonical translation. Perhaps eIF1A stabilizes tRNAiMet binding on initiation 
complexes after eIF2 has departed. In order to test this, I purified 43S PICs as I had 
previously, but treated them with the aptamer to deplete eIF1A before IRES binding and 
further analysis (Figure 33). 
I tested two things first. (1) Does aptamer treatment affect the binding or occupancy 
of eIF2 on PICs? I am testing tRNAiMet recruitment and eIF2 is the major factor that delivers 
it. (2) Do PICs I have purified have detectable levels of tRNAiMet? I used either PICs from 
unstressed or stressed (DTT-treated) cells and pretreated the samples with AS or α-eIF1A 
aptamer before binding the WT HCV IRES (WT) and running the second sucrose gradient 
(Figure 33). Western blotting showed that the levels of eIF2 that migrated with the 40S were 
not affected by the addition of RNA aptamer (Figure 34A). This was compared to what was 
initially in the sample before treatment and the second centrifugation step (PIC). In addition, 
145  
by running sucrose gradients on the PICs purified and extracting RNA associated with the 
40S peak I could tell by northern blotting that there was detectable tRNAiMet in the samples 
(Figure 34B). There was approximately six times more tRNAiMet in the unstressed (-) 
samples compared to the DTT samples, but this was expected due to the primary function of 
eIF2-TC being to carry and stabilize tRNAiMet on PICs. Any tRNAiMet associated with the 
DTT-treated PICs is bound either to the ribosome directly or being stabilized by some 
unknown factor. There is no evidence for IRES translation-specific functional replacement of 
tRNAiMet with its elongation-specific counterpart (tRNAeMet) since tRNAiMet has unique 
structural characteristics that facilitate its interaction with the P-site of the ribosome. Yet, I 
northern blotted for tRNAeMet to determine if it was present in PICs. It does associate with the 
PIC sample I generated (Figure 34C, PIC) but it does not stay associated with the PIC after 
the addition of WT HCV IRES (WT) with or without aptamer treatment, suggesting that any 
changes in tRNAiMet levels would be indicative of the initiation competent PICs. 
I chose to continue my study using, almost exclusively, the PICs from DTT stressed 
cells since I was able to remove the complication of eIF2 delivering tRNAiMet. I also already 
had seen that the HCV IRES operated more efficiently in cells when eIF2 levels were low 
and wanted to study the more potent substrate for IRES activity. As a final control to make 
sure that aptamer treatment was not causing any adverse effects to the stability of PICs, I 
assessed the binding of various factors on the PIC with or without aptamer treatment (AS or 
α-eIF1A), with or without IRES RNA (No RNA or WT), or comparing IRES mutants (WT, 
ΔdII, CUG) (Figure 34D). I western blotted for eIF5B, a ribosomal protein (rpS6), and for the 
target of the aptamer, eIF1A. Further I readdressed the presence of eIF2 (eIF2α), and if any 
known tRNAiMet delivery factors were present and/or being altered by aptamer treatment 
(eIF2A and eIF2D). This panel indicating PIC eIF1A depletion and IRES manipulation was 
sufficiently convincing to me that any changes in tRNAiMet on PICs would be a result of the 
removal of eIF1A. 
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To highlight the complication of testing tRNAiMet abundance in the presence of eIF2, 
I used PICs from unstressed cells. I treated them with aptamer and then incubated them 
with either WT or a start codon mutant (AUG-CUG), I have suggested that eIF1A is involved 
in codon:anticodon recognition) (Figure 35A). After analyzing the ratio of tRNAiMet to 18S 
rRNA by northern blotting, I determined that there was no significant effect on tRNAiMet 
binding in the presence of eIF2, and that tRNAiMet levels were quite variable, probably owing 
to the peripheral binding of eIF2 on 43S PICs or a conflict with IRES dII. By using the DTT- 
treated PIC sample I was able to perform the same experiment and now see reproducible 
changes in the levels of tRNAiMet with or without eIF1A (Figure 35B). When bound by the WT 
IRES, tRNAiMet levels dropped markedly when eIF1A was removed, suggesting that eIF1A is 
stabilizing tRNAiMet on the PIC. Removal of dII (ΔdII) seemed to allow tRNAiMet to stay stably 
bound with or without eIF1A, but as we know from translation data, it was likely not in a 
favorable conformation for efficient translation. One structural consequence of dII deletion is 
that a 40S•IRES binary complex stays in a more closely “open” conformation (Filbin et al., 
2012, Hashem et al., 2013b)that may have tRNAiMet bound, but has not allowed it to be fully 
accommodated from the Pout to the Pin state required for initiation. Interestingly, when the 
AUG-CUG IRES was bound, there was a lower level of tRNAiMet bound and that reduction 
was dependent on eIF1A (removal increased tRNAiMet occupancy). This converse effect is 
surprising but is consistent with genetic data suggesting that eIF1A can destabilize 
codon:anticodon mismatches. Further, removal of eIF1A reduced that pressure but, from 
translation data, suggests that the tRNAiMet remaining bound is not bound productively. 
The CTT of eIF1A is known to facilitate subunit joining by communicating with eIF5B 
(Acker et al., 2006). Likely, this function is retained in HCV IRES-driven translation since 
eIF1A has been shown repeatedly to be necessary for subunit joining in canonical 
translation. The NTT extends toward the P-site of the ribosome and, together with its CTT, 
communicates readiness for subunit joining to eIF5B. I expected, given the above 
147  
translation data as well as genetic information from the Lorsch and Hinnebusch labs, that 
the NTT may have been responsible for eIF1A’s contribution to tRNA occupancy (Saini et 
al., 2010, Fekete et al., 2007). I tested this by using the PICs from DTT-stressed cells and 
instead of aptamer treatment I salt-exchanged either the WT recombinant eIF1A or the 
ΔNTT mutant for the endogenous eIF1A (Figure 36A, flowchart). I can see by western 
blotting the 40S associated (rpS6) fraction that the recombinant WT eIF1A is exchanged 
onto PICs but by size alone I am unable to discern between endogenous or ΔNTT eIF1A 
(Figure 36B, left panel). I then blotted for the 6X HIS-tag on these proteins (Figure 36B, right 
panel). The input proteins are easily detectable showing intact tag as well as protein of the 
appropriate size, however despite having clear evidence of the WT recombinant form on 
PICs by an eIF1A western blot, the HIS probe does not detect it but detects the ΔNTT 
mutant. The unbound fraction shows a reduced level of the WT eIF1A by HIS probe 
suggesting that something in the PIC sample is either inhibiting detection of the WT HIS-tag 
or perhaps cleaving the thrombin site leading to the lower band (Figure 36B, left blot; left 
lane). In any event, after eIF1A exchange, I incubated either WT or the CUG start mutant 
HCV IRES with these complexes. After centrifugation, I extracted RNA and northern blotted 
again for the ratio of tRNAiMet to 18S rRNA (Figure 36C). With WT eIF1A (endogenous or 
exchanged) the WT and CUG IRESs bound either high or low levels of tRNAiMet as seen 
before (Figure 35B, eIF1A depletion). Without the NTT, the WT IRES could not stabilize 
tRNAiMet as well. The CUG mutant, though, was unchanged (vs. WT eIF1A). This suggests 
that the NTT tail is responsible for stabilizing tRNAiMet on the WT IRES and that the CTT of 
eIF1A is what is necessary to displace tRNAiMet from mismatched codons. 
Discussion 
A recurring theme in the text of this document, as well as the field of virology itself, is 
the difference between in vitro and in vivo function. The biochemically derived independence 
from eIF1A for type 3 IRES translation has repeatedly published. For the most part, it makes 
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perfect sense. An IRES RNA that places a translation start site directly in the P-site as a 
specific consequence of high affinity binding should not need the help of a scanning factor to 
function efficiently. It should be stated though, that while the literature often refers to the 
start codon selection duo of eIF1 and eIF1A together, they have individual functions. They 
traffic together but eIF1 and eIF1A serve important functions either early in initiation or in the 
later steps in initiation, respectively. The early steps can be classified generally as finding 
the start codon and stabilizing the PIC until elongation can start. Detailed descriptions of 
these functions can be found above as well as reviewed extensively elsewhere (Mitchell and 
Lorsch, 2008, Nanda et al., 2013, Hinnebusch and Lorsch, 2012). 
eIF1A is Necessary for full IRES Activity in Lysates and Huh 7.5 cells 
A crucial tool for the analysis of eIF1A as it pertains to IRES-driven initiation was 
provided by Akihiro Oguro and Yoshikazu Nakamura. They provided the sequence for an 
RNA aptamer that can specifically deplete eIF1A from initiation complexes. They generated 
this sequence through SELEX in a fashion similar to aptamers they had made targeting 
other translation initiation components eIF4A, 4E, and 4G. This aptamer could be used to 
treat RRL and impede the synthesis of methionine containing peptides from cap-driven and 
HCV IRES-driven ORFs as measured by radiolabeled methionine incorporation. In my 
hands, the aptamer could be used to decrease luciferase levels from cap-driven mRNAs in 
both RRL and HeLa lysates. In the same lysates aptamer treatment increased translation 
from an eIF1A-independent form of initiation from the CrPV IRES. It is clear from many other 
studies why depletion of eIF1A is a detriment to cap-dependent translation. Moreover, 
independence of the CrPV from eIF1A is perfectly reasonable since they occupy a similar 
binding site, and eIF1A functions in the steps leading to the delivery of tRNAiMet to an 
initiation complex and yet the CrPV facilitates translation initiation from the non-AUG codon 
GCU from the A-site rather than the P-site. The increase in CrPV IRES-mediated translation 
in HeLa lysate is reasonable due to a level of competition between two independent types of 
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translation. What was unclear, however, is why type 3 IRESs would be negatively affected 
by the removal of eIF1A as I have shown (Figure 30B, C, & E). The dependence of the HCV 
IRES on eIF1A extends to cell-based reporter assays as well. The effect is modest, but 
eIF1A depletion was not complete as evidenced by western blot (Figure 30D). The knock 
down of an essential factor likely has pleiotropic effects, but it is clear that the HCV IRES is 
less efficient when eIF1A is limited. This suggests that the dependence of type 3 IRESs on 
eIF1A is not simply an artifact of translation in cell-free lysates like RRL or HeLa IVT lysate. 
As a proof of concept it was important to show that aptamer treatment did affect 
eIF1A on the IRES-bound complexes I pulled out of cell lysates, and indeed it does. On 
complexes pulled from Huh 7.5 cell lysates there is a noticeable defect in eIF1A association 
for the HCV, CSFV, and SPV-1 IRES, but there does not to be any other changes in the 
occupancy of the other eIFs tested, indicating that aptamer treatment is specific for eIF1A 
and does not lead to the overall destabilization of the IRES-bound complexes. There were 
two possible reasons that eIF1A depletion negatively affects IRES activity. Either overall 
changes in PICs was induced by the removal of eIF1A, or eIF1A performs a specific function 
that assists translation initiation. The former is addressed in IRES pulldowns mentioned 
above and western blotting (Figures 33 and 34), but the latter was addressed by the 
purification and add back of eIF1A to depleted lysates (Figure 32). 
Add back of eIF1A to the control mRNAs used (capped or CrPV IRES mRNAs) 
behaved as expected with a curious nuance. It is common that depletion and add back of a 
protein is not exact and partial rescue is often observed. That was the case with eIF1A 
depletion, except that an N-terminal deletion mutant was more effective in add back than the 
wild type. eIF1A is a peculiar protein in that it has two unstructured tails that are thought to 
orient themselves in much the same space to direct essential and distinct functions in 
translation initiation (Passmore et al., 2007, Fekete et al., 2007). The function of the NTT 
has been studied most closely by genetic means, and so the function of specific mutations 
150  
gets extremely complicated in the form of “suppressor of suppressor” mutations that have 
opposing effects of mutations to other eIFs like eIF1 or eIF5. A specific example of this 
shown in Fekete et al. where mutations to residues 17-21 in the NTT suppress the initiation 
at UUG codons conferred by eIF5 and eIF2β mutations (Huang et al., 1997, Fekete et al., 
2005). Rescue of cap-dependent translation coincided with return of CrPV IRES activity 
back to normal. There were differences between the type 3 IRESs tested and the 
dependence of each IRES on eIF1A. This is not surprising given the differences in eIF1A 
pull down for each IRES, but what was most informative was that it seemed that the NTT tail 
mutant was responsible for different effects between them. WT HCV IRES behaved like 
capped mRNAs in IRES depletion but did not return to normal levels without the NTT like 
the capped messages did. This suggested that NTT of eIF1A was what was performing vital 
functions in HCV IRES translation. The same tail was likely performing opposing functions 
for CSFV and SPV-1 IRES translation. Unfortunately, there is no clear conclusion to be 
made about its function as translation assays in RRL are complicated by the presence of 
abundant eIF2-TC, but some hypotheses could be made. First, an NTT mutant fully rescues 
cap-dependent translation because, without it, there are less checkpoints in translation 
initiation and thus, an ideal message would be able to initiate faster. The same mutant 
would not fully rescue HCV IRES activity because the NTT is necessary for some step in 
IRES-mediated translation. CSFV and SPV-1 have opposing trends in NTT mutant 
translation that are difficult to explain except that they have distinct dII structures, have 
variable eIF2-independent levels of translation, and there is an unknown interplay between 
type 3 IRES dII and the binding of eIF1A. 
The most insightful mutations made to the HCV IRES to understand eIF1A function 
were the dIIb apical loop deletion (dIIb_ΔGCC) and the AUG-CUG start mutant. Recall that 
the dIIb_ΔGCC mutant is a less effective translation initiator, and likely has some problem 
dealing with the presence of eIF2. Depletion of eIF1A does reduce activity, but it cannot be 
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rescued with the addition of WT or ΔNTT eIF1A, suggesting that there is some other 
problem for this mutant arising from depletion. The start mutant however, in contrast to 
every other construct tested, is able to increase activity in the absence of eIF1A. That 
increase is eliminated after the addition of WT eIF1A, and is even decreased. Overall, this 
suggests that while dII of an IRES may be communicating with eIF1A allosterically in the 
decoding groove, and that communication may be monitored in some way by eIF2, the 
function of eIF1A is ultimately dependent on its interaction with the start codon. 
eIF1A controls tRNA Met Binding 
 
A function for eIF1A independent of its interaction with the start codon could mean 
that it is directly contacting and/or placing the AUG and manipulating it in some way, or that 
it is acting indirectly on the AUG or the recognition thereof. The former is unlikely as I have 
already mentioned that the start codon is placed by the action of dII in the case of HCV 
IRES-mediated translation. Further, the real molecular interactions that dictate the 
placement of the AUG, at least in bacteria, seems to be dependent on ribosomal RNA and 
base stacking between the coding RNA and adjacent rRNA nucleotides that effectively 
brace a nucleotide triplet in the P-site. This is shown from a recent structure presented by 
#Wimberly et al. (2016), though the nucleotide specific interactions are somewhat elusive 
due to the limitations in resolution of the structures. Recall that eIF1A is maintained and 
equally stable with or without eIF2 on IRES-bound PICs and that dII, eIF1A, and the start 
codon all seem to communicate within the decoding groove (Figure 27, model). I 
hypothesized based upon that information that eIF1A may be involved in stabilizing tRNAiMet 
on IRES complexes. Further, the original description of eIF1A (as eIF-4C) included its ability 
to stabilize tRNAiMet on a 40S. The “good cop/bad cop” model presented by the Lorsch group 
(Mitchell and Lorsch, 2008) compiles biochemical data on the concerted functions of eIF1 
and eIF1A to strike a balance between efficient scanning-dependent initiation and stringency 
of codon selection. This model suggests that eIF1A is responsible for promoting 
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tRNAiMet:AUG recognition and a stabilizing function between that and subunit joining, a 
function I propose is being enacted during HCV IRES translation as well. 
In the absence of eIF2, tRNAiMet is less tightly associated with PICs (Figure 34A & B), 
suggesting that any factors that can stabilize tRNAiMet either are inefficient compared to eIF2 
or require coding RNA to act. I have shown that known alternative eIFs are, at least, not 
required for HCV IRES function during stress. Now, with the tools I had already generated I 
could determine if eIF1A had a function in stable tRNAiMet binding on the HCV IRES. First 
and foremost, it was clear that with a number of HCV IRES mutants, as well as PICs alone, 
that depletion of eIF1A by aptamer treatment did not affect the composition of the PIC other 
than the absence of eIF1A. It is important to include that I can only describe the PICs as 
“unaffected” insofar as they do not change in relation to factors that I specifically looked for. 
It is possible that they were changing in respect to other proteins that I did not test for, but 
eIF1A itself should not be interacting with any factors aside from eIFs. I discovered that 
eIF1A was, at least in part, responsible for the retention of tRNAiMet on IRES PICs. I 
determined this by analysis of PICs for the ratio of tRNAiMet to 18S rRNA by northern blot. 
Without eIF1A the HCV IRES could not retain tRNA fully. It is important to remember that 
WT IRES (with intact dII and an AUG start) places the ribosome in “post-scanning” 
conformation that can allow full accommodation of tRNAiMet in the Pin-state. Without eIF1A, 
there is likely less tRNA bound because the ribosome is in a conformation that promotes 
tRNA position in its fully accommodated state and eIF1A is not there to provide additional 
interactions through its NTT (Llácer et al., 2015, Maag et al., 2005). A deletion of dII from 
the HCV IRES allows the body of the IRES to bind, but does not promote the same “post- 
scanning” conformation of the 40S that WT IRES does (Filbin et al., 2012). There is not 
significant difference in the binding of tRNAiMet with this mutant, possibly because it never 
promotes a conformation of the 40S that would facilitate initiation and leaves the initiator 
tRNA in the Pout-state that may be more stably bound, but not productively bound (Figure 
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35). A start codon mutation would then place the ribosome in a conformation conducive for 
translation, but a mismatch in the codon:anticodon helix would be unfavorable and would be 
recognized by eIF1A and rejected, presumably through its CTT (Fekete et al., 2005). 
Without eIF1A, however, the slight 40S conformation differences between a WT and AUG- 
mutant IRES place a tRNA closer to the Pout- than Pin-state, thus stabilizing tRNA in an 
unproductive conformation. This explanation is based on some structural and biochemical 
data, but requires detailed biophysical examination to answer completely. 
I have suggested that eIF1A is employing the use of both its N- and C-terminal tail to 
influence tRNAiMet binding during HCV IRES-driven translation, but have only examined 
eIF1A as a whole. As I mention above, a CTT mutant is somewhat problematic as it does 
not release from 40S with eIF5B and interferes with translation potently (Figure 31) (Fringer 
et al., 2007), so I chose not to examine its function further. I do however, have the 
opportunity to examine the function of the NTT specifically by replacing the WT eIF1A with 
its ΔNTT counterpart. I effectively replaced endogenous eIF1A on PICs from DTT-stressed 
cells with either recombinant WT or ΔNTT mutant eIF1A. In this way, I can test the effect of 
the NTT on tRNAiMet binding on the HCV IRES. As I suggested, the NTT is what stabilizes 
tRNAiMet on PICs with the WT IRES. Without it (Figure 36, yellow bars), initiator tRNA levels 
look exactly the same as when eIF1A was removed. The start mutant was less able to 
cause stable association of tRNA with either endogenous or recombinant eIF1A, but when 
the NTT was removed, there was no rescue of tRNA binding like when eIF1A was 
completely removed (Figure 36, green bars). The results in Figures 35 & 36 compel me to 
conclude that the NTT is responsible for stable tRNAiMet binding on “subunit joining-read” 
48S PICs. Theoretically, this same complex would be formed by eIF2-dependent translation 
(after eIF2-GTP hydrolysis and eIF2 release) and also after eIF2-independent tRNAiMet 
acquisition. In this way eIF1A would function in any known pathway of type 3 IRES-driven 
translation. Further, it is also clear the CTT of eIF1A is what queries the start codon and 
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promotes the dissociation of tRNAiMet on non-cognate codons. Again, a function that would 
be beneficial in eIF2-dependent and eIF2-independent translation. 
 
A New Model for Type 3 IRES-Mediated Translation 
Given the data presented in the preceding chapters, I have revised the current model 
of HCV-like IRES translation (Figure 37). My adaptation of the model reconciles a number of 
contradictory observations between biochemical data and data from cells or infection 
systems: 
The first, and most fundamental, change revolves around the starting point in 
initiation. Previous models come in two flavors, either that an apo-40S is the target of an 
IRES followed by eIF3 binding or that a 43S complex of only 40S•eIF3•eIF2-TC is what the 
IRES finds first. My model is predicated on the idea that within any given cell, most if not all 
40S subunits are being actively used in translation or are being actively turned over and 
recycled for subsequent round of translation. Any 40S that are not taking part in translation 
are probably sequestered and non-functional in translationally silent bodies like stress 
granules, and heavily associated with non-translation factors. This change in perception 
would allow an IRES to use any eIF at the disposal of the small subunit without having to 
recruit it directly. Further, this model accounts for the observation that the HCV IRES uses 
some ITAFs, most likely because the ITAFs mentioned have multivalent functions and are 
acting to modulate PICs rather than any direct action on IRES-specific translation. 
The next change has recurred throughout this text and addresses the function of 
eIF2. It is more than clear that eIF2 is capable of delivering tRNAiMet to PICs on the HCV, 
CSFV, or SPV-1 IRES. I suspect that its necessity is linked to the first change in that, in 
vitro, eIF2 is required because there are not a number of additional factors present on the 
salt washed ribosomes often used. Without the function of other proteins like eIF1A, or 
locally high concentrations of charged tRNAiMet caused by the AARS-complex, eIF2 must be 
present to force tRNAiMet onto IRES 48S particles (again, often referred to as 48S* due to 
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their atypical nature). Without all the other things associated with ribosomes it is no surprise 
that there are differences in the behavior and/or conformation of a 40S subunit. 
The updated model also considers the cell biology of eIF2, in that it is a focal point of 
translation regulation in cells that have been stressed. As a result, it is a poor candidate for 
efficient use during viral infection, especially late in infection. Indeed, other viruses translate 
in an eIF2-independent manner late in infection (White et al., 2011, Ventoso et al., 2006). I 
have also considered an important biophysical consequence of eIF2 inactivation. 
Phosphorylated eIF2α causes the whole heterotrimer of eIF2 to not exchange GDP for GTP, 
the GDP-bound state of eIF2 has near 15-fold lower affinity for Met- tRNAiMet (Kapp and 
Lorsch, 2004). A consequence of this could be the increased concentration of free tRNAiMet. 
Free tRNA could easily bind ribosomes when one considers that charged tRNAs bind 
ribosomes with low nanomolar affinity in vitro (Fahlman et al., 2004). Once thing that I have 
considered is that increased tRNA would mean that other factors would have greater access 
to it and would effectively bind all the tRNAiMet that was released by eIF2, but in lieu of a 
definitive factor that can specifically bind initiator tRNA (eIF2A and 2D stimulate binding to 
the 40S, but do not have high affinity binding to tRNA themselves), the most reasonable 
explanation is that increased local concentrations allow for specific, eIF2-independent, 
tRNAiMet-dependent translation, like type 3 IRES-dependent translation. 
In the event of high levels of eIF2, the IRES can utilize it for tRNA delivery, likely 
through a conformational rearrangement of dII as I have mentioned, but this mode of 
translation initiation may in fact be less efficient. Regardless, once tRNAiMet has been found 
and placed, translation initiation proceeds as biochemically described with eIF5B, the 
eukaryotic homolog of bacterial IF2, performing subunit joining now with the added efforts of 
eIF1A, the eukaryotic homolog of bacterial IF1, which is known to communicate proper start 
site selection and tRNAiMet position through eIF5B anyway. I must mention at this point that 
Terenin et al. (2008) suggested that tRNA delivery was directed by eIF5B. While nothing I 
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have tested directly argues for or against that model of tRNA delivery, some experiments 
performed in that study were done using RRL, meaning that eIF1A was present in the lysate 
but not accounted for. However, some were performed using purified components and must 
be interpreted with the same caution as other experiments from reconstituted systems. 
eIF5B plays an absolutely critical role in type 3 IRES-dependent translation initiation, but 
likely does not affect the PIC until the complex has already been poised for subunit joining, 
meaning that tRNAiMet is already present. Indeed, in my eIF2-free PICs (DTT-stressted), 
tRNAiMet is already present when eIF5B is not stably bound, and as the levels of tRNAiMet 
change with eIF1A manipulation, there is not a corresponding change in eIF5B levels that 
could explain them (Figure 34 and 35). 
Finally, direct tRNAiMet binding to ribosomes is accepted in bacterial initiation, thus 
there is no clear biological reason why it should not occur elsewhere under the right 
conditions. This has interesting consequences for considering the evolutionary link between 
bacterial and eukaryotic initiation mechanisms and the role of IRESs during evolution. I will 
cover that in greater detail in the next chapter. 
Future Directions 
The purpose of reevaluating the model for HCV IRES-dependent translation was 
rooted primarily in finding a way to reconcile in vitro and in vivo data. However, there are still 
some assumptions that I have made to support a unified mechanism for translation 
mediated by type 3 IRESs. Foremost is that I have suggested that tRNAiMet delivery is not 
only suboptimal when eIF2 is present, but is most efficient when factor-less. This must be 
tested to be confirmed. Though difficult, the real test is to determine the concentrations of 
tRNAiMet on a per cell basis, and to determine how much of that is bound by protein (eIF2, 
AARS, etc.) or free. Crosslinking followed by protein precipitation might give clearer 
information about the levels of tRNAiMet bound or unbound under certain conditions, but 
perhaps sequencing of total tRNA populations would be better suited and would give a 
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comprehensive picture of how the absolute levels of tRNA are changing. From that data, 
specifics could be gleaned about tRNAiMet itself. 
Much of the details generated, in this text and other literature, regarding initiation of 
this type is specific to HCV. Especially in regard to eIF1A, I would like to spend time 
performing some of the above experiments using other IRESs. It is clear that translation 
from HCV-like IRESs is somewhat nuanced. It would be interesting to see if the anti- 
correlation in eIF1A dependence and eIF2-independent translation is a result of the ability of 
each IRES to direct tRNAiMet delivery. The SPV-9 IRES has already been observed to 
efficiently direct tRNA to the P-site by nature of its extended dII. That likely extends to SPV- 




Figure  27:  Model  of  the  HCV  IRES,  tRNA,  and  eIF1A in  the  40S  Decoding  Groove. 
Shown here is a model of what the concurrent binding of the HCV IRES (magenta), tRNAiMet 
(green), and eIF1A (blue) would look like in the decoding groove of the 40S. The HCV IRES 
is modeled from PDB: 5A2Q while the 40S, tRNA, and eIF1A are modeled from the yeast 
“closed” PIC, PDB: 3JAQ. Inset is zoomed in on the A-, P, and E-sites to highlight that there 
is no steric conflict in the functional centers of the ribosome. 
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Figure 28: An Aptamer Targeting eIF1A Inhibits Cap-dependent and IRES-dependent 
Translation. 
(A) Predicted secondary structure of the SELEX-generated RNA aptamer provided for the 
following studies. (B) A cartoon of the bicistronic reporter used in this figure is shown at the 
top; Rluc (Renilla luciferase), CAT (chloramphenicol acetyl-transferase). The blot below is an 
autoradiograph of 35S-labeled methionine incorporation in translation assays from RRL. 
Protein production during aptamer treatment (+ apt) was slowed when compared to control 
conditions with no RNA added or when a randomized 40 nucleotide RNA aptamer (+ N40) 
was added. Reactions were run on an SDS-PAGE gel at the indicated time points. 
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Figure 29: Aptamer Treatment Inhibits Cap-dependent but not  IGR IRES-mediated 
Translation. 
(A) Monocistronic reporter constructs used for this figure. (B) A cap-driven and CrPV (type 4, 
eIF-independent)-dependent luciferase production was measured in RRL with (α-eIF1A) or 
without (AS, antisense) the aptamer targeting eIF1A. (C) Reporter mRNAs were tested 
similarly in a HeLa translation lysate system. Reporters were measured independently and 
100% luciferase activity is luciferase activity under antisense (AS) aptamer pretreatment. 
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Figure 30: Type 3 IRESs Require eIF1A to Function Optimally in Lysate and in Cells. 
(A) Western blot for factors bound to type 3 IRESs from Huh 7.5 cell lystates pretreated with 
AS or α-eIF1A aptamer. eIFs are unaffected except for eIF1A. (B) Translation assays from 
monocistronic reporters in RRL that was treated with the AS or α-eIF1A aptamer. (C) Similar 
translation assays using type 3 IRES reporters translated in HeLa lysate. 100% activity is the 
luciferase activity of the AS treated condition for each reporter. (D) Western blotting showing 
the siRNA-mediated knockdown of eIF2A and eIF2D or eIF1A in Huh 7.5 cells. β-actin serves 
as a loading control. (E) Translation mediated by the HCV IRES in a bicistronic reporter during 
siRNA-mediated knock down of eIF1A or eIF2A and eIF2D. The relative effect of knock down 
is compared when cells are not stressed or when they have been stressed with thapsigargin 
or DTT. 100% activity is the HCV IRES activity during scrambled siRNA (Ctrl) treatment. Each 




Figure 31: Addition of eIF1A Tail Mutants to Translation Assays Affects Cap-dependent 
Translation. 
(A) Purification of recombinant eIF1A WT, ΔNTT, or ΔCTT. (B) The addition of eIF1A ΔNTT 
caused a marginal increase in cap-dependent translation in RRL when compared to a buffer- 
only control. (C) Luciferase activity of a capped, CrPV IRES, or HCV IRES reporter when 
eIF1A ΔCTT was added to RRL compared to a buffer-only control. The ΔCTT mutant serves 
as a potent general inhibitor of translation; note log-scale. 
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Figure 32: Depletion of eIF1A can be Rescued by the Addition of Recombinant Protein. 
(A) Bicistronic reporter constructs used in this figure. (B) Comparison of cap versus CrPV (eIF- 
independent) IRES translation in RRL. Luciferase activity during AS aptamer treatment (grey) 
was compared to eIF1A depletion (α-eIF1A, blue), eIF1A depletion and WT eIF1A add-back 
(α-eIF1A + WT, green), or eIF1A depletion and add-back of an N-terminal deletion mutant of 




Figure 33: Workflow for tRNA Met Analysis of PICs. 
Schematic showing the purification strategy of 40S-associated complexes (PICs) after eIF1A 
aptamer treatment and IRES binding. PICs were then analyzed for tRNAiMet content by RNA- 
extraction and northern blotting. Western blotting was used to validate eIF1A depletion. 
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Figure 34: Aptamer Treatment of 43S PICs does not Affect eIF Composition. 
(A) Western blot of eIF2α in PICs purified from unstressed (left) or stressed (right, DTT) cells. 
Input (PIC, first centrifugation step) was compared to 40S-bound after aptamer treatment (AS Met 
or α-eIF1A, second centrifugation step). (B) The relative levels of tRNAi in 50 pmol 43S 
PICs from unstressed (-) or stressed (DTT) cells. (C) Northern dot blot against elongator 
tRNAMet  (tRNAeMet) from the input of DTT-stressed PICs or after the second centrifugation 
Met 
step. eIF1A depletion does not cause methionine elongator tRNA (tRNAe ) to associate with 
PICs preferentially. (D) Western blotting showing the composition of 40S-bound complexes 
after aptamer treatment and/or WT HCV IRES (WT), domain II deletion (ΔdII), or AUG-CUG 
start mutant (CUG) IRES addition. A select set of eIFs was tested, only eIFs that are implicated 
in tRNAiMet delivery. Blots show differences between IRES RNAs, but not with or without 
aptamer treatment (with the exception of eIF1A). Factor content is compared to the input 
sample. 
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 Figure 35: eIF1A is Responsible for Stable tRNAiMet Binding on IRES-bound PICs. 
(A) Northern blot quantification of tRNAiMet content of PICs bound to the WT or AUG-CUG 
start mutant HCV IRES. Unstressed PICs (contain eIF2) were used and were pretreated with 
AS or α-eIF1A aptamer. (B) DTT-stressed PIC samples were treated similarly and analyzed 
for tRNAiMet content. 1.0 represents the tRNAiMet bound to an eIF1A-containing (AS aptamer 
treated), WT HCV IRES-bound (WT) PIC. IRESs that don’t manipulate ribosome conformation 




Figure 36: The NTT and CTT of eIF1A have Distinct Roles in tRNA Met 
bound PICs. 
Retention on IRES- 
(A) Workflow of PIC complex formation used in this figure. Red text highlights differences 
between these experiments and those from Figure 32. (B) Western blotting showing the 
exchange of endogenous eIF1A with recombinant eIF1A WT or ΔNTT. Left panel shows 
detection of a ribosomal protein (rpS6) and an eIF1A antibody. Right panel shows detection 
of the recombinant form containing a 6XHIS-tag. (C) Northern blot quantification of tRNAs 
from PICs exchanged for recombinant eIF1A. The WT HCV IRES was compared to a start 




Implications of this Study on Type 3 IRES Function 
A general mechanism of type 3 IRES-dependent translation initiation can be 
presented based on the addition of my data. In Figure 37, I have revisited the current model 
of translation initiation by the HCV IRES, which was first described in 1998 and has not 
changed much since. I have changed two important details regarding the model; the binding 
of the IRES to a 43S instead of a free 40S, and the potential of tRNAiMet to be delivered to an 
eIF1A-containing IRES PIC instead of by eIF2. The real question is, why do any of the 
changes that I have proposed matter? Recall, that the conformation of the 40S is directly 
linked to its capacity for translation. Recall also, that the binding of eIFs dictates the 
conformation of the 40S. We can then suggest, quite easily, that a ribosome in the right 
conformation may be a much better substrate for ligand binding, than one in an unfavorable 
conformation. This is a simple principle of structural biology. An IRES that has bound a 43S 
PIC has one of two routes available to it, based on structural data. It either must resolve a 
steric conflict with eIF2 and IRES dII, or it could bind a 43S PIC that has not acquired eIF2 
(e.g. under low eIF2-TC conditions). I have observed that variations in dII length and 
predicted structures of type 3 IRES correlates with variable activities of the IRES in reporter 
assays, and that mutations to dII can influence the relative efficiencies of eIF2-independent 
translation. In fact, it is clear that given the same substrate, domain mutants of the HCV 
IRES can cause different PIC compositions, or can select for them from partial complexes 
generated stochastically. Again, this shows that an IRES binding is at least capable of 
binding directly to an assembled PIC. The retention of eIF1A on these complexes is 
important because it influences the retention of tRNAiMet on PICs in the absence of eIF2-TC. 
How tRNAiMet binds to IRES PICs is still a mystery, though there may be redundant 
contributions of many eIFs (alternative or canonical). Bacterial translation, though, is widely 
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accepted to be capable of operating by the factor-independent binding of fMet-tRNAifMet to 
30S ICs (La Teana et al., 1996). This is obviously the weakest prediction made by the 
updated model, and needs to be tested directly. Further study in this area, for me, would be 
related directly to the state of tRNAiMet in mammalian cells (protein-bound or free). 
Ultimately, this new model of translation from type 3 IRESs is “updated” in that it coherently 
reconciles three things: (1) biochemical data regarding the mechanism of IRES-dependent 
eIF2-mediated translation, (2) eIF2-independent translation in vivo, and (3) the evolutionary 
connection between bacterial and eukaryotic translation initiation. I will make a clear note on 
the last point, however. The suggestion that HCV IRES translation operates in a prokaryotic 
(bacterial)-like mode is not unique to these studies. The idea of “prokaryotic-like” by Pestova 
et al. (1998) was described to mean that the IRES mRNA bound directly to the ribosome 
without scanning, and the idea of “bacterial-like” by Terenin et al. (2008) included the 
tRNAiMet delivery to eIF2-deficient, IRES-bound ribosomes was accomplished by eIF5B (the 
counterpart to IF2). My suggestion is discussed next. 
I suggest that the real factor requirements in vivo boil down to eIF1A, eIF5B, and 
eIF3. An IRES-bound PIC with those components available will have no problem recruiting 
tRNAiMet. Direct tRNAiMet binding to ribosomes is accepted in bacterial initiation, thus there is 
no clear biological reason why it should not occur elsewhere under the right conditions. 
Indeed it has already been proposed by Terenin et al. that translation directed by the HCV 
IRES can operate in a bacterial-like mode using eIF5B to facilitate tRNA binding in a way 
that mimics its bacterial counterpart, IF2 (Terenin et al., 2008). My data now allows the 
extension of this analogy by including eIF1A, the functional homolog of bacterial IF1. 
Although IF1 lacks the CTT and NTT of eIF1A, similar functions have been reported for both 
factors. Specifically, both occupy similar positions on the ribosome, stabilize tRNAiMet 
binding, and communicate with eIF5B (or IF2) (Boileau et al., 1983, Choi et al., 2000, 
Laursen et al., 2005). This model does not include a homolog of IF3, but one major function 
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attributed to IF3 is prevention of premature subunit association (Grunberg-Manago et al., 
1975), a function ascribed to eIF3 (Goumans et al., 1980, Siridechadilok et al., 2005). 
Hence, the combination of eIF1A, 5B, and 3 with the 40S subunit comprise a set of factors 
that parallel IFs 1, 2, and 3 working with the 30S subunit. Combining this observation with 
the ability of the IRES to bind directly to the ribosome with an AUG placed in the P site (a 
strategy described as “prokaryotic-like” (Berry et al., 2010, Pestova et al., 1998b)), the 
process of translation initiation by type 3 IRESs in the absence of eIF2 is can really be 
called bacterial-like. This has interesting consequences for considering the evolutionary link 
between bacterial and eukaryotic initiation mechanisms and the role of IRESs in that 
evolution. 
Subtle sequence and structure differences between IRESs could cause two distinct 
outcomes; (1) it is possible that each IRES has been evolutionarily tuned to operate the 
exact same way in different cellular environments, or (2) that tuning of individual IRESs is 
important for subtle differences in translation rates that are key to driving translation in a 
virus-specific manner. I have made initial observations regarding the efficiency of many 
different IRESs during stress conditions, but I did not further examine important details of 
their translation efficiency. I examined translation from three IRESs in three different species 
cell lines, and it was clear that each IRES operated differently normally and during stress. 
These results suggested that subtle differences between the IRESs dictated the way they 
functioned in different cellular environments, but why they were different is unknown. IRESs 
are non-coding and thus are not constrained by codons. They perform the same function, 
and theoretically could retain the same structure or a co-varied sequence, but they do not 
(Hellen and de Breyne, 2007). Are the sequences changed in such a way that they 
effectively perform identically when in their species-specific environment? For example, 
would the IRES from avian encephalitis virus (AEV) form bird PICs with the exact same 
affinity and kinetics as the porcine teschovirus (PTV) IRES binding to porcine PICs? Another 
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possibility is that the IRESs have been fine tuned to operate either faster or slower on all 
species of ribosomes so that they can promote translation as dictated by the speed of viral 
infection? For another example, if the HCV IRES is placed in a simian picornavirus would 
the virus infect better or worse? Is that a result of the translation from the HCV IRES being 
too fast or too slow relative to the translation preferred by SPV? My data shows that the 
SPV-1 IRES is less active overall compared to the HCV IRES in human cells, though it 
belongs to a picornavirus that replicates much faster and more destructively than a 
hepacivirus. The CSFV IRES, however, belongs to a virus that acts similarly to HCV, but 
contains an IRES that can be upwards of 10 times more active in human cells. What are the 
biological consequences of the, seemingly small, changes between IRESs? There are 
outstanding questions that would provide a fundamental look into the differences, not only 
between IRES RNAs, but also at the translation machinery. Sequence conservation of rRNA 
can approach 100% identity in mammals. Ribosomal proteins are also, in many cases, 
nearly identical. Why would an IRES evolve changes if the machinery it needs is effectively 
the same? I suspect that the former outcome is the most likely because, qualitatively, when 
an IRES is in the right species, it tends to have the most stable translation (e.g. SPV-1 in 
Vero cells) perhaps because it can effectively deal with regulation imposed by the cell (eIF2 
regulation). It would be supremely fascinating to explore this question. 
The addition of eIF1A to the PIC of these IRESs supplies a practical solution to the 
problem of eIF2-TC limitation during virus-induced stress. The IRES can utilize a factor that, 
at once, direct tRNAiMet and communicate subunit joining. It even becomes possible that 
eIF2-independent translation initiation may not just be preferred, it may be the only type of 
translation initiation that is actually accessed in the cell. This mode of translation initiation is 
now completely independent of common regulatory mechanism in place during cellular 
stress. Now, as replication complexes develop, there is no need to “switch modes” of 
translation. 
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Implications of this Study on the Function of eIF1A 
eIF1A may not need eIF1 to facilitate its function in all cases, though they are often 
referred to as a pair (Pestova et al., 1998a). The primary function of eIF1A is in the later 
stages of scanning-dependent initiation. It functions with eIF1 to promote the proper 
initiation complex conformation needed for scanning, but works against eIF1 to induce a 
complex that is finished scanning. eIF1A can bind to a ribosome without eIF1, but its affinity 
for the ribosome is dependent on the 40S adopting the “closed” conformation. A hallmark of 
the conclusion of scanning is the departure of eIF1, and my results suggest that IRES 
binding triggers eIF1 release, except in cases where IRES mutants cannot adopt the 
“closed” conformation readily. Mine is the first observation that eIF1A functions in authentic 
translation initiation without the need of eIF1, in fact, the addition of recombinant eIF1 to 
RRL impedes IRES-dependent translation initiation. Retention of eIF1A likely facilitates 
subunit joining and eIF5B release in a manner similar to cap-dependent translation initiation, 
though I have not tested that specific hypothesis. 
The specific capabilities of eIF1A may explain why it does not travel in the MFC with 
other 43S components (Sokabe et al., 2012, Asano et al., 2000). Hypothetically, if eIF1A 
can function independently of eIF1, or other eIFs, in the context of scanning-independent 
messages then perhaps it should be free of a complex that increases local concentration of 
eIFs. eIF1A can travel with eIF3, and thus eIF1, to ribosomes in vitro (Olsen et al., 2003), 
but the cooperativity between eIF3 and eIF1A in vivo has not been explored. In this text, I 
have addressed the link between MFC binding and recycling in priming 40S subunits for 
subsequent rounds of translation, but it is not clear that all translation events require eIF3. 
Indeed, the specific example of calicivirus reinitiation has been suggested to operate 
independently of eIF3 in vitro (Zinoviev et al., 2015). One could imagine that if eIF1A were at 
sufficient concentrations, and the 40S were in a “closed” conformation that eIF1A may be 
able to bind independently of eIFs. eIF1A is a relatively low-copy eIF in yeast (von der Haar 
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and McCarthy, 2002). Perhaps eIF1A must be more tightly regulated than other factors 
because it is capable of promoting specialized translation. Only when global translation is 
limited should eIF1A-specialized translation be able to compete with cap-dependent 
translation initiation. One could also hypothesize that eIF1A association with PICs is one of 
the last steps in functionalization of a recycled 40S. 
Retaining a bacterial-like mode of translation initiation makes sense evolutionarily, 
but poses important questions regarding the availability of factor-free tRNAs within a cell. 
The expansion of initiation factors to include cap-binding factors (eIF4F) and tRNAiMet - 
delivery complexes (eIF2) through evolution is likely linked to the need for higher orders of 
regulation for multicellular organisms to adapt gene expression to the extremely complicated 
hierarchy development- and tissue-specific expression needs. However, there is no obvious 
reason why eukaryotes would not maintain the capacity for prokaryotic modes of translation 
initiation. As I mentioned above, the three bacterial IFs are maintained through homologous 
proteins, and the ribosomal RNA core is remarkably well conserved across all life. It seems 
likely, given my study, that eIF1A, eIF5B, and eIF1/eIF3 may be able to direct the translation 
of some non-scanning messages. Such messages have yet to be observed, however, and 
represent an interesting avenue in the study of translation. 
Perspective 
I would like to consider for a minute, the relationship between translation and the 
success of a virus. This text is primarily focused on translation initiation, but I use viral RNAs 
as tools. I discuss, in this chapter, the possibility that IRESs are fine-tuned to promote 
favorable translation kinetics for each virus. Some viruses may favor rapid translation, some 
may favor more moderate translation so that translation is properly balanced with cellular 
control. An example would be that HCV, CSFV, as well as bovine diarrheal virus (BVDV), 
are often isolated as non-cytopathic viruses, meaning that they do not lead to significant cell 
death upon infection in culture systems. Cytopathic effect is important because it can be 
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used to infer how abrasive a viral infection is. In the case of CSFV, one study suggests a 
correlation between cytopathicity and attenuation in the host (Gallei et al., 2008), though that 
study was specifically testing protease activity and not translation initiation efficiency it 
proposes an interesting idea. While that may seem counterintuitive, perhaps rapid infection 
(triggered by rapid translation) is too severe and triggers an effective immune response 
while a slower infection can be rooted more strongly by the time antiviral states are highly 
activated. 
Most picornaviruses, however, are highly cytopathic and use IRESs that are higher 
activity in most cells. Type 1 and type 2 IRESs often have much higher (greater than an 
order of magnitude) activity compared to type 3 IRESs in translation reporter assays (my 
observations, but I do not discuss them in greater detail). Picornaviruses also replicate much 
faster than hepaciviruses or pestiviruses and may require cell lysis for viral egress. I 
examine the function of the SPV-1 IRES often throughout my studies, but there is relatively 
little known about its course of infection. Perhaps a type 3 IRES on a picornavirus slows 
down its replication or limits its cytopathicity to levels near those of pestiviruses. I have done 
nothing to test this particular consideration, but it is clear that successful viruses are able to 
strike a balance between viral growth and cellular defense that ultimately allows greater 
dissemination. 
As I have often heard from Dr. Kieft, viruses represent valuable repositories of 
mechanistic insight into eukaryotic biology. Under his tutelage I contributed another example 
of this idea. The function of the HCV IRES has been studied intensely since its discovery, 
and we have learned a great deal about the way it and related RNAs direct translation 
initiation. We were reasonably confident that its secrets had been revealed. It turned out, 
however, that we had missed some things. A simple control experiment turned out to be a 
treasure chest of information about the function of type 3 IRESs in a cellular environment. 
More importantly, study of that specific RNA led to the advancement of our overall 
175  
understanding of translation. The contribution of eIF1A to IRES-mediated translation 
initiation is not trivial. Its presence on IRES-bound PICs better explains how initiator tRNA 
stays stably bound after it is acquired, and provides further justification for the maintenance 
of and AUG start site of the viral polyprotein. eIF1A would also facilitate the binding of eIF5B 
and the enhancement of subunit joining eIF5B provides, as it is known to do in cap- 
dependent translation. It rightly poses a question regarding the likelihood of other messages 
requiring eIF1A to operate like this. Do some specialized cellular mRNAs operate in a 
bacterial fashion as well? There are multiple observations of non-canonical translation, 
including those I have mentioned here, but are there truly bacterial-like messages? Binding 
of mRNAs directly to the ribosome are restricted to viral examples, as well as reinitiation 
events. Are there de novo initiation sites in cellular mRNAs that bind directly to the ribosome 
and operate only with eIF1A, eIF5B, and eIF1? 
The results of my graduate work also presents an interesting engineering 
perspective. We know a great deal about the workings of cap-dependent translation and 
IRES-driven translation and so any gene-engineering currently operates within the 
framework of those paradigms. Perhaps evidence of bacterial translation modes in 
eukaryotes will galvanize development of ribosome-binding mRNAs that can take advantage 
of eIF1A. I will reiterate that there is no evidence that prokaryotic translation modes exist in 
cellular mRNAs, but it stands to reason that if eukaryotes have maintained the “old” duties of 
eIFs there is a cellular need to do so. As we learn more about the mechanisms that govern 
translation, it is my expectation that these isolated examples of unique or specialized 
translation will become less rare and we will see more of an “evolutionary gradient” on which 
bacterial translation and cap-dependent translation represent limited or extensive regulation 




Figure 37: Updated Model of HCV IRES-dependent Translation Initiation. 
This model has important departures from the model presented in Figure 7. This model takes 
advantage of a recycling intermediate present in cells, and binds factor-associated 43S PICs 
(grey circle). IRES binding remodels the PIC by ejecting eIF1 and rearranging eIF3. eIF2-TC 
is preferentially displaced or blocked from the IRES-bound PIC because of steric conflict with 
dII. tRNAiMet may bind independently of eIF2 like in bacterial translation. This may be more 
efficient than eIF2-mediated tRNAiMet deposition, and would increase as eIF2 becomes 
inactivated by cellular stress. Retention of eIF1A from the 43S PIC helps stabilize tRNAiMet 
until eIF5B-mediated subunit joining and the progression to 80S formation and elongation. 
The mechanisms of IRES release after initiation are unknown (not shown here), but may be 
directed by the release of eIF3 through IRES•eIF3 high affinity interactions. 
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CHAPTER VI 
MATERIALS AND METHODS 
Buffers 
RNA sample loading buffer: 9 M urea, 1% (w/v) xylene-cyanol, 1% (w/v) bromophenol blue 
SDS-PAGE sample buffer: 250 mM Tris·HCl, pH 6.8, 10% SDS, 30% (v/v) Glycerol, 10 mM 
DTT, 0.05% (w/v) Bromophenol Blue 
10X SDS-PAGE running buffer: Dissolve 30.0 g of Tris base, 144.0 g of glycine, and 10.0 g 
of SDS in 1 L of water. 
Western transfer buffer: 25 mM Tris-HCl pH 7.5,192 mM glycine, 20% methanol 
TBS-T: 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Tween-20 
Blocking buffer: TBS-T, 5% (w/v) (nonfat milk powder or BSA depending on antibody, 
Appendix B) 
AA-tRNA buffer: 20 mM Tris-HCl pH 6.5, 25 mM KOAc, 3 mM Mg(OAc)2, 2 mM DTT 
10X Ribo A buffer: 200 mM HEPES-KOH pH 7.4, 1 M KOAc pH 7.6, 25 mM Mg(OAc)2 
Buffer A: 20 mM Tris-HCl pH 7.5, 50 mM KCl, 4 mM MgCl2, 2 mM DTT 
Buffer B: 20 mM Tris-HCl pH 7.5, 25 mM KCl, 3 mM MgCl2, 2 mM DTT 
Buffer C: 20 mM Tris-HCl pH 7.5, 25 mM KCl, 3 mM MgCl2, 2 mM DTT, 0.1 mM EDTA, 0.25 
M sucrose 
10X transcription Buffer: 300 mM Tris pH 8.0, 100 mM DTT, 0.1% (w/v) Triton-X100, 0.1% 
(w/v) spermidine 
Buffer D: 20 mM Tris pH 7.5, 2 mM DTT, 0.1 mM EDTA, 10% (v/v) glycerol 
Buffer E: 20 mM Tris pH 7.5, 2 mM DTT, 0.1 mM EDTA, 5% (v/v) glycerol 
Buffer G: 20 mM Tris-HCl pH 7.5; 10% (v/v) glycerol 
Hybridization solution: 20 mM NaPO4 pH 7, 300 mM NaCl, 0.5% (w/v) SDS 
AA-tRNA (HPLC) buffer: 50 mM ammonium acetate pH 5.5, 300mM NaCl 
RRL aptamer buffer: 20 mM Tris pH 8.0, 100 mM KOAc, and 2 mM DTT 
178  
 
Sequences and Plasmids 
 
Sequences 
Hepatitis C virus subtype 1b internal ribosome entry site (HCV IRES, AB691953) nt 40-372 
Classical Swine Fever Virus strain HCLV internal ribosome entry site (CSFV IRES, 
AF531433) nt 69-401 
Simian sapelovirus 1 strain 2382 internal ribosome entry site (SPV-1 IRES, AY064708) nt 
327-772 
Cricket paralysis virus isolate CrPV-3 internal ribosome entry site (CRPV IRES, KP974707) 
nt 6025-6246 
Human β-globin 5’ untranslated region (AF007546) nt 1-49 
Homo sapiens translation initiation factor 1A X-linked (eIF1A, AAH00793) 
 
Plasmids 
DBS: The DBS vector was assembled using the Fluc gene and backbone from the 
pGL3-control (Promega) reporter vector with the Rluc gene cloned from the pRL-CMV 
(Promega) cloned between the Hind III and Xba I restriction sites. IRES sequences cloned 
into the resulting bicistronic reporter vector were cloned between the EcoR I (5’) and Nco I 
(3’) sites and placed in frame with the downstream Fluc coding sequence. 
pUC19 (Invitrogen) was purchased and constructs containing IRES sequence alone 
or IRES sequences in frame with the Fluc reporter gene were amplified from the DBS vector 
using forward IRES primers with an additional 5’ T7 sequence and a reverse primer 
corresponding to the 3’ end of the IRES or the cut site of BamH I in the DBS vector. A 
subsequent round of PCR added the appropriate 5’ and 3’ sequences to clone the insert 
between the EcoRI and BamHI sites in the pUC19 vector 
pET-28b was used for the recombinant expression of human eIF1A. The plasmid 
with eIF1A sequence inserted between the NdeI and XhoI sites was provided as a gift from 
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Tatyana Pestova (SUNY Downstate). All eIF1A constructs were recloned into the same 
vector with tandem STOP codons inserted at the 3’ of the sequence at the XhoI site (to 
remove the vector encoded C-terminal HIS6 tag). 
All cloning for insertion of the WT or any mutant sequences into the DBS, pUC19, or 
pET-28b vectors was performed using the InFusion HD ligation independent cloning 
strategy (Clontech). Briefly, PCR fragments to be inserted were generated using an 
additional 12 nt overhang on both 5’ and 3’ ends of the insert adjacent to the restriction site 
sequence. Plasmid was linearized by restriction digest and cleaned up by the Wizard PCR- 
clean up kit (Promega). Insert and vector were then incubated at a molar ratio of at least 3:1 
but approximately 200 ng insert to 100 ng vector at 50˚C for 15 minutes with 1X InFusion 
reaction mix, cooled, then transformed into DH5α chemically competent E. coli for 
propagation. 
Mammalian Cell Culture 
 
Adherent Cell Culture 
Huh7.5 (also Huh 7 and Huh 7.5.1): Cells were maintained in Dulbecco’s 
modification of Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 
10mM HEPES, and 1X non-essential amino acids (NEAA). Cells were routinely passaged 
every 48-72 hours and split 1:5. Cell lines were a gift from Hugo Rosen (UC Denver) 
Hela: Cells were maintained in DMEM supplemented with 10% FBS and 
passaged every 48-72 hours and split 1:10. 
PK-15 (ATCC CCL-33): Cells were maintained in ATCC-formulated Eagle’s Minimum 
Essential Medium supplemented with 10% FBS and routinely passaged every 48-72 hours 
and split 1:4 
Vero: Cells were maintained in DMEM supplemented with 10% FBS. Cells 
were routinely passaged every 48-72 hours and split 1:10. Cells were a gift from Thomas 
Morrison (UC Denver) 
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Suspension Cell Culture 
293F: Cells were grown in FreeStyle 293 Expression Media (Invitrogen) with shaking 
in vented Erlenmeyer flasks. Cells were passaged by splitting 1:2 when cell density reached 
~2x106 cells/mL and were harvested at a density of ~3x106 cells/mL. Cells were a gift from 
Elan Eisenmesser (UC Denver) 
Hela S3: Cells were grown in MEM (Jokliks modification, Sigma) supplemented with 
5% FBS and incubated with shaking in vented Erlenmeyer flask. Cells were split 1:2 at a 
density of 5x105 and harvested at a cell density of approximately 1x106 cells/mL 
Transcriptions 
Transcriptions were performed one of two ways. Smaller (under 500 nt) 
RNAs including IRESs, tRNAs, and aptamers were translated using a recombinant 
Bacteriophage T7 RNA polymerase purified by Kieft Lab members forin vitro transcription 
system. Larger (reporter) RNAs were transcribed using either MegaScript or mMessage 
mMachine T7 kits (Ambion). 
Bacteriophage T7 polymerase was expressed and purified according to 
Shrader 1996. Briefly the protein was expressed in E. coli in the vector pQE8 (Qiagen) and 
containing an N-terminal HIS6 tag. It was then purified in a single step by IMAC (immobilized 
metal affinity chromatography).Transcriptions were started by generating PCR templates 
using a forward primer that had the minimal T7 promoter sequence added to the 5’ end and 
an additional ‘GGG’ to enhance transcription. PCR quality was then analyzed by agarose 
gel. PCR reactions were then added to transcription reactions of the following composition: 
30 mM Tris, pH 8.0, 10 mM DTT, 0.1% Triton X100, 0.1% spermidine, NTPs (8 mM each), 32 
mM MgCl2, 200 μL PCR/mL transcription, 10 μL T7 polymerase/mL transcription. 
RNA was then generated by incubation at 37˚C for at least 2 hours or up to 16 hours. 
Transcription time was determined for each RNA. 
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Kit-based transcriptions were carried out according to manufacturer’s 
recommendations. MegaScript reactions were used to make monocistronic IRES:Fluc 
reporters and were often generated using PCR templates. mMessage mMachine kits were 
used to generate bicistronic reporter constructs using purified, linearized (BamHI) DBS 




In Vitro Transcribed 
RNAs from large scale in vitro transcriptions were purified using urea PAGE 
and in-gel elution. Transcriptions were stopped by the addition of 3 volumes cold 100% 
EtOH. They were then precipitated by incubation at -20˚C for at least 1 hour. RNAs were 
pelleted by centrifugation and resuspended in urea PAGE loading buffer (9 M urea, 1% 
bromphenol blue, 1% xylene cyanol) and incubated at 65˚C until the pellet was dissolved. 
The RNA samples were then resolved on urea PAGE gel. Acrylamide percentage was 
chosen based on RNA size from 6% to 12%. After RNAs had been sufficiently resolved 
(anywhere from 3 to 8 hours run time). Gel slices containing RNAs were visualized by UV 
shadowing on a fluor-coated TLC plate and were excised, crushed, and eluted in RNase- 
free water overnight. Eluted RNAs were then concentrated and washed in centrifugal 
concentrators (Millipore). The final concentration of nucleic acid was determined by 
NanoDrop spectrophotometer measurement. 
Cellular RNAs 
Isolation of total cellular RNAs for any downstream application (e.g. rRNA 
analysis, RT-PCR, cDNA synthesis, etc.) was done by nucleic acid extraction followed by 
EtOH precipitation. Cell pellets from cell culture or bacterial growth were thawed on ice from 
storage at -80˚C. Thawed pellets were then resuspended in 1X PBS (approximately 2 mL/g 
cells) on ice and immediately mixed with 1 volume tris buffered PCIAA 
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(phenol:chloroform:isoamyl alcohol 25:24:1, Fisher). For purification of aminoacylated RNAs 
cell pellets were resuspended similarly, but using 50 mM ammonium acetate pH 6.5 and 
acid-buffered phenol:chloroform pH 4.5 (Ambion). Cell mixture was then vortexted 3X for 30 
seconds with 1 minute on ice in between. Mixture was then centrifuged to separate organic 
and aqueous phases. The aqueous phase was then placed in a new tube and 0.1 volume 2 
M sodium acetate pH 6.5 was added. Finally 2.5 volumes cold EtOH was added and mixed 
before freezing at -20˚C for at least 1 hour. RNA was then pelleted by centrifugation, 
washed once in 70% EtOH in water, and dried before being either stored dry or 
resuspended for use. RNA concentrations were determined by NanoDrop. 
Bulk Aminoacylated tRNA Purification by Chromatography 
 
FPLC 
HEK293F cells were grown to a density of ~4x106 cells/mL and were harvested by 
centrifugation before being rinsed in PBS and stored at -80˚C. Cell pellets from 0.5 L were 
thawed at 37˚C, resuspended in 10 mL of 1X Ribo A and subsequently refrozen in liquid 
nitrogen and thawed at 37˚C before being placed on ice and passed 5X through a 26G 
needle. Lysate volume was brought up to 50 mL in 1x Ribo A and cell lysate was clarified by 
centrifugation in a Sorvall F21 6X50y rotor at 10,000 rpm and 4˚C for 15 minutes. Clarified 
lysate was loaded into Beckman Coulter polycarbonate centrifuge tubes and centrifuged in a 
50.2Ti rotor at 40,000 rpm and 4˚ C for 4 hours to remove ribosomal fraction. 
Supernatant was then added to an equal volume of acid buffered 
phenol:chloroform:isoamyl alcohol before it was vortexed for one minute on ice and then 
phases separated by a spin in an F21 6x50y rotor at 10,000 rpm and 4˚C for 15 minutes. 
Aqueous phase was added to 2.5x cold EtOH and precipitated at -20˚C before pelleting in 
an F21 6x50y rotor at 15,000 rpm and 4˚C for 1 hour. Pellets were washed once in 70% 
EtOH in water. Pellets were resuspended in AA-tRNA buffer and run on a HiPrep S75 gel 
filtration column in AA-tRNA buffer to separate aminoacylated from deacylated tRNA pools. 
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HPLC 
Tissue culture cells of the indicated type were grown to confluency (~2x107 cells) in 
15cm plates and treated for 3 hours with indicated drug. Cells were washed once, scraped, 
washed, and pelleted in 1X PBS then frozen at -80°C until use. Cell pellets were thawed on 
ice and resuspended in 2 mL AA-tRNA (HPLC) buffer. Acid buffered phenol:chloroform pH 
4.5 (Ambion) was added 1:1 then extractions were alternately vortexed and chilled on ice 5X 
for 30 seconds. Extractions were then spun at 3400x g for 30 minutes to separate phases. 
Aqueous layer was then removed and added to 2.7 volumes ice cold 100% EtOH and 
precipitated at -80°C at least two hours before centrifugation at 3400x g for 1 hour at 4°C. 
RNA pellets were washed once with cold 70% EtOH then dried and frozen at -80°C until 
further analysis. 
Total RNA was then loaded and eluted with an Agilent HPLC on a Zorbmax 300SB 
C18 reverse phase column in a shallow gradient of 50 mM ammonium acetate pH 6.5 to 
50% acetonitrile in water. The gradient was run at 0.5mL per minute with a 1% increase in 
50% acetonitrile every ten minutes. Absorbance at 254 nm was plotted over time. tRNA 
eluted from 100-200 minutes with the deacylated tRNA eluting first followed by 
aminoacylated populations of tRNA eluting later. 
Nucleic Acid Modification 
DNAs or RNAs were modified in two forms. They were either biotinylated at the 5’ 
end, or they were radiolabeled at the 5’ end. 
Biotinylation 
Fifty micrograms of transcribed wild-type or mutant IRES RNAs were added to T4 
polynucleotide kinase reactions (NEB) containing 2 µg adenosine 5’-[γ-thio]triphosphate 
(Sigma) instead of ATP. Reactions were carried out at 37°C for 1 hour then 0.4 µg biotin 
(long arm) maleimide (Vector Labs) was added and the reaction was finished at 65°C for 1 
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hour. Reactions were purified by phenol:chloroform extraction and subsequent ethanol 
precipitation as mentioned for in vitro transcribed RNAs above. 
 
Radiolabeling 
DNAs and RNAs were 5’ end labeled using [γ-32P]ATP (Perkin Elmer). DNA oligos 
synthesized by Integrated DNA Technologies Inc. were generated using solid phase synthesis 
and thus contained a 5’-OH modification. In vitro transcribed RNAs, however, required 
dephosphorylation of the 5’ end before labeling. Total yield from transcriptions eluted from 
PAGE (below) was concentrated and ~1 mg of total RNA was added to a calf intestinal 
phosphatase (CIP) reaction according to manufacturer’s protocols (NEB). RNAs were then 
extracted and precipitated as described above. 5’-OH RNAs were then added to T4 
bacteriophage polynucleotide kinase reactions (PNK, NEB) as follows. 100 pmol DNA oligos 
were added with 0.1 mCi [γ-32P]ATP to a 20 μL PNK reaction. 5 μg 5’OH RNA was added with 
0.01 mCi [γ-32P]ATP to a 20 μL PNK reaction. PNK reactions were allowed to proceed for 1 
hour at 37˚C before they were purified from unicorporated [γ-32P]ATP by urea-PAGE. 
The human β-globin leader sequence (nucleotides 1-80) was transcribed using the 
mMessage mMachine Kit as described above and due to the 5’ modified cap, was 3’ 
radiolabeled using the 3’ EndTag Kit (Vector Labs) 
Urea-PAGE 
Tris-Borate EDTA (TBE) Urea-polyacrylamide gels were prepared to 1X (90 mM Tris- 
borate pH ~8, 2 mM EDTA pH 8.0) and 7 M urea with acrylamide (Acryl:Bis 29:1, VWR) 
percentages ranging from 6-10%. Gels were polymerized by the addition of 10% ammonium 
persulfate (1:100) and TEMED (1:1000) to the gel stock. Samples were electrophoresed 
through polymerized gels in 1X TBE. For quality analysis of RNA, 3-5 μg RNA was run on 1 
mm thick gels and visualized by ethidium bromide. For bulk preparation of RNAs, 2-5 mL 
transcriptions were run on 3 mM thick gels and visualized by UV shadowing on a silica gel- 
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coated TLC plate. Purification of nucleic acid from urea-PAGE was done by cutting out of 
gel slices containing nucleic acid and incubation in RNase-free water overnight at 4˚C. 
 
Northern Blotting 
Approximately 250 ng of purified RNAs were applied to wet HyBond XL (Amersham) 
nylon membranes using a dot-blot apparatus. After RNA application, the membranes were 
briefly air-dryed, then RNA was crosslinked by baking at 80˚C for 30 minutes. RNA 
crosslinked membranes were then equilibrated in hybridization solution for thirty minutes at 
room temperature. Membranes were then incubated with radiolabeled DNA oligo probes 
targeting either human 18S rRNA, tRNAiMet, or tRNAeMet (Table 3). 100,000 cpm of labeled 
18S probe was added to membranes to detect ribosomal RNA. 500,000 cpm of labeled 
tRNAiMet or tRNAeMet probe was added to membranes to detect methionine tRNAs. Probes 
were incubated in 10 mL hybridization solution at 60˚C overnight in a hybridization oven. 
The following morning, membranes were washed 3X 15 minutes at room temperature in 
hybridization solution to remove unbound probe. Membranes were then exposed to a 
phosphorscreen for 24-48 hours before imaging on a Typhoon Imager (Molecular 
Dynamics). 
SDS-PAGE 
Protein samples were analyzed for purity or composition using SDS-PAGE. 
Analysis of cell lysate, ribosome-associated proteins, or purified eIFs was done by loading 
either 30 μg total cellular protein, ~10 μg ribosome-associated protein, or 0.5 μg purified 
protein in 10 μL to 2 μL SDS-PAGE sample buffer before heating to 95˚C for 5-10 minutes. 
Boiled, denatured samples were then loaded onto Mini-Protean TGX 4-20% acrylamide 
gels. Gels were electrophoresed in SDS-PAGE running buffer until loading dye reached the 
bottom of the gel. 
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Western Blotting 
SDS-PAGE gels were transferred to nitrocellulose membranes (Bio-Rad) for 
analysis by western blot. Standard gels (8.6 x 6.7 x 0.1 cm) were transferred using a semi- 
dry transfer cell (Bio-Rad) in western transfer buffer for 20 minutes at 15 V. After transfer, 
membranes were blocked in blocking buffer at least 30 minutes at room temperature. Blots 
were then incubated with primary antibody at their indicated dilutions (Appendix D) overnight 
in blocking buffer with 1% blocker (milk or BSA). The following morning blots were washed 
3X with TBS-T before further incubation for 1 hour at room temperature with the appropriate 
HRP-conjugated secondary antibody in blocking buffer. Blots were then washed 3X 20 min 
in TBS-T before visualization. Blots were incubated 1-5 minutes with Clarity western ECL 
substrate (Bio-Rad) as indicated by the manufacturer. Chemiluminescence was detected 
using a Bio-Rad ChemiDock system. 
Initiation Factor Expression and Purification 
The genes encoding human eIF1 and eIF1A were cloned between the BamHI/NotI 
and the NdeI/XhoI sites respectively in the pET28-b expression vector, though the eIF1A 
constructs contained an added stop codon to terminate the peptide upstream of the vector- 
encoded C-terminal HIS-tag. Mutants of eIF1A were made as follows; WT aa1-143, ΔNTT 
aa21-143, ΔCTT aa1-117, and ΔNTT&CTT aa 21-117. Expression of recombinant human 
eIF1 and eIF1A and its mutants was carried out in BL21 Star (DE3) pLysS E. coli (Life 
Technologies) grown to an OD600 of 0.5 and induced using 1 mM IPTG for 3 hours at 37°C 
then harvested by centrifugation and frozen at -80°C until purification. 
Purification of eIF1 and eIF1A was carried out as previously described (Methods in 
Enzymology Pestova and Hellen) with minor alterations. Cell pellets from 1L of induced 
culture were resuspended in 20 mL Buffer G + 300 mM KCl. Resuspended cell pellets were 
lysed using sonication and clarified by centrifugation in a Sorvall RC 6+ F21 6x50y rotor at 
15,000 RPM for 20 minutes. Supernatant is then passed over Ni2+-NTA beads (Thermo) 
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pre-quilibrated in Buffer G + 300 mM KCl. After binding, beads were then washed 
subsequently with 10mL aliquots of Buffer G + 300 mM KCl, Buffer G + 800 mM KCl, Buffer 
G + 100 mM KCl, and finally elute using Buffer G + 100 mM KCL and 300 mM imidazole. In 
the cases of eIF1, eIF1A WT, and eIF1A ΔNTT&ΔCTT;  eluted protein was then applied to a 
HiPrep S75 gel filtration column and eluted in Buffer E + 100 mM KOAc. Further purification 
of eIF1A ΔNTT and eIF1A ΔCTT was carried out using a MonoQ and MonoS anion 
exchange columns, respectively, over KCL gradients from 100-500mM KCl. Fractions 
containing homogeneous truncated protein were then pooled and dialyzed into Buffer E + 
100mM KOAc. All purified protein was then aliquoted and stored at -80°C until use. 
Translation Assays 
Translation assays were performed in one of two contexts. The first was in vitro 
using translation lysate systems; either rabbit reticulocyte lysate (RRL, Promega), or HeLa 
cell in vitro transcription and translation lysate (HeLa IVT, Pierce). The second was to 
transfect in vitro transcribed mRNAs into cultured cells to assay translation in vivo. 
In Vitro 
RRL was thawed on ice. RRL reactions were prepared according to manufacturer’s 
instructions for translation assays only incorporating control or IRES-reporter assays. 
Translation assays were performed with the following modifications to address the function 
of eIF1A in IRES-mediated translation. RRL translation mixture was prepared with 80% 
lysate supplemented with 5% 1mM amino acid mixture, 10% 45µM RNA aptamer (negative 
control or α-eIF1A aptamer) refolded in the presence of 2.5µM Mg(OAc)2, and 5% water. 
This mixture was incubated at 30°C for 20 minutes. The resulting aptamer-treated lysate mix 
was then added 2:1 to 20µM eIF1A WT, ΔNTT, or ΔCTT in RRL aptamer buffer or a buffer 
only control. Depleted lysate with added-back eIF1A was then used to translate 0.5µg 
reporter mRNA (mono- or bicistronic) for 15 minutes at 30°C. Four volumes of 1X PLB 
(Promega) was added to stop the reactions. Luciferase activity was measured using the 
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Promega Dual-Luciferase system on a GloMax Multi+ instrument (Promega). Raw luciferase 
values were reported as ratios of α-eIF1A aptamer-treated translation to negative control 
aptamer-treated translation for each message. 
In Vivo 
Translation assays in vivo were carried out in either Huh 7.5, PK-15, or Vero cells. 
The cells were stressed with either thapsigargin (Sigma), Tunicamycin (Sigma), DTT, or 
sodium arsenite (Sigma) or they were mock treated with similar volumes of DMSO. Huh 7.5 
cells were treated at 300 nM thapsigargin, 2 μg/mL tunicamycin, 2 mM DTT, or 0.5 mM 
sodium arsenite. PK-15 cells were treated at 3 μM thapsigargin, 2 μg/mL tunicamycin, 2 mM 
DTT, or 0.5 mM sodium arsenite. Vero cells were treated at 1 μM thapsigargin, 2 μg/mL 
tunicamycin, 2 mM DTT, or 0.5 mM sodium arsenite. 
Transfections 
Cells were grown to 80% confluence in 24-well plates then pretreated with drug at 
the concentration mentioned above or mock treated with DMSO for 1 hour. Pretreated cells 
were then transfected with 1µg bicistronic reporter RNA using Lipofectamine LTX (Life 
Technologies) for 2 hours during drug treatment before the cells were washed with PBS and 
lysed in 1X Passive lysis buffer (Promega). Samples were then analyzed for translation of 
the Renilla and Photinus luciferase gene using the Dual-Luciferase Reporter Assay System 
and a GloMax Multi+ plate reader. 
siRNA Knockdowns 
Depletion of eIF2A and eIF2D using siRNA was carried out using ON-TARGETplus 
SMARTpool siRNA (Dharmacon) to either gene at a final concentration 5nM. Cells were 
transfected in 24-well plates at ~40% confluence using RNAiMAX according to 
manufacturer’s specifications. eIF-depleted cells were additionally treated with drugs and 
transfected with reporter mRNAs, as mentioned above, 48 hours after siRNA treatment. 
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RNA Pulldowns 
Biotinylated IRES RNAs were used to pulldown ribosomes from Huh 7.5 cell lysates. 
Approximately 7x106 cells were scraped and pelleted from 15cm plates left untreated or 
treated 3 hours with 2mM DTT. Cells were frozen at -80°C then thawed and resuspended in 
100 µL 1X Ribo A buffer + protease inhibitors (c0mplete EDTA-free, Roche). Cells were 
lysed by 15 passes through a 26g needle and cell debris was removed by centrifugation at 
15,000x g for 15 minutes at 4˚C. Clarified cell lysates were held at 4°C. Ten micrograms of 
biotinylated IRES was added to 50 µL high capacity streptavidin-agarose bead slurry (Life 
Technologies) that had been equilibrated in 1X Ribo A. IRES-bound beads were then 
incubated at room temperature for 30 minutes with intermittent gentle mixing. Unbound RNA 
was then washed away using 1X Ribo A. Washed, IRES-bound agarose beads were then 
incubated with 100 µL cell lysate for 30 minutes at 37°C. After incubation, beads were 
washed 6X with 1X Ribo A then resuspended in 25µL 1X Ribo A and 25µL 2X SDS-PAGE 
sample buffer to prepare them for western blotting. 
Ribosome Assembly Assays 
Assembly assays were performed to address the capability of given RNAs to 
assemble ribosome complexes of different types, representing the different steps in 
translation. These assays were performed in RRL and using 5’ radiolabeled RNAs. RRL was 
thawed on ice and supplemented with KOAc to a final concentration of 292 mM (formulated 
at 192 mM in production) and MgCl2 to a final concentration of 1.5 mM (formulated at 0.5 
mM in production). Supplemented RRL was aliquoted into 0.05 mL fractions, one per 
reaction and left untreated or pretreated for 30 minutes at 30˚C with 1.5 mM Guanosine 5- 
[β,γ-imido]triphosphate (GMP-PNP, Sigma) to block GTP-dependent steps in translation 
initiation. 10,000 cpm of either 5’ radiolabeled IRES RNA or 3’ radiolabeled human β-globin 
leader sequence was added to a 0.05 mL aliquot of RRL. Reactions were incubated at 30˚C 
for 30 minutes before loading onto a 10-30% sucrose gradient buffered with buffer B. 
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Gradients were ultracentrifuged in an SW-41 swinging bucket rotor at 36,000 rpm and 4˚C 
for 4 hours. Gradients were then fractionated into 0.75 mL fractions while monitoring and 
recording UV absorbance at 254 nm (A254). 0.3 mL of the above fractions were blotted onto 
a membrane stack (TOP: nitrocellulose, nylon, BOTTOM: filter paper) using a 96-well 
vacuum manifold. The purpose of this contraption was to allow ribosomal protein (and 
associated labeled RNA) binding to the nitrocellulose while unbound RNAs in each fraction 
would pass through the nitrocellulose onto the nylon membrane. In this way we could 
expose both membranes to a phosphorscreen to track ribosome-bound RNAs in the 
gradient and compare them to the unbound and total RNAs. Membranes were exposed for 
24 hours before imaging on a Typhoon scanner and quantification by ImageQuant software. 
Radioactivity was plotted as the cpm for each fraction normalized by total radiation (Σ(cpm 
on nitrocellulose) + Σ(cpm on nylon)). 
Ribosomal Subunit Purification 
Ribosomes in these studies were purified in one of two general ways. The first was 
purification of so-called “salt washed” or factor-deplete ribosome subunits for use as size 
standards or for purification of specific species of rRNA. The second was purification of 
ribosomes under “native” conditions, or specifically isolation of 40S-containing complexes 
that are still bound with cellular factors involved in translation initiation but have not 
progressed to a subunit-joining step, 43S particles. 
Salt Washed 
HEK293F cells were grown to cell densities approaching 4 x 106 cells/mL before 
being ready to harvest. Cell pellets were generated from 0.5 L of cell in 293 FreeStyle 
expression media and were washed in PBS before storage at -80˚C. Cell pellets were 
thawed at 37˚C and resuspended in 10 mL 1X Ribo A + 0.5 M KCl + protease inhibitors and 
RNasin (Promega). Cell slurry was then frozen in liquid nitrogen and thawed at 37˚C before 
this process was repeated. Freeze-thawed cells were then passed 5X through a 26G needle 
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to ensure efficient cell lysis. Lysate volume was brought up to 50 mL in 1x Ribo A + 0.5 M 
KCl + protease inhibitors and RNasin and cell lysate was clarified by centrifugation in a 
Sorvall F21 6X50y rotor at 10,000 rpm and 4˚C for 15 minutes. Clarified lysate was loaded 
into Beckman Coulter polycarbonate centrifuge tubes and centrifuged in a 50.2Ti rotor at 
40,000 rpm and 4˚ C for 4 hours to pellet ribosomes. Supernatant was removed and pellets 
were washed in 2 mL cold buffer A + 0.5 M KCl + protease inhibitors. Washed pellets were 
then resuspended by gentle agitation overnight in 2 mL buffer A + 0.5 M KCl + protease 
inhibitors at 4˚C. Resuspended ribosomes were then applied to 10-40% sucrose gradients 
buffered with buffer B + 0.5 M KCl + protease inhibitors and separated by centrifugation in a 
SW-28 rotor at 27,000x g and 4˚C for 15 hours. After the spin, gradients were fractionated 
into 1 mL fractions while A254 was monitored. Ribosomes segregated into two peaks 
representing the two ribosome subunits at roughly 2:1 60S to 40S absorbance intensity 
while a large peak of unbound factors stayed at the top of the gradient. Fractions containing 
either subunit were pooled and concentrated in Amicon centrifugal concentrators while 
being buffer exchanged into buffer C. Integrity of rRNA was determined by RNA extraction 
and urea-PAGE analysis. 
Native 43S 
HEK293F cells were grown to cell densities approaching 4 x 106 cells/mL before 
being ready to harvest. Prior to pelleting cells were left untreated (NEG) or they were 
pretreated for 3 hours with 2 mM DTT (DTT). Cell pellets were generated from 0.5 L of cell 
in 293 FreeStyle expression media and were washed in PBS before storage at -80˚C. Cell 
pellets were thawed at 37˚C and resuspended in 10 mL 1X Ribo A + protease inhibitors and 
RNasin (Promega). Cell slurry was then frozen in liquid nitrogen and thawed at 37˚C before 
this process was repeated. Freeze-thawed cells were then passed 5X through a 26G needle 
to ensure efficient cell lysis. Lysate volume was brought up to 50 mL in 1x Ribo A + protease 
inhibitors and RNasin and cell lysate was clarified by centrifugation in a Sorvall F21 6X50y 
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rotor at 10,000 rpm and 4˚C for 15 minutes. Clarified lysate was loaded into Beckman 
Coulter polycarbonate centrifuge tubes and centrifuged in a 50.2Ti rotor at 40,000 rpm and 
4˚ C for 4 hours to pellet ribosomes. Supernatant was removed and pellets were washed in 
2 mL cold buffer A + protease inhibitors. Washed pellets were then resuspended by gentle 
agitation overnight in 2 mL buffer A + protease inhibitors at 4˚C. Resuspended ribosomes 
were then applied to 10-40% sucrose gradients buffered with buffer B + protease inhibitors 
and separated by centrifugation in a SW-28 rotor at 27,000x g and 4˚C for 15 hours. After 
the spin, gradients were fractionated into 1 mL fractions while A254 was monitored. Gradients 
often showed a large 80S peak with a discernable shoulder containing 60S subunits. 
Adjacent, and more slowly migrating, was the smaller 40S containing peak desired. 
Unbound or dissociated factors were segregated to the top of the gradient. Fractions 
containing 43S particles (approximate middle of the gradient) were pooled and concentrated 
in Amicon centrifugal concentrators with careful care taken not to concentrate more than 
20% volume in an individual spin. During concentration, the buffer was exchanged for buffer 
C for storage. Concentration was determined by OD260 via NanoDrop spectrophotometer. 
Native 43S particles were stored at -80˚C at ~12-15 OD260/mL. 
 
43S PIC Remodeling by IRES RNAs 
Native 43S particles were used to assess the ability of IRES RNA binding to alter the 
composition (or remodel) intact PICs. Approximately 100 pmol 43S were used for each 
reaction. NEG or DTT 43S samples were thawed on ice before being left untreated, 
pretreated for 15 minutes at 37˚C with 3μM AS aptamer, or pretreated for 15 minutes at 
37˚C with 3μM α-eIF1A aptamer. 43S samples were then additionally treated with 5 μg IRES 
RNA for 15 minutes at 37˚C. After RNA additions the reactions were allowed to cool on ice 
for at least 5 minutes. After this, cold reactions were applied to the top of 10-30% sucrose 
gradients buffered in buffer B + protease inhibitors and were centrifuged at 36,000 rpm and 
4˚C for 3.5 hours. Gradients were fractionated into 0.75 mL fractions while the A254 was 
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monitored. 40S-containing fractions (mid gradient) were pooled and concentrated in Amicon 
filters before being subjected to western blotting to detect eIFs and/or ribosomal proteins. 
 
JFH-1 Infection 
Hepatitis C virus strain JFH-1 cDNA was transcribed, gRNA was transfected to make 
virus, and used to infect Huh 7.5 cells according to published protocols (Gottwein et al., 
2011). Huh 7.5 cells grown to 50% confluence in T-150 flasks were infected with virus at an 
MOI of 0.1 in 10mL of fresh media. The next day, media was replaced with 20mL fresh 
media. Infected cells were trypsinized and split 1:5 two days later (~100% confluent) into T- 
150s. Three days later, JFH-1-infected cells were washed, trypsinized, and pelleted in 1X 
PBS then stored -80°C. Total RNA from pellets was isolated as described above. 
Statistical Analysis 
GraphPad Prism software was used for statistical analysis. Data are expressed as 
mean values SEM. Data were analyzed by analysis of variance (ANOVA) coupled with 
post-hoc Bonferroni test for multiple pairwise comparisons. Probability values of P < 0.05 
were considered to be statistically significant and significance was indicated as  P < 0.05 = 
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HCV F CTCCCCTGTGAGGAACTACTGTCTT 
CSFV F CACCCCTCCAGCGACGGCCGAAC 
SPV-1 F GTGGTAAGTGATGTTAGTCATTG 
CrPV F AGCAAAAATGTGATCTTGCTTGTA 
CSFV R GGTATAAAAGTTCAAAGTGATTCAACTC 
SPV-1 R CTCCGAGGAGTCATCCTCATAGATTGCCATCTTAGAGAATGTCTT 
eIF1A_WT F ATGCCCAAGAATAAAGGTAAAGGAG 
eIF1A_WT R TTATCATGCGGCCGCAAGCTTGATGATGTC 
eIF1A_ΔNTT F TCTGAAAAAAGAGAACTGGTATTC 
eIF1A_ΔCTT R TTATCAAGTTTCATTGATTTTAGCATGC 
CSFV_ΔdII F ACTAGCCGTAGTGGCGAG 
HCV_ ΔdII F ACCCCCCCTCCCGCCGGGAGAG 



























Primers used in these studies 




Antibodies Used in these Studies 
 
 
Target Item no. Source 
eIF1 12496 Cell Signaling Technology 
eIF1A sc-84243 Santa Cruz Biotechnology 
eIF2α sc-11386 Santa Cruz Biotechnology 
eIF3b sc-16377 Santa Cruz Biotechnology 
eIF5B C15728 Assay BioTech 
eIF2A 11233-1-AP ProteinTech Group 
eIF2D 12840-1-AP ProteinTech Group 
rpS6 2217 Cell Signaling Technology 
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